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ABSTRACT
Analytical methods for extraction, detection, and 
quantitation of sulfadimethoxine (SDM) residues in channel 
catfish muscle and plasma were developed for a tiered 
residue monitoring program. The plasma and muscle 
concentrations of SDM and its primary metabolite in. 
channel catfish, 4-N-acetylsulfadimethoxine (N-acetyl 
SDM), were determined in SDM medicated fish. Drug 
extraction methods using matrix solid phase dispersion 
(MSPD), drug screening methods using enzyme-linked 
immunoassay (ELISA), and drug residue quantitation methods 
using high pressure liquid chromatography (LC) are 
presented. All methods were developed for the 
simultaneous extraction and analysis of the parent 
compound and metabolite. MSPD extracts of muscle or 
plasma were reconstituted in mobile phase for LC analysis 
or in a buffer suitable for use in an ELISA system. The 
performances of four commercially available ELISAs as 
screening assays were evaluated using MSPD derived 
extracts of catfish muscle fortified at concentrations of 
0, 25, 50, 100, 250 ng/g. Overall sensitivities of 98- 
100% and specificities of 71-94% were obtained for the 
four ELISAs examined. Cross-reactivity with a number of 
compounds was examined. All four assays reacted equally 
well with SDM or N-acetyl SDM. Performance results
xi
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indicated that MSPD extracts can be used in these 
immunoassays for screening catfish muscle for violative 
SDM residue levels (>100 ng parent and metabolite/g). 
Methods for the LC analysis of MSPD derived muscle and 
plasma extracts are presented and evaluated. Results of 
the LC analysis of MSPD extracts of catfish muscle and 
plasma indicated that these extracts may be used for 
quantitation of SDM and N-acetyl SDM residues at 
concentrations of 50-1000 PPB. Drug concentration ratios 
were determined for total SDM residues in channel catfish 
plasma and muscle. Fish maintained in 27°C water were 
dosed once daily for five days and sampled at intervals of 
6, 12, 24, 48, 72, 96 hours after the last dose. The mean 
plasmaimuscle total SDM residue ratio was 1.8:1. The 95% 
confidence interval for individual fish was (1.2:1,2.4:1). 
Such a tissue concentration ratio enables one to use a 
rapid screening method, such as an immunoassay, with a 
reference body fluid as an indicator of the presence of 
violative drug residues in an edible target tissue.
xii




Aquaculture is a large and rapidly growing industry. 
Seafood consumption has shown tremendous growth in the 
last 10 years and is expected to continue. This increase 
in seafood consumption and a decline in landings from wild 
fishery stocks has led to an increased demand for 
aquaculture products [1.1]. Accompanying the increase in 
seafood consumption is a heightened concern regarding the 
safety of this food source from pathogenic bacteria and 
viruses, parasites, biotoxins, and chemical residue 
hazards [1.2-1.4]. However, with the exception of certain 
shellfish, continuous and systematic seafood inspection is 
not required in the United States [1.2].
Regulatory authority for seafood safety in the United 
States is divided among a number of local, state, and 
federal agencies. The U.S. National Marine Fisheries 
Service offers a voluntary federal seafood inspection 
program. However, this voluntary program is primarily a 
product grading system and plant sanitation inspection 
service with only a quite limited number of food safety
1
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analyses performed annually. The U.S. Food and Drug 
Administration has the regulatory authority to require the 
inspection of any domestic or imported seafood product but 
such inspection is at the discretion of the agency and is 
not performed on a systematic or continuous basis [1.2]. 
Further, analytical methods for only two drugs - 
chloramphenicol in shrimp and oxolinic acid in salmon - 
have been validated for regulatory use by these agencies 
for monitoring drug residues in aquatic food resources 
[1.5-1.8]. Because of the lack of validated analytical 
methods for enforcement purposes the FDA is in the process 
of developing methods for a number of veterinary drugs 
used in a variety of cultured aquatic species [1.9]. The 
growth and increased visibility of the seafood and 
aquaculture industries and a public perception that the 
nations seafood supply is not adequately inspected have 
led to calls for a mandatory federal seafood inspection 
program similar to the ones that now exist for red meat 
and poultry [1.2-1.3].
RESIDUE ANALYSIS
Pending U.S. federal legislation concerning 
establishment of such an inspection program for seafood 
will require analytical methods that are rapid, accurate,
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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sensitive, and specific for determination of chemical 
residues in food fish [1.10]. Traditional drug residue 
screening methods, such as microbial inhibition tests, 
thin layer chromatography, and colorimetric assays, as 
presently used in poultry and red meat inspection, lack 
one or more of these characteristics. There is also a 
lack of residue screening methods suitable for use in a 
field setting by an aquaculturist for the pre-harvest 
detection of violative drug residues, a practice which 
would greatly reduce violations and consequent producer 
losses from condemnation.
A tiered approach to residue monitoring utilizes 
analytical techniques of varying sensitivity, specificity, 
and precision for chemical residue detection, 
quantitation, and identification. Such methods may be 
generally classified as 1) rapid initial screening assays 
such as microbiological inhibition tests (MIT), thin layer 
chromatography, or receptor-based assays, 2) quantitative 
methods such as high performance liquid chromatography 
(LC), gas-liquid chromatography (GLC), high performance 
thin layer chromatography, and some MITs, and 3) residue 
identity confirmatory methods such as mass spectrometry 
and infra-red spectrometry [1.11]. All require varying 
degrees of sample extraction and manipulation to remove 
target analytes. With recent improvements in analytical
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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instrumentation and the introduction of new rapid 
screening and determinative methods, a major limiting 
factor in the efficient utilization of such assays has 
been identified as the process for the extraction and 
isolation of the analyte(s) from tissues.
The classical methods of extraction that have 
traditionally been employed for analyte isolation from 
various tissue matrices involve mechanical homogenization 
and repeated sample manipulations. Such techniques are 
labor and solvent-use intensive and limit the number of 
samples that can be practically analyzed in a day. Newer 
methods of analyte isolation that eliminate many of the 
disadvantages of traditional extraction methods are needed 
if one is to fully benefit from recent advances in the 
determinative aspects of residue analysis. Isolation 
techniques that have recently become available include 
supercritical fluid extraction, solid phase extraction, 
and matrix solid phase dispersion (MSPD). Matrix solid 
phase dispersion, in particular, offers a technique for 
greatly decreasing extraction time, solvent volumes, and 
tissue mass when compared to traditional methods [1.12]. 
The relative advantages of these methods are reviewed in 
Chapter 2.
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Sulfonamides are a class of anti-bacterial compounds 
widely used for therapeutic and prophylactic purposes in 
animal agriculture. However, the use of these compounds 
in food animals may result in unwanted sulfonamide 
residues in edible tissues. The presence of such residues 
in animal origin foods may pose a health hazard to 
consumers. Chronic consumption of foods containing sub- 
therapeutic levels of sulfonamides may lead to the 
development of plasmid-mediated bacterial drug resistance. 
Further, sulfamethazine has been implicated as a potential 
carcinogen. Because of these concerns, the FDA has set 
the maximum residue limit for most sulfonamides at 100 
ng/g in meat, poultry, and aquaculture products.
Drug residue violations in the United States red meat 
and poultry industries most commonly occur with approved 
drugs not used in accordance with label directions 
[1.13,1.14]. If a similar trend holds for violations in 
the aquaculture industry, then the greatest number of drug 
residue violations would be expected for approved drugs 
that have been used in a non-approved manner. Therefore, 
efforts to develop methods for drug residue detection for 
domestically produced aquaculture products should 
initially focus on extraction and detection methods for 
the limited number of currently approved drugs. One such 
compound is sulfadimethoxine. Sulfadimethoxine is the
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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sulfonamide component of the potentiated sulfonamide 
Romet-30®, which is commonly used in channel catfish 
aquaculture. Sulfadimethoxine may, therefore, serve as a 
model for the application of new extraction and detection 
technologies to monitoring of residues in food animals and 
for the design of an overall approach to aquaculture drug 
monitoring.
One technique with potential as a residue screening 
method for regulatory laboratory and field use is the 
enzyme-linked immunosorbent assay (ELISA). Enzyme-linked 
immunosorbent assays for detection of chemical residues 
are relatively inexpensive, easy to use, require no 
special equipment, and are commercially available. They 
also provide the sensitivity and specificity required for 
residue monitoring at tolerance [1.15], The sequential 
use of MSPD for drug extraction and ELISA for drug 
detection can accommodate the need for rapid, practical, 
and efficient extraction, and also provide the sensitivity 
and specificity required for a drug residue monitoring or 
surveillance program. Application of combined techniques 
to food animal tissues would result in a more efficient 
residue monitoring program by increasing the number of 
samples analyzed, by decreasing the turnaround time for 
sample analysis, and by providing a method for pre-harvest 
residue determination on site.
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However, the simplest residue screening method is one 
that uses the presence of the drug and/or its 
metabolite(s) in a reference biological fluid to indicate 
the presence of violative residues in a target tissue(s) 
and does not require tissue extraction. Before such a 
technique can be implemented, a relatively constant 
relationship between the drug concentration in the target 
tissue and the reference biological fluid must be 
demonstrated. The correlation between plasma drug 
concentration (central compartment) and muscle drug 
concentration (peripheral compartment) is the basis for 
pharmacokinetic principles and residue depletion time 
estimation [1.16,1.17]. For compounds where a stable 
correlation between plasma/muscle concentrations can be 
experimentally determined, plasma may be used directly in 
a screening assay, such as an ELISA, for prediction of 
violative drug residues in muscle.
Tolerances for animal drugs, as set by the FDA, are 
often based on total residue present, including parent 
drug and all metabolites, in edible tissues [1.18]. A 
marker residue, parent compound or metabolite, is often 
used to indicate the total residue present in the target 
tissue of interest. To establish such a marker residue, a 
constant relationship between marker residue concentration 
and total residue in the target tissue(s) over the
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
concentration range of interest must be known.
Nonetheless, such information is often lacking for drug 
behavior in non-approved species or for non-approved drug 
uses. In the absence of such information, extraction, 
detection, quantitation, and confirmatory methods should 
be capable of simultaneous extraction or analysis of the 
parent drug and its important metabolites.
The primary metabolite of sulfadimethoxine (SDM) in 
channel catfish is 4-N-acetylsulfadimethoxine (N-acetyl 
SDM)[1.19]. However, because the ratio of parent SDM:N- 
acetyl SDM over a range of tissue concentrations, 
including tolerance (100 ng SDM/g), is not known, there is 
a need for a chromatographic assay to quantify these two 
compounds simultaneously about tolerance. Such a 
chromatographic system would also enable determination of 
recovery of both compounds when using MSPD extraction. 
Additionally, information concerning the relative degree 
of cross reactivity of this metabolite and other compounds 
with available ELISAs is required to properly interpret 
test results.
Suspect samples, identified by screening assays 
require further confirmation of the concentration and 
identity of the drug/metabolite for regulatory action. 
Quantification and identification of veterinary drug 
residues is most commonly accomplished with high
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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performance liquid chromatography (LC) or gas-liquid 
chromatography (GLC) combined with mass spectrometry. 
However, there are presently no LC methods available for 
the simultaneous determination of SDM and N-acetyl SDM in 
channel catfish.
PURPOSE
In summary, a model residue monitoring program 
applying new or improved methods for extraction, 
screening, quantification, and identification of drug 
residues in aquaculture species is needed. Protocols for 
such a program may include MSPD for drug isolation, ELISAs 
for initial detection, and LC methods for quantification 
and presumptive identification. Alternately, where a 
tissue concentration relationship between a biological 
fluid (plasma) and target tissue (muscle) can be 
demonstrated, the use of such a fluid, not requiring 
extraction, may be used for initial residue screening.
It is the purpose of this research to develop the 
analytical methods and basic tissue compartment 
concentration relationships required for a drug residue 
monitoring program for sulfadimethoxine residues in 
channel catfish. Specific research needs for the creation 
of such a program include the development of matrix solid
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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phase dispersion techniques for the simultaneous 
extraction of SOM and N-acetyl SDM in plasma and muscle, 
evaluation of MSPD-derived extracts in commercially 
available immunoassays, development of LC methods for 
plasma and muscle for the simultaneous analysis of SDM and 
N-acetyl SDM, and a residue depletion study with groups of 
fish sacrificed at various time points in order to 
characterize the relationship of SDM concentrations in 
channel catfish plasma and muscle. The following chapters 
offer a review of the literature concerning historical and 
present seafood inspection protocols for chemical residues 
in aquatic food resources and present the results of 
methods development research for development of a model 
drug residue monitoring program for aquaculture.
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CHAPTER 2
REVIEW OF LITERATURE 
EXTRACTION AND ANALYSIS OF DRUGS 
IN AQUATIC SPECIES 
INTRODUCTION
Aquatic resources are monitored for the presence of 
tissue residues of chemical agents for two main reasons:
1) for food safety— to identify and remove from commercial 
markets any edible tissues that contain potentially 
hazardous levels of drug or other chemical residues and 2) 
for environmental monitoring— to help identify 
geographical areas where environmental quality may have 
been significantly compromised. This review will focus 
primarily on the food safety aspects of veterinary drug 
residues in aquaculture products.
With increasing reliance on aquatic species as a 
source of dietary protein there is a strong public 
interest in the safety of edible aquatic resources. This 
interest is based on concerns about potential unacceptable 
health risks associated with eating fish containing 
residues of veterinary drugs, agricultural pesticides, and 
environmental pollutants [2.1]. Such residues may exist
13
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in fish bought by consumers in commercial markets or in 
fish caught for recreational purposes from rivers, lakes, 
and oceans. Further, seafood sold in the markets of one 
country may often have been imported from another with 
different regulatory policies concerning drug and 
pesticide use in aquatic environments. For example, 
imports accounted for over 60% of the fish and shellfish 
consumed in the United States in 1990 [2.2]. Therefore, 
analytical methods are needed for compounds that may be 
present in domestic or international products. There is 
also a need for an international consensus regarding 
residue levels and concerns.
In this regard, the Joint Food and Agriculture 
Organization (FAO)/World Health Organization (WHO) Expert 
Committee on Food Additives (JECFA) serves as a scientific 
advisory body to FAO, WHO, the Codex Committee on Residues 
of Veterinary Drugs in Foods (CCRVDF), and the Codex 
Committee on Food Additives and Contaminants, concerning 
the safety of residues of food additives, contaminants, 
and veterinary drugs. Recommended acceptable daily intake 
and maximum residue level (MRL) for many of these 
substances have been proposed by JECFA and are used by 
many countries to formulate regulations regarding chemical 
residues in foods— including aquatic food resources. The 
analytical needs of an effective residue monitoring 
program are in part determined by the MRLs as set by a
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nation's regulatory authorities. Appropriate analytical 
methods for these programs are recommended by the CCRVDF.
A listing of reports and other documents published by the 
JECFA is available [2.3].
Although aquatic species are sporadically monitored 
for veterinary drugs and various environmental 
contaminants, fish products are not required to pass 
unified continuous federal inspection. Additionally, some 
of the existing seafood inspection efforts are not 
designed to be of direct use in evaluating many aspects of 
seafood safety concerns. This is due in part to the fact 
that the present voluntary seafood inspection program 
administered by the National Marine Fisheries Service of 
the U.S. Department of Commerce is primarily a plant 
sanitation and product grade inspection program. It is 
not designed to be of direct use in evaluating the safety 
of aquatic food products in regards to chemical residues, 
although a limited number of chemical residue analyses are 
done [2.4]. The U.S. Food and Drug Administration has 
regulatory authority under the Food Drug and Cosmetic Act, 
the Public Health Service Act, and other acts to assure 
seafood product wholesomeness. This authority includes 
mandatory inspection of seafood processing plants and 
products, and regulation of aquaculture products, drug 
use, and aquaculture production practices [2.4,2.5]. The 
FDA has announced its intention to implement a Hazard
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Analysis Critical Control Point (HAACP) program to help 
ensure seafood product safety and has begun testing 
domestic and imported aquaculture products for residues of 
the veterinary antibacterials chloramphenicol and oxolinic 
acid [2.6,2.7]. The FDA is also in the process of 
developing additional analytical methods for a numbe r  of 
veterinary drugs used in aquaculture [2.8] Nonetheless, 
fish products are not at present monitored on a continuous 
basis by any regulatory agency for residues of the 
veterinary drugs used domestically or internationally in 
aquaculture. Further, efforts at drug residue monitoring 
are hampered by a lack of personnel and a dearth of 
legally defensible methods of residue analysis [2.4].
As a result of public concern over the safety of 
seafood, the failure of environmental and drug monitoring 
programs to contribute valuable residue data for human 
food analysis, and the fact that present seafood 
monitoring and inspection programs lack both the frequency 
and direction sufficient to ensure effective 
implementation of current regulatory limits for seafood 
safety, several governmental bodies, including the U.S. 
government, have declared their intention to develop a new 
seafood inspection system [2.4,2.5]. There is early 
recognition that the key to the success of this new system 
will be development and application of more efficient and 
cost-effective analytical methods.
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Several classes of chemicals that will need to be 
included in any aquatic food safety program and in 
existing and future environmental monitoring programs are 
veterinary drugs, agricultural pesticides, and industrial 
pollutants [2.4,2.9]. This review offers an overview of 
present methods of veterinary drug residue analysis as 
used in domestic farm animals, their potential 
applicability to aquatic species, and a summary of 
existing methods for the analysis of many of the drugs 
used in aquatic species. Several major drawbacks of the 
methods are discussed and three relatively new methods 
that offer solutions to these problems are described.
DRUG RESIDUE PROBLEMS IN AQUACULTURE
Diseases are the single most important cause of 
economic loss in intensive aquaculture and necessitate the 
use of antibacterial and other therapeutic compounds to 
maintain the health and production of cultured species 
[2.2], Although there is a degree of variability there 
are numerous therapeutants which are consistently used 
worldwide in aquaculture [2.10-2.13]. These agents belong 
to a wide range of chemical and therapeutic classes such 
as antibacterials (e.g., sulfonamides and potentiated 
sulfonamides, aminoglycocides, j8-lactams, tetracyclines, 
quinolones, macrolides, etc.), parasiticides (e.g.,
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mebendazole and dichlorvos), disinfectants, pisicides, 
herbicides, algacides, anesthetics, water treatments, and 
dyes. This large range of chemical classes presents a 
problem for effective residue monitoring, and requires the 
use of screening tests to adequately detect the presence 
of illegal residues.
A residue may be defined as "any compound present in 
edible tissues of the target animal that results from the 
use of the sponsored compound, including the sponsored 
compound, its metabolites and any other substances formed 
in or on food because of the sponsored compound's use" 
[2.14,2.15]. Metabolites are considered to be as toxic as 
the parent compound unless shown otherwise [2.14,2.15]. 
Under the FDAs general food safety requirements for 
metabolism studies, individual metabolite identification, 
concentration, and persistence should be obtained for 
metabolites comprising 100 ppb or >10% of the total 
residue (whichever is lower) at zero withdrawal [2.16].
For approved veterinary drugs used in accordance with 
label directions, a marker residue (Rm)(parent compound or 
metabolite) is often used to indicate the total residue 
level in a target tissues(s). However, for drug residue 
surveillance in cases of extra-label drug use where such 
concentration relationships are lacking, the extraction 
and analytical methods used must be capable of providing 
extraction and analysis for both the parent drug and its
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important metabolites present at or less than MRLs in the 
tissues of interest.
However, MRLs are not always static. Toxicological 
data are always being updated and the JECFA periodically 
issues recommendations for MRLs based on such available 
toxicology information for selected veterinary drugs, 
including those used in aquaculture. Many countries have 
established MRLs based on JECFA recommendations for a 
number of these compounds. A listing of WHO publications 
containing JECFA recommended MRLs is available [2.3].
The use of therapeutants in aquaculture not only may 
result in unacceptable residues in edible tissues but also 
in the environment. Drugs used in aquaculture may be 
directly introduced into the environment, as with 
ectoparasiticides, or indirectly introduced in medicated 
feeds (via non-consumption of the feed, poor 
bioavailability, and limited biotransformation). The 
environmental degradation, accumulation, and persistence 
of these agents is affected by water temperature, sediment 
microenvironment, and factors affecting dispersion [2.17]. 
It has been estimated that 70 to 80% of orally 
administered oxytetracycline remains in the environment
[2.18]. Furthermore, there are large variations in the 
persistence of antibiotics in sediments from fish farms. 
Furazolidone exhibits a very short half-life (18 hr.)
[2.19] and oxytetracycline a half-life of 32 to 64 days
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depending on sediment conditions [2.18]. The 
environmental fates [2.17-2.26] and effects [2.19,2.27- 
2.32] of several compounds commonly used in aquaculture 
have been the subject of recent studies. However, the 
environmental metabolism, fate, and effects of most drugs 
introduced into the aquatic environment is poorly 
understood and relatively few methods are available for 
the multitude of compounds, environmental matrices, and 
environmental conditions that are of importance in 
assessing the environmental impact of these compounds.
The National Environmental Policy Act of 1969 requires an 
environmental impact assessment for aquaculture drug 
approval in the United States [2.33,2.34], and the FDA has 
proposed a requirement that each new animal application 
include a section on the environmental effects of the use 
of the drug [2.35]. Additionally, periodic monitoring of 
fish farm effluents for drug residues may be required. 
Therefore, methods of analysis of therapeutic agents in 
environmental samples are now part of the drug approval 
process and should be part of our continuing environmental 
concern.
Development of new methods of analysis of 
therapeutants was identified at a recent joint FDA-U.S. 
Department of Agriculture (USDA) sponsored Interregional 
Research Project Number 4 (IR-4) meeting as a priority 
need in aquaculture [2.36]. In general, new methods for
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veterinary drug residue analysis in aquatic species are 
needed for screening, quantitating, and confirming tissue 
residues of drugs used domestically and those present in 
imported aquacultural products. The methods should also 
be suitable for analyzing environmental samples for drug 
and contaminant residues.
Because efficient, cost-effective, universal methods 
for the extraction, detection, quantitation, and 
confirmation of these residues in aquatic matrices do not 
exist, the need for a better approach to analysis has 
recently been acknowledged. The research and development 
plans of regulatory agencies, such as the FDA, currently 
include commitments to increase and improve capabilities 
for testing for veterinary drug residues in aquaculture 
products [2.8,2.37,2.38].
METHODS OF DRUG RESIDUE ANALYSIS IN AQUATIC 
SPECIES
Regulatory agencies require practical analytical 
methods for detecting, quantifying, and identifying 
violative residues that may occur in food animal tissues. 
These agencies use available methodology for monitoring 
and surveillance and for enforcement action. However, 
practical methods are not available for many compounds of 
interest that may occur as tissue residues. Further, the
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reliability of analytical results obtained with some 
'official' methods may be questioned. For enforcement of 
regulatory limits for chemical residues in any food 
animal, analyses employed must withstand legal challenges 
for reliability and accuracy.
Accordingly, the FSIS categorizes analytical methods 
into three levels according to their intended use for 
screening, quantitation, or confirmation; and within each 
level by the method's relative degree of validation, the 
confidence that may be placed in test results, and it's 
suitability for regulatory action. Validation is the 
process of assuring that an analytical method is capable 
of performing as intended with acceptable accuracy and 
sensitivity. The most widely accepted procedure for 
validation is the interlaboratory collaborative study
[2.39]. However, interlaboratory validation is often not
possible for the multitude of compounds and matrices a 
regulatory laboratory must examine. Therefore, standard 
evaluation criteria for detection and quantitation of 
analytes may be used [2.40]. The term 'official 
validation' may refer to validation by the Association of 
Official Analytical Chemists International (AOAC) or 
validation by a regulatory agency. The US Department of 
Agriculture, Food Safety and Inspection Service (FSIS) 
classifications for method status are listed as follows in
decreasing order of confidence of result:
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A. AOAC Official Methods. These are methods published 
in the AOAC publication Official Methods of Analysis 
[2.41]. Interlaboratory validation of these methods has 
been obtained with five or more participating 
laboratories. Such methods are considered the most 
authoritative and legally defensible methods for residue 
analysis [2.39]. Seven methods are listed as AOAC 
Official Methods of Analysis (AOAC/OMA) for the detection 
of antibacterials in milk, but only three official methods 
are listed for the detection of antibacterial residues in 
other food animal tissues, and no methods are listed for 
veterinary drug residue determination in aquatic food 
resources [2.41].
B. Validated Methods. These methods have been subjected 
to an interlaboratory study in two or three laboratories 
with at least three independent analysts and the results 
peer-reviewed by government scientists.
C. Federal Register Methods. This group includes 
analytical methods published in the Federal Register and 
later incorporated into the Code of Federal Regulations.
D. Historical Official Methods. Methods that were 
regarded as the best available at the time of initial 
acceptance and are in continued use due to the absence of 
improved methods.
E. Non-Validated Methods. Methods for quantitation 
and/or identity confirmation that have not undergone a
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collaborative study involving at least three independent 
analysts.
F. Published Methods. These methods have undergone 
study by a single analyst or laboratory and the data peer- 
reviewed by government scientists.
G. Correlated Methods. These methods have not been 
subjected to interlaboratory study, but results obtained 
with the method have been compared to results obtained 
with a current method for regulatory enforcement using the 
same samples and the data peer-reviewed by government 
scientists.
A tiered approach to residue monitoring employs 
methods for screening, quantitation, and confirmation.
The FSIS has classified analytical methods into three 
levels based on relative combinations of accuracy, 
specificity, and practicality. Each of the three levels 
may contain methods classified by validation status as 
given above.
Level I — These are assays that provide unequivocal 
data concerning concentration and identity of the analyte 
at the level of interest. Level I methods have the 
highest level of credibility and are often combinations of 
two or more assays such as gas liquid chromatography/mass 
spectrometry or high performance liquid chromatography/ 
mass spectrometry.
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Level II — These are assays used to determine analyte 
concentration and perhaps provide presumptive 
identification based on retention time, UV spectrum, or 
biochemical characteristics but do not provide unequivocal 
results. Level II methods include various chromatographic 
and microbial inhibition assays.
Level III — This level includes screening methods to 
indicate the presence or absence of an analyte or class of 
compounds in food animal tissues. These assays are used 
because of their high throughput or field applicability, 
but results from these tests require verification by Level 
I or II methods for regulatory action [2.9]. Alternately, 
some Level II methods may be used as screening assays when 
they are applied to reference biological fluids to 
indicate the residue level in the target tissue of 
interest [2.42].
All official methods for the analysis of drugs in 
animal tissues published in the AOAC/OMA [2.41], FDA 
Animal Drug Analysis Manual (ADAM) [2.43], or the FSIS 
Compound Evaluation and Analytical Capability Manual 
(CEACM) [2.9] are for use with red meat, poultry, or milk, 
although some of the methods could likely be adapted for 
use with tissues from aquatic species. The FDA's 1973 
Food Additives Analytical Manual (FAAM) [2.44] contains 
methods of residue analysis supplied by the manufacturer 
as a part of a new animal drug application - including
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drugs for use in aquaculture. Some FAAM methods have been 
evaluated in FDA laboratories, but very few have undergone 
complete AOAC validation. The FAAM will be inactivated 
once the methods listed in the FAAM are incorporated in 
the ADAM [2.43].
Many of the methods currently being used by 
monitoring agencies for residue analysis in red meat and 
poultry are based on 'classical' methods of extraction and 
analysis [2.9]. Some of these methods have undergone 
rigorous multi-laboratory calibration studies and work 
well under certain conditions and for certain purposes. 
Perhaps the greatest drawback to their continued use is 
their inefficiency as screening methods. Some of the 
methods are sufficiently complex as to not allow the 
generation of relevant data in time to prevent 
contaminated foods from entering the marketplace and 
analytical results are often obtained too late to prevent 
enforceable removal of the contaminated product. 
Additionally, the complexity of these methods and the 
length of time required to perform them limits the number 
of samples that can be practically analyzed in a day.
A variety of methods for the analysis of drugs in 
aquatic species have been published in the literature. 
However, a review of the literature for analytical methods 
used to extract and quantitate residues of therapeutic 
agents used in aquatic species reflects the confusion
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currently felt in the field concerning which protocols are 
most efficient, accurate, reliable, and cost-effective 
(Table 2.1 [2.45-2.97]). Additionally, only one inter­
laboratory validation study for a veterinary drug residue 
analytical method for use with aquatic food products was 
found [2.98] although a second validated method is in 
press [2.99].
Since there is presently only one validated method 
for the analysis of veterinary drugs in aquatic species, 
an opportunity exists to introduce analytical methods for 
this purpose which utilize improved methods of extraction, 
screening, and determination rather than simply adapting 
existing methods used in other inspection programs. A 
number of analytical techniques developed in the last 
decade can potentially be employed in a drug residue 
monitoring program for food fish.
Recently introduced drug screening methods include 
radioimmunoassay, competitive bacterial receptor binding 
assay, enzyme immunoassay, high performance thin layer 
chromatography, and several forms of bioautography. At 
present such residue screening methods are not validated 
by any federal agency [2.100]. The development of rapid 
screening tests that are practical and rugged would allow 
for routine monitoring and surveillance of larger numbers 
of samples in a shorter time period with greater 
sensitivity and selectivity than is often currently
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available using conventional methods. Use of screening 
methodology also allows chromatographic instrumentation to 
be reserved for confirming positive samples. The 
development of such screening tests may soon be required 
by many governments as a part of the methods package 
needed for drug approval of new animal drugs [2.14].
Further, present methods of analysis as used by 
several regulatory agencies have failed to fully utilize 
the dramatic improvements in reliability and sensitivity 
that determinative methods such as LC, GLC, and MSD have 
undergone in the last decade. Likewise, advances in 
extraction methodology have not been fully implemented. A 
review of traditional and recently introduced methods for 
veterinary drug residue isolation and determination 
follows this section.
MICROBIAL INHIBITION TESTS
Antibacterials have historically been detected in 
animal tissues and fluids by microbial inhibition tests 
(MIT) and these tests continue to be in wide use. All 
MIT's are based on the inhibition of bacterial growth by 
residues of antibacterial compound(s) present in a 
biological fluid or tissue. Early assays for 
chlortetracycline and oxytetracycline residues in milk 
utilized reduction of methylene blue as an indicator of
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 9
bacterial growth, and therefore, the absence of the drug 
[2.101,2.102], Numerous MITs for the detection and 
quantitation of antibacterials in fish tissues have since 
been described [2.103-2.111]. MITs are relatively simple 
to use, detect many classes of antibacterial compounds, 
and selective sensitivity for specific classes of 
antibacterials can be obtained by changes in the culture 
medium, indicator bacteria, or pH [2.112,2.113]. However, 
these methods often lack the specificity and sensitivity 
required for residue detection at MRLs, may be affected by 
non-specific inhibitors, do not detect microbiologically 
inactive metabolites [2.114], and often have a 20-24 hour 
incubation time. Imprecision occurs as a result of zone 
size differences between replicate plates. Zone size may 
vary as a result of differences in agar layer thickness, 
agar quality, uneven seeding of bacterial spores on the 
agar surface, or incubator temperature variation [2.115]. 
Additionally, bacteriostatic drugs such as sulfonamides 
result in a diffuse zone while bacteriocidal drugs provide 
a sharply defined zone of inhibition.
Plate assay MITs are performed by streaking a uniform 
suspension of indicator bacterial spores over an agar 
medium. Swabs or disks soaked in a body fluid are placed 
on the plate and incubated. A positive control is 
provided by a neomycin sensitivity disk. The observed end 
point can be a zone of inhibition surrounding a sample or
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a color change resulting from pH changes. MITs currently 
in use by the USDA-FSIS for screening red meat and poultry 
tissues for antibacterial residues are the Swab Test On 
Premises (STOP), Live Animal Swab Test (LAST), and the 
Calf Antibiotic and Sulfa Test (CAST) [2.116]. The USDA- 
FSIS is currently evaluating the Fast Antibiotic Screen 
Test (FAST) as a replacement for the STOP and CAST methods 
[2.117]. All of these MITs can potentially be adapted for 
use with aquatic animal tissues.
SWAB TEST ON PREMISES
The STOP test is used to detect antibiotic residues 
in kidney and other tissues of slaughter animals [2.118]. 
The STOP method is relatively simple and requires only a 
few minutes of analyst time [2.119]. A cotton swab is 
inserted directly into the meat sample, left in place for 
thirty minutes, and the cotton tip placed on a test plate 
containing Difco Antibiotic Medium No. 5 previously 
streaked with a spore suspension of Bacillus subtilis.
The plate is incubated at 29°C overnight (16-20h) and 
observed for inhibition of bacterial growth surrounding 
the swab. Johnston et al, reported 94% agreement with 
results of STOP and standard microbial assays [2.120]. 
Korsrud and MacNeil [2.112] reported varying sensitivity 
with different media using standard solutions of
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tetracyclines. With the standard Antibiotic Medium No. 5, 
limits of detection (LOD's, ppm) were 6.2 (CTC), 3.1 
(OTC), and 1.6 (TC). With Antibiotic Medium No. 2, LODs 
were 0.06 (CTC) and 1.6 (OTC and TC). Minimal detectable 
levels using Antibiotic Medium No. 5 as reported by 
Johnston, et al. [2.118], were 0.01 ppm (CTC) and 0.08 ppm 
for OTC and TC. In a comparison of STOP, high performance 
liquid chromatography (LC), MIT, and thin-layer 
chromatography-bioautography (TLCB) by MacNeil, et al. 
[2.120], STOP lacked the sensitivity of LC but had greater 
or lesser sensitivity for OTC than TLCB or MIT depending 
on the growth medium used.
CALF ANTIBIOTIC AND SULFA TEST
The CAST procedure was introduced by the USDA to 
increase sulfonamide detection sensitivity in bob veal 
calves and was the first test available for pre-slaughter 
determination of sulfonamide and antibiotic residues.
This test is also sensitive to a variety of other 
antimicrobials including tetracyclines, and the degree of 
inhibition varies with the compound tested [2.121]. The 
CAST procedure is similar to the STOP and LAST but uses 
Mueller-Hinton Medium and Bacillus megaterium ATCC 9885 as 
the indicator bacteria, and is incubated at 44°C [2.122]. 
Plates are read as for the STOP procedure and kidney is
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used as the sample tissue. Korsrud and MacNeil [2.112] 
reported the CAST procedure was more sensitive than the 
STOP procedure for standard solutions of 22 antibiotics 
tested including CTC, OTC, and TC. Minimum detectable 
levels (ppm) were 0.2 (CTC), 0.8 (OTC), and 0.4 (TC).
LIVE ANIMAL SWAB TEST
The LAST procedure is a modification of the STOP 
procedure differing only in the amount of B. subtilis used
[2.123]. It is used for preslaughter field screening of 
residues in urine and for prediction of residues in edible 
tissues. It was the first on-farm test available for 
screening live cattle for possible residues and is based 
on the correlation between urine and tissue residue 
levels. Urine or blood samples may be used [2.123,2.124]. 
Two sterile swabs are dipped in a urine sample and placed 
on the LAST plate containing Antibiotic Medium No. 5 
streaked with B. subtilis ATCC 6633 spores. A neomycin 
disc is used as a positive control, and incubation and 
test interpretations are carried out as is done for the 
STOP procedure. Several reports indicate a high incidence 
of false positive results using the LAST assay. In one 
study 75% (15 of 20) of untreated cows showed a positive 
result [2.125]. Tritschler et al. [2.123], reported 5.4% 
positive results and 19.9% questionable results from 221
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untreated dairy cows and heifers. TerHune and Upson 
[2.126] had varying results for LAST detection of OTC when 
compared to standard quantitative OTC MIT procedures.
LAST was 100% accurate when urine OTC concentration was 
>4.3 iiq/Tnl and 60% accurate when urine OTC concentration 
was <4.3 ficf/ml. Some 20% of LAST results were false 
positive and 20% were false negative. False positive 
results were associated with high urine osmolarity and 
high urine pH, apparently resulting in inhibition of 
bacterial growth. False negative samples were associated 
with dilute urine. In this study LAST was 100% accurate 
in detecting OTC in the urine and predicting tissue OTC 
residues when OTC concentration was at therapeutic levels. 
However, LAST did not detect OTC in the urine or predict 
OTC concentrations of 0.1-0.4 ppm in tissue.
FAST ANTIBIOTIC SCREEN TEST
The Fast Antibiotic Screen Test (FAST) is a new 
procedure under evaluation by USDA-FSIS and provides 
results within 6 hours. It has undergone field trials 
involving 10,000 samples for comparison with STOP and CAST 
for sensitivity. The FAST assay is similar to the CAST 
procedure but the FAST growth medium contains sugar and a 
purple dye. Bacterial metabolism of the sugar results in 
acid production causing a color change from purple to
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yellow for the pH-sensitive dye used. A sterile cotton 
swab is saturated with fluid from a tissue sample and 
placed on a plate of growth medium streaked with bacterial 
spores and incubated for 6 hours. A purple zone 
surrounding the sample swab indicates the presence of 
antimicrobial agent(s) [2.117].
DELVOTEST P
This test is a qualitative color reaction test based 
on acid production by Bacillus stearothermophilius var. 
calidolactis. The lowered pH changes the color of 
bromocreosol purple to yellow. If antibacterials are 
present, bacterial growth is inhibited and the purple 
color remains. Delvotest P is an AOAC Official Method for 
0-lactams in milk. Sensitivity for 0-lactams is > 0.005 
IU/ml milk. 0-lactam residue is confirmed using 
penicillinase [2.41]. It will also detect a wide range of 
antibiotics including TC at 0.2 fig/ml and OTC at 0.3 fig/ml
[2.124]. Macaulay and Packard reported 11% false 
positives with this test [2.127]. Delvo P is simple to 
run and the color change is easily evaluated as blue vs 
yellow. A disadvantage is the 2.75 hr analysis time.
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BRILLIANT BLACK REDUCTION TEST
The Brilliant Black Reduction Test is another 
qualitative color reaction test and can be used to detect 
antibiotic residues in milk and tissue. Bacillus 
stearothermophilus is the test organism used with an assay 
medium containing brilliant black indicator. The assay 
medium remains blue if bacterial growth is inhibited by 
antibiotic residues, but if no residues are present the 
growth of the bacteria reduces the indicator to a yellow 
color. Limit of detection of tissue extracts for OTC is 
0.1 /jg/ml [2.128].
BIOAUTOGRAPHY
Several residue analysis methods employing a blend of 
physicochemical separation procedures and bacterial growth 
inhibition techniques have been reported. Microbial 
inhibition techniques applied to sample extracts separated 
by various techniques include paper chromatography- 
bioautography [2.129], thin layer chromatography- 
bioautography (TLCB) [2.120,2.130-2.132], and 
electrophoresis-bioautography [2.133]. In these 
techniques developed chromatographic plates or 
electrophoresis gels are placed on bacterial growth medium 
seeded with B. subtilis. The location of zones of
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inhibition are used to identify specific antibiotic 
residues. The sensitivity of the method can be adjusted 
and antibiotic residue determination is quantitative.
Electrophoresis-bioautography is usually preceded by 
a set of MITs and antibiotic identification is based on 
initial MIT results, electrophoretic migration distance, 
and the appearance of the zone of inhibition. This assay 
has been applied to milk and meat samples for residue 
determination and provides qualitative or semi- 
quantitative results. It is however, unlikely to allow 
resolution of related compounds within a drug class 
[2.133]. TLCB is discussed under thin layer 
chromatography.
COLORIMETRIC METHODS
The Bratton-Marshall method, first introduced in 
1939, was the mainstay of sulfonamide residue test methods 
for several decades [2.134-2.136]. However, because of 
relatively high background readings from naturally 
occurring primary aromatic amines and cross reactivity 
with other primary aromatic amines, these methods 
generally lack the sensitivity and specificity required 
for residue analysis at tolerance [2.136], As a result, 
the FSIS has largely replaced these methods with TLC and
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immunoassay for sulfonamide analysis in domestic food 
animal tissues [2.9].
A number of colorimetric assays based on the Bratton- 
Marshall procedure have been published for several 
compounds used in aquaculture in a variety of species. 
These assays have also been frequently used in 
experimental studies [2.137-2.140], A 1981 review of 
methods for sulfonamide residue analysis in animal tissues 
is offered by Horwitz [2.135,2.136]. Specific 
applications of the Bratton-Marshall method used with 
aquatic species include the analysis of sulfamerazine in 
rainbow trout [2.44,2.135], sulfadimethoxine in channel 
catfish, salmonid, and lobster tissues [2.141], and 
sulfachloropyridazine in channel catfish plasma [2.140]. 
Bratton-Marshall colorimetric methods have also been 
reported for the analysis of the fish anesthetics tricaine 
methane sulfonate [2.137] and benzocaine [2.138] as 
residues in several fish species. The limit of 
quantitation of these assays is in the PPM range which 
limits their usefulness for residue analysis at tolerance 
[2.136,2.137].
RECEPTOR BASED ASSAYS
Ligand receptor techniques that show promise as 
screening methods for aquatic species include immunoassays
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[2.142-2.144], bacterial cell receptor assays [2.145], and 
radioimmunoassays [2.146,2.147]. These techniques have 
great potential applicability to regulatory monitoring 
programs, but their efficient utilization is often limited 
by lengthy tissue preparation procedures. To fully 
utilize the speed and simplicity of these tests they must 
be combined with newer extraction methods, or used with a 
reference biological fluid not requiring extraction to 
indicate the residue level in a target tissue. Still, the 
ability of these screening assays to accurately identify 
positive and negative samples must be evaluated based on 
performance parameters such as sensitivity, specificity, 
cross-reactivity, predictive values (positive and 
negative) and efficiency before the test can be included 
in a residue monitoring program.
BACTERIAL CELL RECEPTOR ASSAY
The Charm II test is a proprietary competitive 
microbial receptor binding assay that can detect residues 
of seven classes of antibiotics and is the only AOAC 
Official Method of Analysis for sulfonamides and 
tetracyclines in milk [2.41]. Methods for examination of 
other matrices such as serum, plasma, urine, honey and 
extracts of egg, muscle, liver, or kidney are available 
but are not validated by the AOAC. The test instructions
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also contain a method for analysis of sulfadimethoxine 
residues in fish muscle [2.145]. The Charm II test 
requires 12-15 minutes per individual drug class test 
[2.148]. In this assay, microbial cells possessing 
specific antibacterial class receptor sites are added to 
milk or tissue extract containing added 3H or 14C labelled 
drug. The radio-labelled drug competes with the residue 
of compounds of a drug family that are present in the 
sample for the available bacterial receptor sites. 
Following centrifugation, the sample is decanted, the 
precipitate resuspended, combined with scintillation fluid 
and its activity measured using a scintillation counter. 
Sample activity is compared to a decision point obtained 
using the mean of six replicate fortified samples ± 15%. 
The sample level of radioactivity is inversely related to 
the residue level of the sample. The level of 
radioactivity used (0.5 /iCi/jmol, 0.052 /xCi/test) is 
exempt from Nuclear Regulatory and Agreement State 
regulations [2.145]. Limits of detection (ppb) in milk 
are 3 (CTC), 6 (Democycline), 100 (DC), 4 (MC), 5 (OTC), 
and 1 (TC). Serum, urine, and egg LODs are 100 for TC
[2.145].
Several comparisons of the Charm II with other 
methods of residue analysis for milk have been reported. 
Brady and Katz reported confirmation of Charm II test 
results for CTC by a comparison with MIT assays. Nine
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samples positive for TC with the Charm II were confirmed 
positive by MIT [2.149], However, Collins-Thompson, et 
al. reported that 40 of 48 milk samples positive for TC by 
the Charm II test were negative by disc assay, and 8 
showed indistinct zones of inhibition. Increased 
sensitivity of the Charm II and a possible unknown 
interfering factor were suggested [2.150], Charm and Chi 
reported a 2.3% incidence of false positives for TC in 
milk [2.148], and Senyk et al. reported no false positives 
for TC in milk [2.151].
Because the bacterial receptors bind a functional 
group of the drug, rather than a side chain as with 
immunoassay tests, the Charm II test provides detection of 
a class of antibacterial compounds rather than a single 
compound. Although this test can detect a number of drugs 
within a class, the relative sensitivity of the test to 
individual drugs varies. The Charm II test sums, although 
not in a linear manner, concentrations of various drugs 
within the same class in a sample. The Charm II test 
performed inconsistently among analysts and laboratories 
in FDA studies [2.152-2.154]. Although the Charm II has 
been proposed as a confirmatory method [2.149,2.155], the 
non-specific nature of the test, its variable sensitivity 
for individual drugs within a drug class, and the 
relatively high rate of false positive results restricts 
this test to use as a screening assay.
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RADIOIMMUNOASSAY
Although radioimmunoassays (RIA) are characterized by 
high sensitivity and specificity, relatively few methods 
have been published for RIA detection of drug residues in 
fish. In a pharmacokinetic study, Rolf et al. used RIA 
for gentamicin quantitation in channel catfish plasma
[2.146], and Rattenberger et al. used RIA to examine 
chloramphenicol depletion in rainbow trout plasma and 
muscle [2.147]. Additionally, RIA methods for detection 
of chloramphenicol residues in several red meat and 
poultry products and evaluations of their performance as 
residue screening tests are available [2.156,2.157]. The 
FSIS analytical manual lists RIA as a screening method for 
residues of zeranol and it's metabolite taleranol in 
cattle liver and muscle [2.9], and Daeseleire et al. 
reported a combined LC and RIA procedure as a screening 
method for 19-nortestosterone and methyltestosterone 
residues in beef muscle tissue [2.158].
In addition to the Charm II Bacterial Receptor Test, 
Charm Sciences, Inc. also markets Charm II Antibody Tests 
for the detection of several antimicrobials in milk.
These RIAs may also be used with serum, plasma, urine, 
tissue, and eggs. Tissue and eggs however, require a 
separate extraction procedure before testing. Available 
RIAs from Charm Sciences, Inc. include chloramphenicol,
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gentamicin, sulfadimethoxine, sulfamethazine, and 
tetracycline. In the Charm II Antibody test, ,4C or 3H 
labeled drug competes with any drug residue present for a 
specific antibody bound to microbial cells. These tests 
reportedly are rapid (12 minutes per test) and specific 
with a level of detection of 10 ng/ml for drug residue in 
milk. The principal disadvantages of RIAs when compared 
with other immunoassays involve the use and disposal of 
radioactive compounds and the need for scintillation 
counting equipment [2.41]. As a result, ELISA and 
fluorescent labelled immunoassays are becoming more widely 
used.
ENZYME IMMUNOASSAY
Immunoassays are widely used to monitor therapeutic 
drugs and drugs of abuse in human medicine, for dog and 
racehorse testing, and on dairy farms and processing 
plants to screen milk samples for veterinary drug 
residues. Nonetheless, they have seen limited use for 
analysis of veterinary drug residues in food animal 
tissues. The major market for these tests in agriculture 
has been for dairy products. However, with appropriate 
extraction methodology many of these assays may be used 
for residue analysis of food animal tissues, including 
food fish. Immunoassay offers a cost-effective and rapid
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alternative to conventional methodology for drug residue 
screening. Immunoassays can determine within minutes 
whether edible tissue contains veterinary drug residues 
above or below tolerance, and sample preparation for 
immunoassay is typically shorter and less demanding than 
the comparable preparation methods used for 
chromatography. The reduction in preparation time and 
ability to simultaneously process many samples can greatly 
increase a laboratory's throughput and provide relevant 
residue concentration information in time to allow 
retention or removal of potentially harmful products from 
the food supply [2.159-2.161].
Like radioimmunoassay, enzyme immunoassays typically 
possess high sensitivity and specificity. The high 
specificity of these assays may be advantageous or not 
depending on the intended use of the test, i.e., detection 
of a single analyte or a class of compounds. Although an 
assay using antibodies of moderate specificity may detect 
a class of compounds, immunoassay does not readily lend 
itself to multiresidue detection. It is most useful for 
screening a large sample set for one or a few drugs in a 
given matrix. Nonetheless, the high specificity of 
immunoassays does permit minimal sample cleanup compared 
to chromatographic methods.
Because of the ability to screen large numbers of 
samples and detect analytes in the low parts per billion
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range, early and continuing interest in immunoassays has 
centered on veterinary drug residues of greatest 
toxicological and public health concern. Compounds of 
high regulatory concern, as designated by the FDA, include 
chloramphenicol, nitrofurans, fluroquinolones, quinolones, 
malachite green, nitroimidazoles, and sulfamethazine 
[2.162,2.163], Because of their wide use and toxicity and 
carcinogenicity concerns the two drugs that have generated 
the greatest interest in screening methods development are 
chloramphenicol and sulfamethazine.
Chloramphenicol can induce an idiosyncratic, dose 
independent aplastic anemia in man. Of particular concern 
in seafood is the use of chloramphenicol in shrimp 
mariculture [2.6]. A number of ELISA methods for 
detection of chloramphenicol residues and evaluations of 
their performance in several food animal tissues have been 
published [2.154,2.157,2.164-2.168]. Sulfamethazine 
(sulphadimidine) is widely used in some food animals, is a 
potential carcinogen, and is of high regulatory interest. 
As such, ELISAs were developed early on for this compound 
[2.169-2.172]. Other compounds for which ELISA analysis 
of drug residues are reported include monensin, 
cephalexin, penicillins, sulfathiazole; anabolic agents 
such as nortestosterone and the /3-agonists clenbuterol, 
cimateraol, and salbutamol [2.173-2.180].
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Only three reported applications of enzyme 
immunoassay for detection of veterinary drug residues in 
fish were found. Kitagawa et al. developed an ELISA for 
detection and quantitation of the peptide antibiotic 
colistin in rainbow trout muscle, liver, kidney, spleen, 
serum, and bile. This assay reportedly can detect as 
little as 3 ng per well [2.142]. The EZ-SCREEN® test for 
sulfadimethoxine was evaluated by Wu et al. for detection 
of sulfadimethoxine residues in channel catfish muscle and 
liver. Homogenization and ten-fold sample dilution 
provided detection of sulfadimethoxine at the tolerance of 
100 ng/g [2.143]. Walker and Barker evaluated four 
commercially available ELISAs for detection of 
sulfadimethoxine and 4-N-acetylsulfadimethoxine residues 
at concentrations surrounding tolerance in channel catfish 
muscle [2.144]. This study is presented in detail in 
Chapter 3.
Commercially obtainable enzyme-linked immunosorbent 
assays (ELISA) are available in kit form for several of 
the antibacterials used in land- and water-based 
agriculture. Included are assays for chloramphenicol, 
several /S-lactams, tetracyclines, tylosin, sulfamethazine, 
and sulfadimethoxine. These test kits utilize enzyme- 
linked immunosorbent assays (ELISA) based on the principle 
of direct competitive solid phase enzyme immunoassay and 
compare the relative color development of the sample to a
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negative control as the measurable endpoint. Negative 
samples exhibit the greatest color development and 
positive samples the least development. The tests are 
packaged containing all reagents and components, and test 
procedures are described in directions for use included 
with each kit. Results may be qualitative or semi- 
quantitative respectively when determined visually or 
using optical density (OD) values. Test formats, as 
determined by the type of solid support used for 
immobilization of the antibody, include the MICROTITER® 
well, tube tests, and membrane based ELISAs such as the 
CITE® cup device, CITE® probe device, SNAP™ test, I.D. 
Block™, and the Quik-Card® test.
The FSIS compound evaluation and analytical 
capability manual currently lists EZ-SCREEN® immunoassay 
methods for chloramphenicol, gentamicin sulfate, neomycin 
sulfate, sulfadimethoxine, sulfamethazine, and tylosin as 
non-validated screening methods for red meat and poultry 
[2.9]. EZ-SCREEN® is a qualitative colorimetric 
immunoassay for detection of drug residues in milk, urine, 
serum, and feed using the QUIK-CARD® format. The QUIK- 
CARD® system consists of a solid support card containing 
two membrane-based test ports; negative control and 
sample. Results are obtained within 10 minutes by visual 
comparison of relative color development of the two spots. 
The lower detection limit of the assay is 10 ng/ml. This
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
4 7
test is marketed by Environmental Diagnostics, Inc. of 
Burlington, NC [2.181]. A recent FDA evaluation of the 
EZ-SCREEN® chloramphenicol test for milk indicates that 
this test performs well when testing fresh milk. However, 
thirty-three percent of previously frozen milk samples 
containing one ng/ml provided false negative results.
The primary problem encountered with the test was an 
occasional failure of the sample to properly adsorb into 
the test membrane [2.154].
In addition to the EZ-SCREEN® test, several other 
immunoassays are commercially available for screening food 
animal tissues for drug residues. One such test is the 
SIGNAL® Sulfamethazine Detection Test marketed by 
SmithKline Beecham Animal Health of Exton, PA. This test 
uses the MICROTITER® well format and may be used 
qualitatively or quantitatively. The SIGNAL® test is 
marketed for the detection of sulfamethazine in milk, 
muscle, serum, urine, and feeds, but also exhibits a 
degree of cross reactivity with a number of other 
sulfonamides [2.144].
The IDS Sulfadimethoxine One-Step ELISA is a 
quantitative MICROTITER® well ELISA for the detection of 
sulfadimethoxine residues in serum, milk, urine, muscle, 
liver, kidney, and feed. International Diagnostics 
Systems Corporation of St. Joseph, MI also markets a 
qualitative membrane ELISA for detection of
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sulfadimethoxine under the tradename Sulfadimethoxine I.D. 
Block™ Testing Device. Both tests have a lower detection 
limit of 10 ng/ml [2.182,2.183]. Other ELISAs available 
from this company are sulfamethazine, gentamicin, tylosin, 
and neomycin in MICROTITER® well format, and 
sulfamethazine and gentamicin in the I.D. Block™ device. 
Also immunoassays for forty-two additional therapeutic 
drugs or mycotoxins are available from this firm.
IDEXX Laboratories, Inc. of Westbrook, ME markets a 
number of ELISAs in one of three membrane-based formats; 
the CITE® cup, the CITE® PROBE, and the SNAP™. The CITE® 
cup device holds a membrane filter containing three 
discrete test areas and a negative control spot; each test 
area is coated with antibody to one sulfonamide. Two 
qualitative assays are available in the cup format, the 
CITE® sulfamethazine assay and the CITE® Sulfa Trio™. The 
CITE® Sulfa Trio™ is used for the detection of 
sulfadimethoxine, sulfathiazole, and sulfamethazine 
residues in milk.
The CITE® PROBE is competitive immunoassay that 
visually compares the relative color intensity of a 
control spot with a sample spot. It is packaged as a self 
contained kit and can be easily run on-farm. The CITE® 
PROBE utilizes membrane coated antibody spots located on 
the end of a probe device. The probe is moved through a
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series of four development wells supplied with the kit and 
the result determined visually or with a densitometer.
CITE® PROBE tests available include gentamicin, 
/3-lactam, /3-lactam/sulfamethazine Combo®, /3-lactam 
/tetracycline Combo®, and tetracycline. The /8-lactam 
PROBE test does not use antibodies to specifically bind 
the analyte(s) but rather a penicillin-binding protein 
bound to the membrane matrix [2.184], Other CITE® PROBE 
tests are however, true ELISAs. The CITE® PROBE 
tetracycline test is a multi-residue screening test for 
chlortetracycline, oxytetracycline, and tetracycline 
residues in milk. Assay time is 5 minutes. The limits of 
detection in milk are 40 ppb for chlortetracycline and 
oxytetracycline, and 20 ppb for tetracycline [2.185].
The SNAP™ /8-lactam test is an enzyme-linked receptor- 
binding screening test for penicillin G, ampicillin, 
cephaprin, amoxicillin, cloxacillin, and ceftiofur 
residues in raw whole milk. The level of sensitivity 
varies among the several drugs. The SNAP testing device 
is a single unit containing an antibody coated test area, 
control spot, and all necessary reagents. This recently 
introduced test requires only three steps, no reagent 
measuring, and provides results in ten minutes [2.186].
ELISAs utilizing test tubes coated with antibody are 
available under the LacTek™ brand name from Idetek, Inc. 
of Sunnyvale, CA. LacTek™ screening tests for /8-lactams
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(amoxicillin, ampicillin, cephapirin, cloxacillin, 
hetacillin, nafcillin, oxicillin, and penicillin G), 
ceftiofur, chloramphenicol, gentamicin, sulfamethazine, 
and tetracylines (tetracycline, chlortetracycline, and 
oxytetracycline) in milk are available. For multi-residue 
assays, the relative level of sensitivity varies among the 
individual drugs from 4-10 ng/ml. Up to five samples can 
be tested simultaneously with an assay time of seven 
minutes and only two minutes of actual analyst time. 
Results are determined using a dual wavelength 
spectrophotometer [2.187].
Although a number of ELISAs are currently marketed, 
at present none are certified or approved by any federal 
agency. However, the FDA has recently issued calls for a 
voluntary evaluation of milk residue screening assays, 
including immunoassays, and is presently evaluating 
screening assays for their performance in detecting j8- 
lactam antibiotic residues. Results are pending at this 
time [2.188]. In several published performance 
evaluations, proprietary immunoassays have performed well 
at correctly identifying various tissues as containing 
above or below tolerance [2.143,2.144,2.157,2.167,2.168, 
2.176,2.184,2.189]. Although immunoassays in kit form 
were only recently available for residue analysis, the 
great potential of these tests to improve the efficiency 
of drug residue monitoring programs will clearly result in
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a number of additional assays of this type introduced in 
the future.
CHROMATOGRAPHIC ANALYSIS
There will be the need at some time to provide a less 
equivocable analysis of the residue. Suspect samples 
identified with screening tests require quantitation and 
confirmation of the presence of residues exceeding the MRL 
in the target tissue; hence rapid tissue extraction, 
quantitation, and confirmatory methods must be available 
for regulatory purposes. For many such analyses, 
chromatographic methods provide the necessary specificity 
and sensitivity required for both qualitative and 
quantitative drug analyses. More recent chromatographic 
methodologies can complement microbial or immunoassay 
tests in that they have short analysis times overall and 
limits of detection in the same concentration range.
THIN LAYER CHROMATOGRAPHY
CLASSICAL THIN LAYER CHROMATOGRAPHY
Thin layer chromatography (TLC) is one of the 
simplest and most easily used of the chromatographic 
methods and has long been used for separation and analysis
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of drug and other residues. In classical TLC, an aliquot 
of a biological fluid or tissue extract is added onto a 
porous layer of adsorbent material. Each component in the 
sample has a characteristic mobility pattern on the TLC 
plate for a given procedure. The sample is resolved into 
individual components by the distinctive migration pattern 
of each component. This migration distance is usually 
expressed as an Rf value where Rf = (distance traveled by 
the component) (distance traveled by the solvent front). 
An Rf value identical to that for a standard provides 
presumptive, but not absolute identity of the component. 
Visual determination of the migration distance and 
relative spot size or intensity may be obtained with 
naturally colored or naturally fluorescent compounds.
Other compounds may be visualized by spraying the plate 
with specific reagents, charring, or treatment with vapor 
phase reagents. Alternately, TLC plate coatings may 
contain a fluorescent indicator with UV absorbing 
substances seen as dark areas against the fluorescent 
background. A wide variety of TLC adsorbent materials may 
be used for coating of the TLC plate. Silica gel is most 
commonly used, but reversed-phase layers are available 
with C2, C8, C18, and phenyl phases bonded to silica 
[2.190].
TLC offers several distinct advantages over other 
chromatographic procedures for residue analysis. It's
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ability to analyze several samples simultaneously rather 
than serially may provide significant time savings over 
other methods of chromatography, and solvent system- 
detector compatibility required with LC or GLC for multi­
residue analysis is not needed [2.191]. Additionally, TLC 
provides reproducible results without the potential LC 
problems of column contamination and degradation and TLC 
is relatively inexpensive in terms of equipment when 
compared to other chromatographic methods. Further, the 
components remain in the absorbent layer and can be 
recovered for further analysis.
Several classical TLC techniques are listed in the 
FSIS /official methods' of analysis manual for 
determination of several veterinary drug residues in red 
meat and poultry [2.9], One such method is the Sulfa on 
Site (SOS) test. This test was developed by the FSIS to 
identify swine samples containing violative levels of 
sulfamethazine and is commercially available in a kit 
format. SOS methods for urine and plasma are calibrated 
so that test readings predict liver or muscle 
concentrations exceeding sulfamethazine tolerance. 
Sulfonamides are visualized on the TLC plate as areas of 
blue-green fluorescence under UV light. Suspect animals 
identified by the SOS test are retained pending 
quantitative analysis by GLC/MS [2.9,2.192]. Other 
sulfonamides, including sulfadimethoxine, can also be
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
5 4
detected with the SOS test. The fluorescent intensity and 
characteristic migration location (Rf value) indicates the 
approximate concentration and provides presumptive 
identification. This test is a reasonably simple and 
accurate method for detecting sulfonamide residues, but 
does require mastery of some technical and manipulative 
skills. It is therefore not suited for on-farm use by lay 
users with few basic laboratory skills [2.193].
Nevertheless, classical TLC techniques, in general, 
lack the precision necessary for residue quantitation of 
target tissue at tolerance. Few published methods for 
classical TLC analysis of drug residues in food fish are 
available. A method for TLC determination of residues of 
the anesthetic tricaine methane sulfonate (MS-222) in fish 
tissues was reported by Allen et al. The method limit of 
detection of 0.2 jug/g and limit of quantitation of 2.0 
/jg/g are however above tolerance, making this method less 
suitable for residue detection use [2.194]. Squibb et al. 
used TLC for separation of SDM and metabolites in channel 
catfish plasma, urine, bile, liver, and muscle in a 
pharmacokinetic and disposition study [2.195]. Barron and 
James used TLC for separation of radiolabelled 
sulfadimethoxine and metabolites in lobster tissue 
extracts with subsequent quantitation by scintillation 
counting [2.196].
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Separation and determination of radiolabelled 
substances may also be obtained using TLC with direct 
radioscanning or autoradiography. Because of its speed 
and improved instrumentation, direct radioscanning of 
developed TLC plates may someday replace scintillation 
counting for radioisotope detection and quantitation in 
drug and metabolism studies. TLC may also be combined 
with other analytical techniques such as mass spectrometry 
or infrared spectrometry to provide more definitive 
identification of compounds [2.190].
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY
A modified planar chromatographic method with 
potential use in residue monitoring as a screening and 
quantitative method is high performance thin-layer 
chromatography (HPTLC). In this technique, sample and 
standard solutions are applied manually or by an automated 
spotting device to a silica gel coated HPTLC plate, mobile 
phase applied, and computer-assisted densitometer or other 
determinative readings obtained following development. 
Determination may be effected using optimal wavelength 
scanning at visible light absorbance, UV absorbance, or 
fluorescence. To facilitate separation or enhance 
detection of analytes, prechromatographic derivatization 
is performed or postchromatographic detection reagents may
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be applied to the plate [2.197]. Using these techniques, 
HPTLC methods can provide results approaching those 
obtained with LC in precision and quantitative accuracy 
[2.191,2.198].
Although HPTLC offers several distinct advantages, 
relatively few methods are published for HPTLC 
determination of veterinary drug residues. One such HPTLC 
technique is the AOAC validated method for simultaneous 
multi-sulfonamide residue screening applicable to swine, 
turkey, and duck tissues. This method provides acceptable 
accuracy and precision near the official tolerance for six 
sulfonamides, but tissue extraction requires 
homogenization and multiple liquid-liquid partitioning 
steps and is labor- and solvent-use intensive 
[2.41,2.191]. The FSIS uses this procedure for multi­
sulfonamide detection and quantitation in red meat and 
poultry [2.9]. Tao published a rapid HPTLC method for the 
determination of flumequine residues in rainbow trout meat 
using chloroform extraction with quantitative analysis 
using UV detection at 254 nm [2.199]. Reimer and Suarez 
used MSPD for the simultaneous extraction of five 
sulfonamides from salmon muscle with quantitation by HPTLC 
using fluorescence detection following fluorescamine 
spray. The method detection limit for SDM was 0.13 0 /xg/g 
[2 . 200].
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TLC-BIOAUTOGRAPHY
Thin layer chromatography-bioautography (TLCB) is 
based on selective tissue extraction, separation of 
components by TLC, and bacterial growth inhibition 
techniques. TLCB provides a multiresidue detection method 
and can be used to identify individual antibiotics within 
a class of antibiotics [2.131]. It has been used in 
Canada since 1984 for the confirmation of positive in- 
plant tests of red meat [2.112]. Neidert et al. reported 
minimum detectable amounts in fortified muscle samples 
(ng/g) as 15 (chlortetracycline) and 30 (oxytetracycline 
and tetracycline) as determined by the minimum amount 
causing visible inhibition zones on 100% of tests at that 
level [2.130]. MacNeil et al. reported TLCB lacked the 
sensitivity of LC for oxytetracycline but was of equal 
sensitivity with MIT. STOP had greater or lesser 
sensitivity than TLCB depending on the growth medium used 
[2.120]. In a related study evaluating the performance of 
five screening tests for detection of penicillin G 
residues in calves, TLCB had greater sensitivity than the 
STOP or CAST, but was less sensitive than the brilliant 
black reduction test, Charm II, or LC [2.201].
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For many of the drugs used in aquaculture the method 
of choice would be HPLC with UV detection, using a 
variable wavelength or diode array detection system.
High performance liquid chromatography (LC) is the most 
commonly reported method for quantitation of veterinary 
drugs in aquatic species, red meat, and poultry. Although 
LC is commonly used, complex extraction procedures and/or 
sample pretreatment are often needed before injection on 
conventional reversed phase analytical columns. Newer 
analytical columns employing internal surface reverse 
phase or immunoaffinity packing permit direct injection of 
plasma and other liquid matrices that cannot ordinarily be 
used with conventional LC columns [2.79]. With such 
improvements LC procedures may approach screening tests in 
speed and simplicity [2.202]. As illustrated in Table 2.1 
[2.45-2.97], a variety of analytical columns and mobile 
phases are reported for a number of drugs. Although many 
LC techniques have been described over the years, one must 
exclude from consideration any strict adherence to LC 
methodologies reported prior to 1985. This fact is in 
large measure due to the very different nature of the 
solid supports available today when compared to those of 
the past. Reverse phase C18 packing is most commonly used 
but other packings reported are dimethyl silica,

















TABLE 2.1 REPRESENTATIVE EXTRACTION AND LIQUID CHROMATOGRAPHIC METHODS FOR DRUGS USED IN 
AQUACULTURE
Compound(s) Matrix Sample Preparation Analytical Column Mobile Phase Detection Method 
& Analysis Time









A. Wako Gel 
(dimethylsilica)
10 pm or
B. Shimadzu Gel 
(polystyrene gel)
10 pm
col A. 0.05 M phosphate buffer - 
ACN 9:1 
col B. 0.04 M  KH2P04 - 0.08 M 
EDTA-MeOH 1:1:8
UV @  370 nm 
15 min
20 ng TC, OTC 






salmon muscle homogenization 
SPE using 
Bond Elute CIS
Merck Hibar 0.01 M  oxalic acid - ACN - 
LiChroCART RP-18 MeOH 
7 pm 73:17:10
photodiode array 
@ 355 nm 
15 min
90 ng/g TC 
80 ng/g OTC 
500 ng/g CTC
[2.46]






0.1 M  citric acid - 0.1 M  trisodium UV @  370 nm 
citrate - 0.1 M NajEDTA - ACN 8 min 
340:5:5:150
5 ng/g [2.47]








[(5 g DAHP + 5 ml DEA)/810 ml UV @  365 nm 
water] - ACN - DMF 8 min 
81:19:6
5 ng/g [2.48]
Oxytetracycline RBT serum, 
liver, muscle
homogenization 





ACN - DMF - 0.01 oxalic acid 
27:6:67
UV @ 355 nm 
8 min
50 ng/ml Serum 
50 ng/g Muscle 
100 ng/g Liver
[2.49]









0.005 M  phosphate buffer -
ACN - THF
81:10:9
UV @  357 nm 
10 min
5 ng/g muscle 
10 ng/g liver
[2.50]























Oxytetracycline channel catfish 
muscle
protein ppt using 
trifluoracetic acid
homogenization 






M  & S pack C,t
direct LC inj and PLRP-S 100 A 
pre-column extraction S pm 
with polystyrenc- 
divinylbenzene
MSPD MicroPak Cl( 
MCH-10
Oxytetracycline Pacific pink homogenization Ultraspherre ODS
salmon muscle filtration 5 pm
SPE using Bakerbond 
cu
Oxytetracycline Pacific pink homogenization Ultrasphere ODS





RBT, yellowtail, homogenization 
red sea bream, SPE using 
eel muscle Sep-pak C,s
Sulfadimethoxine catfish muscle, homogenization




0.02 M  oxalic acid - 
MeOH - DMF 
95:5:5
UV @  350 nm 4 ng on column 
6 min
[2.51]
MeOH - ACN -0.2 M  oxalic acic UV @ 360 nm 50 ng/g muscle, serum
1:1:3.5 12 min 100 ng/g liver, kidney,
bone, skin
0.02 M  aqueous HjP04 - UV @350 nm 12 ng/ml
ACN - THF 8.5 min
89:6.3:4.7
0.02 M  oxalic acid - photodiode array 50 ng/g
ACN - MeOH @  365 nm (1.25 ng on column)
70:27.5:2.5 6 min
0.02 M  phosphate buffer - MeOH UV ® 365 nm 50 ng/g
19:6 20 min
0.025 M  aqueous oxalic acid - UV @  355 nm 50 ng/g
ACN-THF 30:9:1 15 min
containing
octanesulfonic acid at 10 mM
0.05 M  monobasic sodium UV @  265 nm 50 ng/g OTC, CAP,
phosphate - ACN 30 min SMM, SDM, FZD
65:35 100 ng/g CTC
1000 ng/g DFZ



























Sulfadimethoxine chinook salmon homogenization 
Ormetoprim muscle SPE using
Sep-Pak C)8





















Sulfadiazine Atlantic salmon, homogenization
Trimcthioprim RBT plasma, liquid/ liquid
muscle, & liver Spin-X filter
Sulfadimethoxine channel catfish MSPD 



















ACN - MeOH - 0.1 M  H5P04 
17:10:73
UV @ 280 nm 200 ng/g each (2.59]
30 min
0.017 M  H3P04-ACN 65:35
0.05 M phosphate buffer - ACN 
65:35
aqueous 35% ACN containing 
0.1 % formic acid
ACN - 0.01 M  ammonium acetate 
gradient composition
0.025 M  sodium phosphate with 
hexane sulfonate (pH 2.8) - ACN 
with 0.1% triethylamine 
77:23 Plasma 
80:20 Tissue
0.017 M  HjP04-ACN 
71:29 muscle 
73:27 plasma
photodiode array 50 ng/g [2.60]
@  270 nm (1.25 ng on column)
10 min
UV @  265 50 ng/g serum, muscle, [2.61]
25 min liver, kidney
100 ng/ml bile
photodiode array 25 ng/g 




@  270nm 
57 min
UV @ 270 nm 
10 min plasma 
20 min tissue
photodiode array 
® 265 nm 
12 min
-100 ng/gSDZ 
66 ng/g SMR 
228 ng/g SMT 
150 ng/g SDM 
48 ng/g SP
plasma 
50 ng/ml SDZ 
250 ng/ml TMP 
muscle 









































Atlantic salmon homogenization 
muscle & liver liquid/ liquid 
SPE using 
Bond Elut NH]
yellowtail, eel, homogenization 
sweet fish, RBT, SPE using 
red sea bream Bond Elut C,s
eel homogenization
yellowtail liquid/ liquid











Baker 10 Amino 
Cartridge
SPE using 


















ACN - water UV @  400 nm 5 ng/g
16:84 8 min
containing 0.001 M  Na2EDTA&
0.1 M KNOj
0.005 M aqueous oxalic acid - UV @  265 nm 20 ng/g OA
ACN 25 min 50 ng/g SMM, SDM,
55:45 SSZ, NA, PA, FZD
100 ng/g NFS
THF - ACN - HjP04 - water UV @  260 nm 20 ng/g OA
29:1:0.06:69.94 40 min 40 ng/g SMR, FZD, NA
60 ng/g SMM, SSZ, 
SDM,DFZ
80 ng/g PA, NPN, FMZ
ACN - MeOH - 0.01 M  oxalic UV @  295 nm 50 ng/g each
acid 8 min
3:1:6
ACN - THF -
0.02 M  orthophosphoric acid 
20:15:65
0.025 M  oxalic acid - ACN - 
MeOH - THF 
gradient composition
fluorescence 5 ng/ml OA 
262 nm excitation 10 ng/ml FEQ 
380 nm emission 
13 min
fluorescence 3 ng/ml OA 
325 nm excitation 5 ng/ml FEQ 


























































on line dialysis 




















Nucleosileel plasma, liquid-liquid 
aquaria water
table con'd.
0.002 M HjP04- ACN - THF fluorescence 0.5 ng/g OA 
65:20:15 260 nm excitation 2 ng/g FEQ
380 nm emission muscle and liver 
12 min
ACN - THF -
0.02 M  orthopliosphoric acid 
20:14:66
fluorescence 4 ng/g OA 
325 nm excitation 7 ng/g FEQ 
365 nm emission 
15 min
ACN - THF -
0.02 M orthophosphoric acid 
20:15:65
UV @  260 nm 2 ng/g OA
0.002 M H,P04 
64:21:15





325 nm excitation 
365 nm emission 
13 min
ACN - THF fluorescence
260 nm excitation 
380 nm emission 
12 min
MeOH - ACN - fluorescence
324 nm excitation 
363 nm emission 
8 min
ACN - DMF - [(3g HjP04 + 
TMAC)/675 ml water] 
125:200:675
lg
3 ng/g FEQ 
using fluorescence
5 ng/g OA 
10 ng/g FEQ
fluorescence 


















































channel catfish MSPD 
muscle &  bile
channel catfish MSPD 
muscle & liver













Nova-Pak C„ MeOH - (7.5 g/1 KH2P04 • 2HjO UV @  258 nm 1 ng/ml [2.78]
4 pm + 2.5 g/1 Na2HP04 • H20) 15 min
4:6
Regis Pinkerton GFF ACN - 0.1 M KH2P04 UV @  254 nm 10 ng/ml serum (direct inj) [2.79]














MeOH - 0.01 M  oxalic
MeOH - 0.05 M GAA 
gradient composition
MeOH - 0.05 M  GAA 
gradient composition
fluorescence 
327 nm excitation 
369 nm emission 
4 min
UV @  260 nm 
65 min








20 ng/g muscle 
60 ng/g liver 
using radioactivity
0.05 M Na H2P04 - ACN 
65:35
Muscle 50 ng/g 
serum 50 ng/ml 
liver, kidney 100 ng/g 
bile 100 ng/ml

































SPE using Cj 
























































0.002 M HjP04 - ACN UV ® 289 nm 1 ng/ml serum
8:2 or fluorescence 1 ng/g tissue
278 nm excitation using fluorescence 
440 nm emission 
12 min
0.002 M H3P04 - ACN - MeOH 
72:20:8
0.002 M H3P04 - ACN - MeOH 
73:19:8
ACN - DMF - [(1.13 g HjP04 + 
0.38 g TMAC)/700 ml water] 
1.5:1.5:7
MeOH-0.02 MNa2HP04- 
0.01 M  citric acid 
15:42.5:42.5
MeOH - water 
15:18
fluorescence 5 ng/g
278 nm excitation 
440 nm emission
7 min
fluorescence 5 ng/g enrofloxacin
278 nm excitation 10 ng/g sarafloxacin
440 nm emission
8 min
UV ® 278 nm —
UV ® 222 nm 30 ng/g
40 min (3 ng on column)
UV ® 225 nm 1.25 ng 
20 min
MeOH - water 
15:85
UV ® 10 ng/g each
225 & 270 nm 
30 min
water - ACN 
65:35



























Febendazole channel catfish homogenization MicroPak C,t
plasma, kidney, SPE using MCH-10
fat, muscle, diatomaceous earth
bowel contents, liquid/ liquid
urine
Malachite Green RBT muscle & homogenization PLRP-S polymer
liver liquid/ liquid 5 pm
Malachite Green pond & SPE using pBondapak C,8
tap water Baker 10 diol 10 pm 
and Pb02
postcolumn reactor
Praziquantel fish muscle, homogenization Supelcosil LC-18
liver, kidney liquid/liquid 5 pm
SPE using Bond Elute
C2 and SI
17oi-methyl- RBT muscle homogenization Hypersil C, and
testosterone centrifugation Nucleosil C„
liquid/liquid 5 pm each
SPE using and immobilized
Lipidex 5000 & enzyme reactor
Sep-Pak silica
Abbreviations (Table 2.1)
ACN acetonitrile FEQ flumequine
CAP chroramphenicol FMZ furamizole
CTC chlortetracycline FZD furazolidone
DAHP diammoniumhydrophosphate GAA glacial acetic acid
DEA diethanolamine NA nalidixic acid
DFZ difurazone NPN nifurpirinol
DMF dimethylformamide NFS nifurstyrenate
OA oxolinic acid




0.02 M  HjP04 - ACN - THF 
49:40:1
UV @  615 nm 1 ng/g muscle [2.94]
6 min 10 ng/g liver
MeOH - (0.05 M Na acetate + UV @  618 nm 2.83 ng/L chromatic form [2.95]
0.1 M  GAA) 
85:15
17 min
2.01 ng/L leuco form
water - ACN 
1:1
UV @  210 nm 
25 min
5 ng/g [2.96]
MeOH - water 
75:25
fluorescence 1 ng/g 
340 nm excitation 
470 nm emission 
or UV @  254 nm 
35 min
[2.97]
OTC oxytetracycline SMM sulfamonomethoxine
PA piromidic acid SP sulfapyridine
RBT rainbow trout SSZ sulfisozole
SDZ sulfadiazine TC tetracycline
SDM sulfadimethoxine THF tetrahydrofuran
SI silica TMAC tetraethylammoniumchloride




polystyrene gel, ion-pair, polystyrene divinylbenzene, and 
Regis Pinkerton internal surface reverse phase. Detection 
by UV using fixed or variable wavelength detectors or 
diode array is most frequently reported, but fluorescence 
detection gives greater sensitivity for the tetracycline 
and quinolone antibiotics. Reported limits of detection 
for some of the LC methods listed in Table 2.1 are above 
the current MRLs of many countries and only one of the 
methods has undergone interlaboratory validation studies 
[2.80,2.98]. Therefore, legally defensible LC methods 
validated for use about the MRL are needed for the 
analysis of veterinary drugs and their important 
metabolites in edible fish tissues.
GAS CHROMATOGRAPHY
There are a limited number of publications involving 
the application of gas liquid chromatography (GLC) to the 
analysis of veterinary drugs used in aquaculture [2.99, 
2.203-2.207]. Many of the compounds used therapeutically 
in aquaculture are of high molecular weight, relatively 
non-volatile, and thermally labile; therefore chemical 
derivatization is generally required to obtain sufficient 
volatility and stability for GC analysis. Additionally, 
the methylation of sulfonamides with diazomethane prior to 
GLC produces N'-methyl and ring-methyl derivatives. The
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68
formation ratio of the two isomers is variable and the 
ring-methyl derivative does not elute from the GLC column. 
The incorporation of deuterium or 13C labelled sulfonamides 
prior to derivatization and the use of isotopic ratios 
corrects for variable isomer formation but increases the 
cost and complexity of the analysis [2.208],
As a result of the extensive sample preparation and 
cleanup necessary prior to derivatization, GLC is not as 
frequently utilized as LC in drug residue analysis. Early 
reports by Allen and Sills for the GC analysis of the fish 
anesthetic quinaldine used a packed column and an alkali 
flame detector and had a limit of quantitation of 0.01 
Mg/g [2.203,2.204]. A method for determination of 
sulfamethazine residues in swine muscle is the only AOAC 
OMA method for the GLC determination of a veterinary drug 
residue in animal tissue [2.41]. A GLC-MS method for 
determination of chloramphenicol residues at the low 
parts-per-billion level in shrimp tail muscle has since 
undergone interlaboratory validation and is in press 
[2.99-2.208]. A multi-residue GLC method for thirty-six 
veterinary drugs in red meat and poultry has been reported 
[2.209], A number of these drugs or related compounds are 
also used in aquaculture and the methods could potentially 
be applied to food fish tissues. Additionally, techniques 
employing GLC separation and mass spectrometric detection
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of quinolone antibacterials in fish tissue are described 
in the following section.
HASS SPECTROMETRY
'Absolute' confirmation of the presence of a compound 
as required for regulatory action may often be secured 
using gas liquid chromatography/mass spectrometric 
detection and confirmation (GLC/MSD). Although such 
methods provide quantitation and identity confirmation, a 
GLC/MSD method for sulfamethazine residues in swine 
tissues is the only AOAC OMA validated method available 
[2.41]. Only two methods were found in the literature for 
GLC/MSD determination of veterinary drug residues in 
aquatic animals. Takatsuki reported a GLC/MSD method for 
oxolinic acid and a similar multi-residue GLC/MSD method 
for determination of oxolinic acid, nalidixic acid, and 
piromidic acid in silver salmon using selected ion 
monitoring [2.205,2.206]. In both methods, reduction of 
oxolinic acid, nalidixic acid, and piromidic acid with 
tetrahydroborate (sodium borohydride) gives compounds that 
are sufficiently volatile for GLC. The method was 
reported capable of performing quantitative analyses with 
a detection limit of 0.003 fiq/g, but the classical sample 
preparation technique is complex and time consuming.
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Liquid chromatography/mass spectrometric detection 
(LC/MSD) is becoming more available and because of 
simplified sample preparation requirements, may someday 
exceed GLC for the purpose of confirming many of the polar 
drugs used in aquaculture. At present however, only two 
reported applications of LC/MSD determination of 
veterinary drugs in aquaculture products could be found. 
Pleasance et al. determined sulfadimethoxine residues to 
0.025 Mg/g in salmon flesh using LC/MSD and LC/MSD/MSD via 
a ion-spray interface [2.62]. A thermospray LC/MSD method 
reported by Horie et al. provided quantitation and 
identification of residues of naladixic acid, oxolinic 
acid, and piromidic acid in sweet fish and yellowtail 
muscle to 0.05 jug/g [2.210]. Thermospray LC/MSD is a 
relatively mild ionization method and only molecular 
weight information from MH+ ions is generally obtained. 
Since fragment ions are not produced, the additional 
molecular and structural information useful in 
identification of organic compounds is lacking. 
Nonetheless, the combination of molecular weight, 
chromatographic retention time, and UV spectrum 
information should provide sufficient verification for 
regulatory purposes.
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Veterinary drug residues have also been readily 
detected by a variety of other means. In this regard, the 
fluorescence of tetracyclines under UV light has been used 
as an indicator of previous tetracycline treatment. This 
technique has been used for the detection of 
oxytetracycline residues in bone and injection sites, but 
fluorescence is non-specific and persists in bone for an 
extended time after treatment [2.120,2.211]. Because of 
its persistence in bone, oxytetracycline has been used for 
long term identification of released fish in stocking 
studies [2.212].
Experimental methods using radiolabelled drug and 
liquid scintillation counting [2.114,2.195,2.196,2.213, 
2.214] or whole body autoradiographic studies [2.215- 
2.218] have been used to provide information on 
pharmacokinetic behavior, metabolite formation, 
disposition, depletion rate, and extraction efficiencies 
for compounds used in aquaculture. These methods are, 
however, unsuited for use in routine drug residue 
analysis.
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METHODS OF ISOLATION
Determinative technologies for residue analysis 
require the use of tissue isolation methods that are 
simple, fast, and efficient. Sample preparation, 
isolation, and cleanup are becoming the major rate- 
limiting factors in sample analysis as improvements in 
analytical methods proceed [2.219]. This fact is 
especially important in light of efforts to introduce 
rapid screening tests such as immunoassays. The choice of 
a sample extraction method for a particular application is 
dependent upon what the analyst must or needs to 
accomplish and is determined by several interrelated 
factors. These include the following variables:
a. The sample size available or necessary to obtain a 
given limit of detection with the analytical 
instrumentation available.
b. Matrix characteristics and the availability of 
existing methods for analyte isolation from the specific 
matrix.
c. Specificity requirements of the analysis; i.e., 
isolation of a single compound within a drug class, 
several compounds within a drug class, or several drug 
classes from a single sample.
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d. Number of samples analyzed daily and turn-around time 
requirements.
e. Overall cost of the method including supplies and 
disposables, time and labor involved, and the costs of the 
instrumentation that will be applied [2.220].
Several approaches have been used over the years for 
the preparation, isolation, and cleanup of veterinary 
drug, pesticide, and environmental contaminant residues 
from aquatic matrices. Historically, the classical 
approach to isolation of drugs from tissues has most often 
been reported [Table 2.1]. This approach involves tissue 
homogenization followed by liquid-liquid partitioning of 
the homogenate, with or without additional cleanup or 
concentration steps. Liquid-liquid partitioning may also 
be used with biological fluids. Homogenization and 
liquid-liquid partitioning methods may provide adequate 
separation of the drug from matrix but are often expensive 
in terms of time, labor, material use, and organic solvent 
disposal costs. Such approaches also tend to be highly 
nonspecific in their isolation of the target drug(s).
Furthermore, these traditional isolation methods may 
be generating more contamination than they are 
satisfactorily removing. Table 2.2 provides an indication 
of the problem by listing the volumes of solvent required 
and waste solvent produced for extraction of various drugs 
from aquatic animal tissues.

















TABLE 2.2 COMPARATIVE SOLVENT USE AND HASTE PRODUCTION OF REPRESENTATIVE EXTRACTION 
METHODS FOR DRUGS USED IN AQUACULTURE







SPE using Amberlite XAD2





SPE using Bond Elute Cl8
29 20 90 [2.46]
oxytetracycline RBT muscle homogenization
SPE using Amberlite XAD2
825 750 430 [2.47]
oxytetracycline RBT muscle & liver homogenization 
SPE using Sep-Pak C,8
10 5 47 [2.48]




SPE using Bond Elut Cl8
5 5 50 (serum) 
100 (tissue)
[2.49]




Bondasil C8 or C18
11 9 82 [2.50]
oxytetracycline RBT plasma protein precipitation using 
trifluoracetic acid
-0- -0- -0- [2.51]


















sulfadimethoxine catfish muscle, liver, homogenization
ormetoprim kidney liq / liq
sulfadimethoxine
ormetoprim
chinook salmon muscle homogenization 
SPE using Sep-Pak C,8
sul fadimethoxine channel catfish muscle MSPD




SPE using Bond Elut NH2
OA, NA, PA, eel, yellowtail, RBT homogenization
FZD, DFZ, NPN, 




OA, NA, PA eel, RBT, sweetfish, 
red sea bream, 
yellowtail tissue
homogenization




salmon plasma SPE using Bond Elute C2
flumequine 
oxolinic acid
Atlantic salmon liver homogenization 
liq / liq 
on-line dialysis 




Atlantic salmon muscle homogenization 
liq / liq 
on-line dialysis 
on-line SPE using 
polystyrene-divinylbenzene
table con'd.
10 9 -0 - [2 .58]
25 5 10 [2.59]
16 8 -0- [2.60]
57 22 30 [2.66]
367 95 70 [2.68]
65 55 -0- [2.69]
10 10 6 [2.70]
5 5 19 [2.71]






































channel catfish muscle, 
bile
channel catfish muscle, 
liver
RBT & Amago salmon 
serum, muscle, liver, 
kidney, bile









SPE using Sep-Pak Accell 
or liq / liq
direct injection
homogenization























































































RBT & African catfish 
plasma
yellowtail tissue
channel catfish plasma, 
kidney, fat, muscle, 
bowel contents, urine
pond & tap water
liq / liq
homogenization
SPE using Sep-Pak Florisil
homogenization 
SPE using diatomaceous 
earth 
liq / liq
SPE using Baker 10 diol
See Table 2.1 for list of abbreviations
3 0.6 -0- [2.88]
134 130 -0- [2.89]
49 12 7 [2.93]
2 2 -0- [2.95]
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Many of these solvents are of greater toxicological and 
environmental concern than the compounds they are used to 
isolate. During extraction and isolation procedures, much 
of this solvent volume is evaporated into the atmosphere, 
which contaminates millions of cubic feet of air, and 
solvents are often not disposed of properly, which leads 
to further contamination of the atmosphere, aquifers, and 
aquatic habits and resources.
As previously mentioned, a further problem with 
excessive use of solvents is that they make these methods 
very expensive to perform. The purchase price and 
subsequent disposal costs of organic solvents and wastes 
can be limiting factors in analyses performed by 
government agencies operating on a restricted budget. 
Employee costs can also be a limiting factor in residue 
analysis. Present official methods generally require 
extensive training of laboratory technicians in order to 
guarantee consistent, reliable results and most such 
methods are not amenable to automation. Therefore, costs 
for materials and labor can limit the number of samples 
which can be consistently analyzed to provide adequate 
regulatory enforcement and consumer protection from 
illegal residues and to provide a statistically sound 
evaluation of the magnitude of contamination.
Any method for the isolation of drugs or other 
chemical contaminants must take these factors into
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consideration. Thus, extraction methods that use large 
sample sizes and, thus, require large volumes of organic 
solvent to adequately perform residue isolation are 
becoming increasingly unacceptable. All of the above 
problems indicate that the use of classical 
homogenization/extraction and determinative methods for 
screening purposes should be severely curtailed and phased 
out as new more appropriate methods are developed and 
validated for sample screening.
EVOLVING METHODS OF RESIDUE ANALYSIS
Recent advances in the field of residue analysis 
offer several promising techniques as possible solutions 
to the problems caused by outmoded and complex analytical 
methods. Four techniques, solid phase extraction (SPE), 
immunoaffinity, supercritical fluid extraction (SFE), and 
matrix solid phase dispersion (MSPD), are receiving 
particular attention because they have the potential to 
greatly reduce analysis costs and reduce analyst-generated 
waste and pollution. All of these methods may prove 
useful for a given application.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
80
SOLID PHASE EXTRACTION
In the SPE process, a compound is isolated from a 
liquid sample based on its relative solubility in the 
liquid mobile phase compared to its solubility in a solid 
support-bound liquid stationary phase of differing 
polarity or its affinity to a solid support stationary 
phase of differing polarity. Isolation is accomplished by 
passing the analyte dissolved in solvent (organic or 
aqueous) through a column containing the stationary phase 
with subsequent elution using an appropriate solvent. 
Several solid phase extraction methods have been developed 
to facilitate the extraction and cleanup of biological 
liquid and tissue samples.
For plasma, acceptable residue recovery may be 
obtained using protein precipitation and direct LC 
injection without prior cleanup with SPE [2.51]. However, 
the many impurities present can affect the chromatogram 
and accumulate on the LC analytic column, thus resulting 
in increasing back pressure and decreased column life.
SPE cleanup helps avoid these problems and works well with 
biological fluids such as serum, plasma, urine, and 
cerebral spinal fluid. In addition, SPE extraction and 
analysis can be automated and done on-line [2.70,2.71, 
2.74] and/or with on-line dialysis and column switching. 
However, before SPE can be used with solid tissue (e.g.,
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muscle and liver), a separate homogenization step and 
often multiple filtration, sonication, centrifugation, and 
liquid-liquid cleanup steps are required. While SPE may 
improve cleanup of these solid tissue samples, the 
additional labor and materials costs make SPE less 
suitable, in some cases.
Solid phase extraction methods published for fish 
tissues are often combinations of SPE with other methods 
such as homogenization, liquid-liquid partition, 
filtration, sonication, and centrifugation (Table 2.1). 
Because choice of SPE column depends on the matrix and on 
the particular compound of interest, a wide range of solid 
phase columns of differing polarities have been used for 
drug extraction in fish and include C2, C8, C18, NH2, 
amberlite resins, and PLRP (polystyrene-divinylbenzene) 
polymers (Table 2.1).
IMMUNOAFFINITY
The simplest method of extraction however, is one 
that requires minimal or no sample manipulation. These 
are the methods that /extract' the drug directly from the 
sample matrix by means of specific or selective antibodies 
or receptors. High performance immunoaffinity 
chromatography (HPIAC) is one such method that combines 
immunoassay and LC. Immunoaffinity techniques may be
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either single or multi-residue methods depending on the 
specificity of the antibody and the number of specific 
types of antibodies immobilized on the beads. These 
techniques may be categorized as 1) single antibody/single 
analyte, 2) single antibody/multi-analyte, or 3) multi­
antibody/multi-analyte [2.221,2.224].
In HPIAC, a flow-through cartridge containing 
antibody immobilized on glass or porous beads is used in 
place of an LC analytical column. Following sample 
injection, the drug (antigen) is captured on antibody- 
coated beads, the cartridge washed to remove unbound
material, and the drug eluted from the cartridge.
Detection may be by UV or other LC detection methods. The
cartridge is regenerated by passage of several volumes of
equilibrium buffer. Assay formats other than the on/off 
format that may be used include sequential, competitive, 
or sandwich assays. The sandwich assay format uses a 
second enzyme-tagged antibody to form a three-part layer 
consisting of tagged antibody, bound antibody, and 
immobilized antibody. The limits of detection of the 
on/off, competitive, and sandwich assay are 100-500 ng, 10 
ng, and 10 pg respectively [2.221]. These methods are 
most applicable to aqueous solutions of the drugs, such as 
urine, serum, plasma, or tissue homogenate supernatant.
Immunoaffinity isolation and chromatography provides 
great specificity for the target analyte(s) and the
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ability to concentrate the analyte(s) to the level 
required for detection and measurement. The specificity 
of antigen-antibody bonding, although not absolute, is 
much greater than physico-chemical isolation and 
separation systems now available. While immunochemistry 
methods typically possess high specificity, cross­
reactivity with other drugs or their metabolites or 
naturally occurring compounds in the sample can occur and 
lead to false positive results. A further concern is that 
the drug may remain bound to sample proteins or be in 
complexes that do not bind with a given antibody, leading 
to false negative results or a reduced response. This is 
especially of concern for drugs like the tetracyclines 
that possess both high protein binding and complex 
formation potential [2.220].
Immunoaffinity isolation techniques have most 
commonly been used for sample cleanup prior to 
conventional analysis. One such clean-up method uses a 
small syringe barrel or column containing antibody-coated 
beads or Sepharose™. The sample is applied to the column 
to isolate and concentrate the target analyte and the 
column washed to remove unbound sample material.
Following elution, the isolate may be analyzed off-line by 
GC-MS [2.225,2.226] or another determinative method 
[2.222]. Such columns may also be fashioned in a co­
column arrangement with SPE, MSPD or other methods of
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isolation to provide a highly selective extraction 
process. Applications of immunoaffinity isolation or 
chromatography to veterinary drug residue analysis have 
been limited but techniques are reported for 
nortestosterone and methyltestosterone in beef muscle 
[2.225]; the jS-agonists clenbuterol, salbutamol, 
terbutaline, cimaterol, and mabuterol in bovine and 
porcine urine and liver [2.226]; the anabolic agents 
zeranol and its metabolite /3-zearalanol in calf urine 
[2.227]; and chloramphenicol residues in milk, eggs, and 
swine muscle [2.228,2.229].
Although the application of immunoaffinity techniques 
to the isolation and analysis of veterinary drug residues 
is a recent development, this technique has great 
potential for improving single or multi-residue drug 
analysis in aquatic and other species. High performance 
liquid chromatography compatible cartridges containing 
"flow through" porous beads coated with Protein A or 
Protein G for antibody immobilization have recently become 
commercially available [2.221,2.230]. The main limitation 
to greater use of immunochemical techniques for residue 
isolation and analysis is a lack of commercially 
availability antibodies to many of the veterinary drugs of 
interest as residues [2.223].
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SUPERCRITICAL FLUID EXTRACTION
With the supercritical fluid extraction (SFE) 
process, supercritical fluids (usually supercritical 
carbon dioxide [SC-C02]) are used in place of organic 
solvents to extract residues. The solubility of a 
compound in a supercritical fluid is determined in part by 
the density of the extracting fluid. Therefore, the 
solubility of compounds in SC-C02 can be varied by changes 
in temperature and pressure or the addition of organic 
solvent modifiers [2.231]. Carbon dioxide becomes a 
supercritical fluid if handled above its critical 
temperature and pressure. Although several other 
compounds have suitable critical points and could be used 
for SFE, C02 is naturally occurring, easily obtainable, 
inexpensive, non-flammable, non-toxic and can be vented to 
the atmosphere. Therefore, the use of SC-C02 as an 
extracting fluid or chromatography mobile phase eliminates 
the need for large volumes of organic solvents
[2.232,2.233].
The majority of reported SFE applications have been 
for lipophilic environmental pollutants such as pesticides 
and polycyclic aromatic hydrocarbons which are readily 
soluble in SC-C02 [2.233,-2.236]. However, various other 
lipophilic chemicals and associated tissue lipids are also 
soluble in the non-polar liquid SC-C02, and are co­
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extracted and concentrated once the pressurized C02 is 
brought back to atmospheric pressure. Because the 
extracts contain contaminating lipid-soluble materials, a 
pre- or post-extraction cleanup step is usually needed 
before samples can be injected onto analytical instruments 
such as LC or GLC apparatuses. Cleanup is usually 
accomplished with gel permeation chromatography or 
Florisil adsorption chromatography [2.233]. In-line 
cleanup could be conducted by using disposable or reusable 
SPE cartridges or newer disc SPE technologies and changing 
the pressures of the supercritical fluid. Coupling this 
system directly to an LC/MSD type interface or a GLC/MSD 
interface could provide a complete analytical process for 
the desired analysis [2.237]. A newly introduced 
automated system combining SFE and supercritical fluid 
chromatography (SFC) is also available. Detection for SFC 
is by one of the several types of gas or liquid phase 
detectors.
The application of SFE to the isolation of polar 
drugs from animal tissues poses an additional problem. 
Extraction of these compounds from animal tissues is 
complicated by the fact that polar drugs are likely to 
have greater solubility in the aqueous phase of the tissue 
than in the non-polar SC-C02 extracting fluid. Thus, a 
decreased extraction efficiency of polar compared to non­
polar compounds results. The solubility of polar analytes
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in SC-C02 may however be enhanced by the addition of co­
solvents such as methanol or ethanol to the SC-C02 
extracting fluid [2.232,2.238]. Unfortunately, the 
addition of such extraction modifiers to SC-C02 also 
enhances the recoveries of lipids and other non-polar 
compounds, thus decreasing the selectivity of the 
extraction [2.235-2.236].
Only four reports of SFE/SFC of polar veterinary 
drugs used in food animals could be found. Ramsay et al. 
isolated sulfamethazine, trimethoprim, and three steroids 
from homogenized and freeze-dried fortified swine kidney 
using SFE with a gradient mixture of methanol(0-20%)/SC- 
C02. SFC/tandem mass spectrometry was carried out using a 
moving belt interface. The detection limits of the assay 
were above tolerances for these compounds [2.237].
Perkins et al. examined the use of SFC for the 
simulatanous analysis of nine sulfonamides in standard 
solutions. Sulfamethazine analysis was also examined in 
porcine kidney tissue fortified at 3.3 pg/g. The method 
of detection was UV absorbance or MS. Interface of the LC 
with MS was accomplished by moving belt or thermospray 
techniques [2.238]. In a similar study, the same authors 
examined SFC-MS analysis of standard solutions of four 
veterinary drugs - chloramphenicol, furazolidone, 
levamisole, and lincomycin [2.239]. Cross et al. studied 
the solubility of six sulfonamides in various SFE media
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and their extraction from chicken liver and swine muscle 
following blending of the tissues with sand. LC analysis 
of extracts indicated highly variable recoveries among 
sulfonamides and ranged from 27-97% [2.232],
More work will be necessary to further develop the 
SFE/SFC process. The application of these techniques to 
fish tissues [2.234] has been quite limited. However, 
these processes have the potential to provide a near 
solventless, in-line, automated process for the rapid 
analysis of chemical residues from edible aquatic 
resources.
MATRIX SOLID PHASE DISPERSION
Of the three techniques being considered, matrix 
solid phase dispersion, in particular, has the strongest 
potential to meet the demands of future residue monitoring 
of aquatic resources for drugs and environmental 
pollutants. In general terms, the process involves 
blending a tissue sample (0.1-1.0 g) with lipophilic 
polymer-derivatized silica particles (e.g., octadecylsilyl 
[ODS]-derivatized silica [C,8]), which simultaneously 
disrupts and disperses the sample. This blend of C18 and 
tissue becomes part of a potentially multiphasic column 
that possesses unique chromatographic character. Elution 
of the MSPD column with a solvent or solvent sequence can
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provide a high resolution fractionation of target analytes 
that can be further purified by simultaneous use of co­
columns of Florisil, silica, alumina, C18 or other silica- 
bonded phases. The final eluate can, in most cases, be 
directly analyzed or further concentrated or manipulated 
to meet the demands of the individual analysis. The 
extracts obtained from these methods are most often 
detected by LC (in the case with drugs) or GLC with 
electron capture detection (in the case with pesticides) 
or mass spectrometry. Additionally, when reconstituted in 
an appropriate buffer, the extract can also be used in 
immuno- [2.144,2.172] or other receptor assays.
Additionally, the MSPD process is generic and can be 
modified for a particular application by 1) a change in 
the eluting solvent or solvent sequence, 2) use of a 
different polarity polymer or solid support, and 3) 
blending of the Ci8/tissue in the presence of modifiers 
such as chelators, acids, bases, etc.
MSPD could also be used in conjunction with SFE. The 
water in biological matrices often interferes with the SFE 
extraction process and analysts have used samples blended 
with diatomaceous earth to remove water from the sample
[2.233]. However, blending samples first with polymer- 
coated silicas, as is done in the MSPD process, would 
remove water and provide an initial stage of fractionation
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at the point of elution of the analytes with supercritical 
fluid and modifiers.
In general, the three main advantages of MSPD are 1) 
it allows for rapid turnover of samples and hence, access 
to timely data on residue levels present in samples, 2) 
because of its required small sample size, it considerably 
decreases solvent use compared to the classical methods, 
which in turn decreases environmental contamination and 
increases worker safety, and 3) it is suitable for 
robotics automation. Therefore, MSPD has the potential to 
meet the future demands for conducting drug and pesticide 
analysis for large numbers and varieties of samples.
MSPD APPLIED TO AQUATIC RESOURCES
As seen in Table 2.1, MSPD has been used to provide 
for single or multiresidue analysis of various veterinary 
drugs in several aquatic matrices. Veterinary drugs 
isolated from aquatic animal tissues by this method 
include oxytetracycline [2.54], sulfadimethoxine and 4-N- 
acetylsulfadimethoxine from fortified channel catfish 
muscle [2.60,2.65,2.144], and oxolinic acid as an incurred 
residue from channel catfish muscle and bile [2.81].
Reimer and Suarez reported a multi-residue method for MSPD 
isolation with HPTLC or LC analysis of five sulfonamides 
in fortified salmon muscle [2.63,2.200]. Jarboe et al.
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[2.82] have demonstrated its applicability to the 
isolation of incurred residues of nalidixic acid from 
channel catfish muscle and liver. Walker and Barker 
evaluated the performance of several enzyme immunoassays 
for the detection of sulfadimethoxine residues using MSPD 
extracts of fortified channel catfish muscle as well 
[2.144]. Other compounds used in aquaculture or related 
compounds have been extracted from various non-aquatic 
matrices using MSPD methods [2.172,2.240] and these 
methods could potentially be applied to aquatic matrices.
Pesticides extracted and isolated from aquatic animal 
tissues by this method include 14 chlorinated hydrocarbon 
pesticides from fortified whole oyster homogenate and 
crayfish hepatopancreas [2.241,2.242], 9 chlorinated 
pesticides from fortified catfish muscle [2.243], and a 
variety of agricultural chemicals from natural fish kills 
[2.244]. These isolation methods are a significant 
advance in the ability to screen more samples because of 
their simplicity and efficiency.
DISCUSSION
Methods development for residue determination should 
focus on rapid screening tests, multiresidue capabilities, 
metabolite detection, and improved sensitivity [2.245].
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Further, the use of determinative methods generally 
requires a method of isolating the compound(s) of interest 
from edible or marker tissues that is rapid, inexpensive, 
and does not generate large volumes of organic solvents. 
Classical isolation methods using homogenization and/or 
liquid-liquid partitioning of biological tissues and 
fluids may be sufficient for some applications but are 
poor for screening purposes because they are often 
lengthy, involving multiple steps and use large volumes of 
solvents (Table 2.2). Solvent disposal is becoming 
increasingly expensive and environmentally unsound. 
Therefore, methods using low solvent volumes are 
desirable. A main purpose of this review was to present a 
case for phasing out existing official methods in favor of 
newer technologies that require less sample, less solvent, 
less employee time, and less cost per sample. Newer 
techniques such as supercritical fluid extraction, solid 
phase extraction, immunoaffinity, and MSPD offer 
alternative isolation strategies. When compared to the 
classical methods, these new methods greatly reduce labor 
and solvents costs and improve throughput. There are a 
few drawbacks to the new methods and more work is needed 
to further develop SPE, SFE, immunoaffinity, and MSPD for 
use with the many different types of matrices that may 
contain residues of chemical contaminants. However, of
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the three new methods, MSPD shows tremendous potential for 
integration into a residue monitoring program.
MSPD methods have been published for the isolation of 
a wide range of compounds in a variety of matrices 
indicating this approach may provide a generic technique 
for single or multiresidue extraction of drugs, 
environmental pollutants, and their metabolites. In 
particular, MSPD has already been used to provide a two- 
step process for the single or multiresidue analysis of 
various veterinary drugs and agricultural pesticides in 
several aquatic matrices. This process, when compared to 
classical methods, has been estimated to reduce solvent 
use by up to 98% and analysis time by 97%. Furthermore, 
once the MSPD column is prepared, the process of solvent 
elution, collection, and analysis can be automated by the 
use of robotics. Cost of analysis is decreased because 
less solvent is needed and fewer laboratory technicians 
need to undergo training. Safety and environmental 
protection are increased because less solvent is needed. 
Finally, data is generated more quickly because of the 
ease of the process and its potential to be automated. 
These features of MSPD make it a general and perhaps 
significantly useful method in designing future residue 
analysis screening programs for aquatic as well as other 
food animal resources.
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CHAPTER 3
EXTRACTION AND ENZYME IMMUNOASSAY OF 
SULFADIMETHOXINE RESIDUES IN 
CHANNEL CATFISH {Ictalurus punctatus) MUSCLE
INTRODUCTION
Disease is the most important limiting factor in 
intensive aquaculture and necessitates the use of 
antibacterial and other therapeutic agents to maintain the 
health and production of cultured species [3.1]. Few 
drugs are approved for food fish use in the US [3.2] but a 
number of chemicals not approved in the US are widely 
employed in other countries [ 3.3,3.4]. Large amounts of 
imported cultured seafood are consumed in the US but are 
not required to pass unified, continuous federal 
inspection [3.5,3.6]. The US Food and Drug Administration 
has begun monitoring imported and domestic aquaculture 
products for selected drugs [3.7], but a lack of 
appropriate analytical methods limits residue monitoring 
efforts. There is presently little information concerning 
the level of drug residues in domestic or imported 
cultured fish or the magnitude of human exposure to these 
residues. Public concern over exposure to potentially 
harmful residues and an increase in the consumption of 
seafood has led to calls for a seafood inspection program
121
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similar to those that exist for red meat and poultry 
[3.5,3.6].
Present and pending seafood inspection programs 
require analytical methods for identification of fish 
containing illegal chemical residues in edible tissues. 
Accordingly, regulatory agencies will need methods that 
are sensitive, specific, and practical for this purpose 
[3.8]. Traditional residue screening methods, such as 
microbial inhibition tests and chromatographic methods as 
presently used in poultry and red meat inspection, lack 
one or more of these characteristics. There is also a 
lack of practical residue screening methods available for 
use by the producer in a field setting for the pre-harvest 
detection of violative drug residues. Field testing could 
reduce the condemnation of harvested fish and subsequent 
producer losses and impact in a positive manner the 
function of a food fish drug monitoring program by a 
reduction in the marketing of fish with over-tolerance 
residue levels. However, there are no such methods 
available for field use at present.
Screening tests may be directed to the detection of a 
class of compounds or to a specific compound. The limited 
number of drugs approved for use in the US for aquaculture 
permits residue detection programs for domestically reared 
catfish to focus on a small number of therapeutic 
compounds. The high specificity of immunochemical assays,
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such as enzyme-linked immunosorbent assays (ELISA), make 
them well suited for the detection of a single compound of 
interest. The recent commercial availability of several 
ELISA-based tests for sulfadimethoxine (SDM) provides an 
opportunity for their application to the detection of SDM 
residues in various food animal tissues. These rapid, 
easy to use, relatively inexpensive, and sensitive tests 
may be used, depending on test format, in field settings 
or regulatory laboratories. Thus, application of 
appropriate extraction and determinative techniques to 
food animal tissues would allow for a more efficient 
monitoring program by decreasing the turnaround time, 
increasing the number of samples analyzed, and providing a 
method for preharvest residue determination on site.
Sulfadimethoxine (SDM) is the sulfonamide component 
of the potentiated sulfonamide Romet-30® and is commonly 
used in channel catfish aquaculture. It is one of only 
two systemic antibacterial agents available in the U.S. 
for use in food fish. The withdrawal period of this drug 
for catfish, when used according to label instructions, is 
three days [3.9]. However, a number of factors can affect 
the ultimate SDM residue levels in muscle tissue of 
treated fish and include water temperature and medicated 
feed intake variation [3.10-3.12]. Off-label use, such as 
prophylactic administration, may also result in violative 
SDM residues in marketed catfish.
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Recently introduced technology, utilizing matrix 
solid phase dispersion (MSPD) for extraction [3.13,3.14] 
and enzyme immunoassay for detection and quantitation 
[3.15], may accommodate the need for rapid, practical, and 
efficient extraction and the sensitivity and specificity 
requirements of detection needed in a screening assay.
Drug extraction from animal tissues is a limiting factor 
in the utility of a screening test for field use, and is a 
labor, solvent, and time cost factor in a regulatory 
screening laboratory. MSPD, when compared to classical 
extraction methods, greatly reduces extraction time and 
greatly reduces the tissue mass and hence the solvent 
volumes needed for drug isolation. The MSPD procedure and 
its application to the isolation of a variety of drugs, 
including several sulfonamides, from various matrices have 
been reported [3.16-3.19].
This study examines the use of MSPD derived extracts 
of SDM fortified channel catfish muscle in four enzyme 
immunoassays for the detection of SDM residues at tissue 
concentrations of 0, 25, 50, 100, and 250 ng/g. This 
paper presents the first application of MSPD technology 
for the isolation, with subsequent determination by 
immunoassay, of SDM as a residue in channel catfish 
muscle.
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EXPERIMENTAL
REAGENTS AND EXPENDABLE MATERIALS
(a) SOLVENTS.— Liquid chromatography (LC) grade 
solvents from commercial sources were used without further 
purification.
(b) CHEMICALS.— Note: Wear rubber gloves and 
protective clothing when handling. Sulfachloropyridazine, 
sulfadiazine, sulfadimethoxine (SDM), sulfamerazine, 
sulfamethazine, sulfapyridine, sulfaquinoxaline, 
sulfathiazole, p-aminobenzoic acid, folic acid, 
tetracycline, chlortetracycline, oxytetracycline, 
erythromycin, lincomycin, flumequine, oxolinic acid, 
nalidixic acid, thiamphenicol, novobiocin, and ampicillin 
were obtained from Sigma Chemical Co., (St. Louis, MO). 
Enrofloxacin was obtained as Baytril® Injection 
(Haver/Diamond Scientific, Shawnee, KS)/ Ormetoprim was 
graciously supplied by Dr. Ronald Thune.
(c) 4-N-ACETYLSULFADIMETHOXINE.— synthesized 
according to the procedure of Nielsen [3.20]. Identity 
confirmed with high performance liquid chromatography and 
direct probe, chemical ionization, positive ion mass 
spectrometry.
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(d) MSPD COLUMN MATERIAL — preparative grade C18, 40 
/tin, 18% carbon load, endcapped; obtained from Analytichem 
International (Harbor City, CA). The C18 was cleaned prior 
to use with sequential washings of 2 volumes each of 
hexane, dichloromethane, and methanol; then vacuum 
aspirated until dry. Stored at room temperature in a 
closed container until use.
(e) SAMPLE COLUMNS — 10 ml disposable plastic 
syringe barrels (Becton Dickinson Co., Franklin Lakes,
N.J.) were washed with hot soapy water, triple rinsed with 
each of tap water, double distilled water, and methanol; 
air dried prior to use. Whatman no. 1, 1.5 cm paper 
filters were placed proximally and distally to the tissue- 
Cjg blend to secure this material in place within the 
column. A syringe plunger, modified by removal of the 
rubber tip, was used to pack material in the column. A 
modified plastic pipet tip (100 fil) was placed on the 
syringe tip to direct and control flow rate through the 
column.
SAMPLES
Channel catfish, with no history of drug 
administration, were obtained from an indoor recirculating 
water culture system. Skinless fillets were stored frozen 
(-20°C) and used within 1 month. Samples had
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concentrations of SDM less than 25 ng/g as determined by 
LC analysis of MSPD extracts [3.19]. A total of 60 
fortified muscle samples (dorsal epaxial muscle group) 
were extracted and evaluated in each of four ELISA test 
systems. Three fish were used; four samples from each 
fish were analyzed at each of the five SDM concentrations 
tested.
EXTRACTION PROCEDURE
A 0.5 g portion of catfish fillet was placed in a 
clean polystyrene weighing boat and injected with 5 fil of 
SDM stock solution (concentrations of 0, 2.5, 5, 10, 25 /xg 
SDM/ml methanol) to give tissue concentrations of 0, 25,
50, 100, and 250 ng/g. The samples were allowed to stand 
2 minutes, placed in a glass mortar containing 2 g of C18, 
and blended using a glass pestle until a homogenous 
mixture was obtained (-1 min.). The resulting blend was 
then placed in a column previously fitted with a 1.5 cm 
disc paper filter frit, another paper filter was placed on 
top of the packing, and the packing was compressed to a 
volume of -4.5 ml using a modified syringe plunger.
The tissue-Clg blend was washed with 8 ml of hexane 
and the wash was discarded. The column was then placed 
over a clean 12 ml glass vial and the SDM eluted using 8 
ml of dichloromethane. The DCM extract was placed in a
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 2 8
35°C water bath and evaporated to dryness under nitrogen. 
The eluent was reconstituted by the addition of 100 p.1 of 
methanol and vortexed. Four hundred fil of a buffer 
appropriate for the test was added to give a final volume 
of 500 fil, and vortexed. Depending on the assay level of 
sensitivity, this solution was either used directly or 
further diluted 10-fold with buffer.
ELISA PROCEDURES
MSPD extracts of SDM fortified catfish muscle and 
sulfonamide standards were analyzed by four commercially 
available ELISAs. These test kits are based on the 
principle of direct, competitive solid phase enzyme 
immunoassay and comparison of the relative color 
development of the sample with a negative control.
Negative samples exhibit the greatest color development 
and positive samples the least development. The tests 
were packaged containing all reagents and components, and 
test procedures were described in directions for use 
included with each kit. Results may be qualitative or 
quantitative, respectively, when determined visually or 
using optical density (OD) values. Test kits were stored 
at 4°C when not in use; all reagents and components were 
allowed to come to room temperature (23°C-29°C) prior to 
use.
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(a) SIGNAL® SULFAMETHAZINE DETECTION TEST (SIGNAL) —  
(SmithKline Beecham Animal Health, Exton, PA); a 
quantitative MICROTITER® well format. The MSPD extract in 
SIGNAL buffer was used without further dilution. The 
SIGNAL test is marketed for the detection of 
sulfamethazine in milk, muscle, serum, urine, and feeds 
but also exhibits a degree of cross-reactivity with SDM 
and several other sulfonamides. Test Procedure: 20 fil of 
sample was placed in the bottom of a test well and 100 fil 
sulfamethazine enzyme conjugate added. The solutions were 
mixed by gentle tapping and incubated at room temperature 
for 20 minutes. The sample wells were emptied and washed
3 times using the supplied wash solution. 150 fil of 
substrate was then added to each well and incubated at 
room temperature for 30 minutes and OD values were 
obtained.
(b) IDS SULFADIMETHOXINE ONE-STEP ELISA (IDS)—  
(International Diagnostics Systems Corp., St. Joseph, MI); 
a quantitative MICROTITER® well ELISA for the detection of 
SDM residues in serum, milk, urine, muscle, liver, kidney, 
and feed. Same procedure as for the SIGNAL test except 
the substrate incubation time was 10 minutes prior to 
reading. This test has a lower detection limit of 10 ng 
SDM/ml, therefore the MSPD extract and SDM standards were 
diluted 1:9 with supplied buffer to obtain an appropriate
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test concentration for the detection of tissue 
concentrations of 100 ng SDM/g.
(c) CITE® SULFA TRIO™ (CITE)— (IDEXX Laboratories, 
Inc., Westbrook, ME); a qualitative assay for the 
detection of sulfdimethoxine, sulfathiazole, and 
sulfamethazine residues in milk by use of a CITE cup 
device. This device contains a membrane filter with a 
negative control spot and three discrete test areas, each 
coated with antibody to one sulfonamide. The MSPD extract 
was used without further dilution. Test procedure: The 
CITE device is wetted using 15 drops of supplied wash 
solution and allowed to completely absorb. Sample (240 
/xl) and conjugate solution (240 fil) were combined, poured 
into the CITE device, and incubated for 3 minutes at room 
temperature. The prefilter was discarded, the membrane 
washed using -2 ml of wash solution, and 3 drops of 
substrate solution were applied to the test spots. The 
device was then incubated at room temperature for 2 
minutes, 15 drops of stop solution were added, and the 
result was visually determined.
(d) EZ-SCREEm:SULFADIMETHOXINE (EZ-SCREEN) —
(Environmental Diagnostics, Inc., Burlington, NC); a 
qualitative assay for detection of SDM residues in milk, 
urine, serum, and feed using the QUIK-CARD® format. The 
QUIK-CARD® system consists of a solid support card 
containing two membrane-based test ports; negative control
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and sample. Results are obtained within 10 minutes by 
visual comparison of relative color development of the two 
spots. The lower detection limit of the assay is 10 ng 
SDM/ml. Therefore, the MSPD tissue extract was diluted 
1:9 with supplied buffer to obtain an appropriate test 
concentration for the detection of tissue SDM 
concentrations of 100 ng/g or greater. Test procedure:
One drop of diluted extract was applied to the sample spot 
and one drop of negative control solution to the control 
spot and allowed to absorb. One drop of enzyme solution 
was applied to all test sites and allowed to absorb. One 
drop of negative control was then applied to all test 
sites, absorbed, and excess fluid cleaned from around test 
sites. Two drops of substrate solution were then applied 
to all test sites, incubated at room temperature for 5 
minutes, and results were evaluated visually.
RESULT DETERMINATION
The ability of an assay to accurately identify 
samples containing SDM above tolerance is essential for 
its use as a screening test. The United States Food and 
Drug Administration (FDA) tolerance for total SDM residues 
in channel catfish muscle is 100 ng SDM/g [3.21].
Therefore, samples containing SDM concentrations less than 
100 ng/g were considered negative and those samples
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containing 100 ng SDM/g or greater were considered 
positive in this study.
SIGNAL and IDS analyses of extracted fortified muscle 
samples and standards were performed with a Dynatech 
MR5000 ELISA plate reader (Dynatech Laboratories, 
Alexandria, VA); absorbance was measured in dual 
wavelength mode, test filter of 630 nm and reference 
filter of 490 nm. The mean of duplicate wells was used 
for determination of test results.
A decision point for the determination of muscle 
samples containing greater than or equal to 100 ng SDM/g 
tissue was developed using the upper end of an interval 
expected to contain 95% of the OD sample/OD blank 
observations for muscle samples containing 100 ng SDM/g. 
This interval was obtained using the 95% t distribution of 
mean OD sample/OD blank values for MSPD extracted muscle 
samples containing 100 ng SDM/g. This interval was 
calculated using (mean ± t*(std. dev.)] where t* is the a/2 
t value for 11 degrees of freedom and alpha is equal to 
0.05. The higher end (lower concentration) of this 
interval was used as a decision point such that OD 
sample/OD blank values less than or equal to the decision 
point were called positive and values greater than the 
decision point were negative.
CITE and EZ-SCREEN test results were evaluated 
visually by 2 independent evaluators in a single blind
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manner. Evaluation criteria for the determination of 
positive or negative results were used as given in the 
product information sheet for the EZ-SCREEN test. The 
criteria for the CITE test as furnished in the product 
information sheet indicated a sample is positive if the 
SDM spot is lighter in color than the negative control 
spot. However, when using MSPD extracts of muscle samples 
containing no SDM, the control spot was often darker in 
color than the SDM spot. Therefore, the procedure and 
evaluation criteria used for the CITE test were modified 
by using undiluted extract and declaring only samples that 
exhibited no color development as positive responses.
Performance as indicated by sensitivity, specificity, 
efficiency, and positive and negative predictive values 
was determined from these results.
RESULTS AND DISCUSSION
PRECISION
Precision was evaluated using intra-assay and inter­
assay variation of the two quantitative MICROTITER® well 
test systems. Percent agreement of results between the 
two evaluators was used as an indicator of the variability
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of response for the two qualitative membrane-based visual 
tests.
INTRA-ASSAY VARIATION — The within-run precision or 
the precision of duplicate wells of the same sample run in 
the same assay under the same conditions. It represents 
the variability inherent in the test that results from 
variations in test components and analytical 
instrumentation. Intra-assay variation is defined as the 
coefficient of variation (CV) of duplicate wells and is 
calculated for each of five concentrations examined and 
overall.
The CV of optical density values at each 
concentration, both MSPD extracted samples and standards, 
was calculated using the mean OD value for the 
concentration and an estimate of the standard deviation 
(SD) of duplicates made by pooling the results of 
duplicate wells of the individual samples [3.22]. The 
estimate of SD was made by: SD = v (ED2) /N , where D =
difference between duplicates, and N = number of 
observations (wells). Overall intra-assay variation for 
the assay is the mean CV of the five individual 
concentrations. Results are presented in Table 3.1 with 
overall intra-assay variability of 5.6% and 7.7% 
respectively for the SIGNAL and IDS tests using MSPD 
extracted samples and 3.6% and 7.1% for SDM standards.
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(ng/g) SIGNAL IDS* SIGNAL1’ IDS*
0 5.2 6.0 6.0 5.2
25 5.4 7.3 --- 6.3
50 3.7 6.8 2.6 9.9
100 9.8 10.5 2.2 7.6
250 3.9 7.7 3.5 6.5
Overall CV 5.6 7.7 3.6 7.1
(mean ± SD) ± 2.5 ± 1.7 ± 1.7 ± 1.8
* N = 24 wells / cone
t N = 6 wells / cone
$ N = 10 wells / cone
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This variability between duplicates is less than 10% as 
recommended by Feldcamp and Smith [3.23].
EVALUATOR VARIABILITY — This is expressed as the 
percent agreement of the two evaluators for the two 
visually determined tests (CITE, EZ-SCREEN) for 60 MSPD 
extracted samples. The formula for calculating % 
agreement was:
% agreement = (# samples with same result/total # samples) 
X 100. The results presented in Table 3.2 show an overall 
evaluator agreement rate of 77% for the CITE test and 95% 
for the EZ-SCREEN test. There was considerable variation 
in agreement depending on tissue concentration examined. 
The CITE test exhibited variable color development of the 
SDM test spot when testing samples containing less than 
100 ng SDM/g. This was especially noticeable at 
concentrations of 25 and 50 ng SDM/g tissue as indicated 
by a higher number of evaluator disagreements at these 
concentrations. The EZ-SCREEN test had 100% agreement 
between evaluators at concentrations of 0, 25, and 250 ng 
SDM/g and 3 disagreements/24 samples at the borderline 
concentrations of 50 and 100 ng SDM/g. Both tests had 
100% agreement in evaluator results for samples containing 
250 ng SDM/g.
INTER-ASSAY VARIATION — This represents the variation 
among different samples of the same concentration and 
includes variables associated with intra-assay variation,
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TABLE 3.2 THE % AGREEMENT BETWEEN OBSERVERS FOR VISUALLY 






0 92 (1) 100 (0)
25 58 (5) 100 (0)
50 42 (7) 83 (2)
100 92 (1) 92 (1)
250 100 (0) 100 (0)
overall* 77 (14) 95 (3)
* () Number disagreed upon/12 samples 
$ () Number disagreed upon/60 samples
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extraction, tissue variation, sample incubation time, 
operator error and other factors. The incubation time 
effect can be normalized by transforming the data using 
sample OD/Blank OD values. Inter-assay variation for each 
of the 5 concentrations was determined for both MSPD 
extracted samples and standards using OD and sample 
OD/blank OD values. Inter-assay variation for each 
concentration is defined as the CV of twelve individual 
samples extracted and assayed at different times. It was 
calculated for each concentration using the mean and SD of 
duplicate well means. Overall inter-assay variation was 
obtained by averaging the individual concentrations' CV's.
The inter-assay variation of the SIGNAL and IDS 
assays is presented in Table 3.3 for MSPD extracted 
samples and standards using both optical density and 
sample OD/blank OD values. The inter-assay variation 
increases with increasing concentration. This is the 
result of a decreasing mean OD or sample OD/blank OD value 
that occurs with increasing concentration, while the SD of 
these means remains relatively constant over all 
concentrations. This is likely representative of the 
inherent variability of extraction, measurement, and the 
assay itself. The repeatability of the assays for 
extracted samples, as indicated by the overall inter-assay 
variation of sample OD/blank values, was 7.9 ± 2.4% for 
SIGNAL and 16.6 ± 7.0% for IDS. This range is typical of

















TABLE 3.3 INTER-ASSAY VARIATION (CV)
MSPD extracted samples* Standards1*
Optical density 
(CV)
Sample OD/Blank OD 
(CV)
Optical density 
(CV) Sample OD/Blank OD (CV)
Tissue SDM 
concentration
(ng/g) SIGNAL IDS SIGNAL IDS SIGNAL IDS SIGNAL IDS
0 13.7 14.9 -- -- 2.8 16.3 --
25 14.1 16.1 6.1 9.8 -- 11.5 -- 5.6
50 13.6 13.5 5.6 11.4 3.8 14.0 4.0 6.4
100 13.1 23.6 9.3 21.8 2.4 19.0 4.2 12.6






















N = 12 samples/concentration; duplicate wells means 
N = 6 wells/concentration for SIGNAL 




ELISAs [3.24-3.26]. Inter-assay variation of standards 
using sample OD/blank OD values was about one-half of the 
variation for the extracted samples and represents the 
between run variation of the assay itself. Optical 
density values of individual MICROTITER® wells obtained 
using MSPD extracts of fortified catfish muscle are 
presented in Appendixes A and B for the IDS and Signal 
assays respectively.
TEST PERFORMANCE
The criteria used to evaluate test performance of the 
four assays were sensitivity, specificity (including 
cross-reactivity), efficiency, positive predictive value, 
and negative predictive value. Sensitivity and 
specificity are fundamental parameters of test performance 
while efficiency and predictive values provide an 
estimation of the likelihood of a test result being 
correct [3.27]. Formulas used to calculate performance 
parameters are given in Figure 3.1. Test performances for 
individual concentrations and overall are given in Tables
3.4 and 3.5.
SENSITIVITY — Sensitivity is the ability of a test to 
correctly identify samples containing greater than or 
equal to 100 ng SDM/g tissue. It is the most important 
criteria for a screening test. For an assay to be useful
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SDM > 100 ng/g 
present____________ absent
positive true positive false positive
Test (TP) (FP)





Predictive value (+) 
Predictive value (-)
[TP/ (TP + FN) ] X 
[TN/ (TN + FP) ] X 
[(TP + TN)/total 
[TP/ (TP + FP) ] X 







FIGURE 3.1 2 X 2  CELL MATRIX ILLUSTRATING THE FOUR 
POSSIBLE TYPES OF TEST RESULTS AND FORMULAS 
FOR CALCULATING PERFORMANCE PARAMETERS.
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TABLE 3.4 RESULTS & PERFORMANCE FROM THE ANALYSIS OF 


















Blank SIGNAL 12 0 100
IDS 12 0 100
CITE 21 3 88
EZ-SCREEN 24 0 100
25 SIGNAL 12 0 100
IDS 12 0 100
CITE 19 5 79
EZ-SCREEN 24 0 100
50 SIGNAL 9 3 75
IDS 10 2 83
CITE 11 13 46
EZ-SCREEN 20 4 83
100 SIGNAL 12 0 100
IDS 12 0 100
CITE 23 1 96
EZ-SCREEN 23 1 96
250 SIGNAL 12 0 100
IDS 12 0 100
CITE 24 0 100
EZ-SCREEN 24 0 100
12 samples/concentration
Signal, IDS; duplicate wells using sample/blank optical 
density values with result determined using 95 % t distribution 
decision point
CITE, EZ; 2 independent visual determinations/sample
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SIGNAL 100 92 95 89 100
IDS 100 94 97 92 100
CITE 98 71 82 69 98
EZ-
SCREEN
98 94 96 92 99
* 60 samples/test; 12 at each of 5 concentrations
(0,25,50,100,250 ng/g) 
t Signal, IDS; duplicate wells using mean sample/blank optical 
density values; result determined using 95 % t distribution 
decision point
$ CITE, EZ; 2 independent visual determinations/sample
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as a screening test it must identify such samples with a 
high degree of accuracy. Sensitivity is defined as the 
percent of correctly identified positive samples (true 
positives) of the total number of known positive samples 
tested. Performance results show all four assays had 
overall sensitivities of 98-100% for MSPD extracted 
samples containing violative levels of SDM and 100% 
sensitivity for samples containing 2.5 times (250 ng 
SDM/g) the FDA tolerance. This indicates that these 
assays, using MSPD extracts, can be used to accurately 
identify catfish muscle samples that contain violative SDM 
residues.
SPECIFICITY — The ability of a test to correctly 
identify negative samples. Muscle samples containing SDM 
at concentrations below the FDA tolerance of 100 ng SDM/g 
were considered negative in this study and included 
concentrations of 0, 25, and 50 ng SDM/g muscle.
Specificity was calculated as the percent of true negative 
samples of the total number of known negative samples 
examined. The SIGNAL, IDS, and EZ-SCREEN tests correctly 
identified all samples containing 0 and 25 ng SDM/g as 
negative. For samples containing half of tolerance (50 ng 
SDM/g) these assays had specificities of 75%, 83%, and 83% 
respectively. Difficulty in evaluating negative samples 
(<100 ng SDM/g) with the CITE test, as a result of 
variable color development of the SDM test spot at these
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concentrations, resulted in a higher rate of false 
positive results than with the other tests. CITE 
specificities were 88%, 79%, and 46% for concentrations of 
0, 25, and 50 ng SDM/g.
The specificity of a test is important in reducing 
the number of confirmatory tests needed as a result of 
false positive results. The specificity of antibiotic 
screening tests for milk has been demonstrated to vary 
considerably among assay kits and has been related to the 
presence of inflammatory conditions of the mammary gland 
[3.28,3.29]. What effect the inflammatory process has on 
the specificity of drug screening tests used with tissues 
from sick fish is unknown.
CROSS-REACTIVITY — The specificity of an assay may be 
influenced by its cross-reactivity with other compounds. 
Cross-reactivity was examined using standard solutions in 
test buffer at concentrations of 0.1, 1, 10, and 100 /xg/ml 
for eight sulfonamides and fifteen other therapeutic 
compounds that are used in aquaculture in the US and 
worldwide or that may be present as feed contaminants.
The N-acetyl metabolite of SDM may comprise a large 
portion of the total SDM residue present in edible 
tissues. Therefore, to accurately assess total tissue SDM 
residues, a SDM residue screening assay should also detect 
N-acetyl SDM present in edible tissues or in biological 
fluids used as reference tissues. The relative
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 4 6
contribution of this metabolite to total SDM residue 
varies among species and tissues. In channel catfish, SDM 
is present in bile almost entirely in the N-acetyl form 
(>90% of total SDM residues) but SDM is present in plasma 
and muscle primarily (>95%) as parent compound [3.30]. In 
rainbow trout, however, N-acetyl SDM accounts for over 
half of the total SDM residue in muscle [3.31]. In this 
study, all four assays detected the N-acetyl metabolite 
equally as well as the parent compound.
Cross-reactivity for the quantitative tests (SIGNAL 
and IDS) was evaluated by a comparison of concentrations 
causing a fifty percent inhibition in color development of 
sample wells compared to blank wells when using standard 
solutions (EC-50). Cross-reactivity for the qualitative 
tests (CITE and EZ-SCREEN) was determined visually over a 
range of concentrations. Results are presented in Table 
3.6.
The SIGNAL test is marketed for the detection of 
sulfamethazine residues in several biological matrices but 
was found to cross-react to varying degrees with a number 
of other sulfonamides. This test should be considered a 
sulfonamide class assay rather than one specific for 
sulfamethazine. The sulfonamides demonstrating the 
highest level of reactivity in this test were 
sulfamethazine, sulfamerazine, SDM, and N-acetyl SDM.
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SIGNAL IDS CITE* EZ-SCREEN
Su1fadimethoxine 0.25 .004 .025* .01
N-acetyl SDM 0.25 .004 .025* .01
Sulfachlorpyridazine 8 76 10
Sulfadiazine 5 — —
Sulfamerazine <0.1 — —
Sulfamethazine <0.1 — —
Sulfapyridine 10 — —
Sulfaquinoxaline 45 100 —
Sulfathiazole 7.6 — —
p-Aminobenzoic Acid — — —
Folic Acid — — —
Ampicillin — — —
Ormetoprim — 86 100
Erythromycin — — —
Lincomycin — — —
Enrofloxacin — — —
Flumequine — — —
Oxolinic Acid — — —
Nalidixic Acid — — —
Chlortetracycline — — —
Oxyt et racyc 1 ine — — —
Tetracycline — — —
Novobiocin — — —
Thiamphenicol — — —
* Cross-reactivity determined using standard solutions in test
buffer
t cross-reactivity for SDM spot only
$ lowest concentration examined
—  EC-50 greater than 100 pg/ml or no reactivity up 100 pg/ml
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 4 8
The IDS test was quite sensitive to SDM and N-acetyl 
SDM with EC-5Os for these compounds of 4 ng SDM/ml. The 
IDS test had no appreciable reactivity with other 
sulfonamides. The CITE and EZ-SCREEN tests were also 
quite sensitive and specific havinq no substantial cross- 
reactivity for the compounds tested.
Fourteen of the non-sulfonamide compounds examined 
showed no cross-reactivity up to concentrations of 100 
lig/ml. Ormetoprim exhibited no reactivity in the SIGNAL 
and CITE tests but had a low level of reactivity in the 
IDS assay with a EC-50 of 86 Atg/ml and in the EZ-SCREEN 
test with a minimum detectable level of 100 /xg/ml. Romet® 
medicated feed for catfish contains ormetoprim at a 
concentration of 420-1650 \igjg feed depending on feeding 
rate [3.32]. This level may confound SDM test results for 
feed extracts of ormetoprim contaminated or medicated 
feeds. The expected therapeutic level of ormetoprim in 
catfish muscle (0.8 ftgfg) is well below the minimum 
detectable levels of these tests for ormetoprim [3.33].
Cross-reactivity of a test for compounds within a 
class of drugs is advantageous for a test intended as a 
drug class detection test. However, to accurately 
interpret test results the relative level of cross­
reactivity of the test with compounds within the class of 
drugs must be known. Additionally, tests marketed for the 
detection of a single compound (i.e. sulfamethazine in
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milk) often do not include information on cross-reaction. 
While cross-reactivity does not invalidate the use of a 
single compound detection test, it may cause 
misinterpretation of a positive result if a cross-reacting 
compound(s) is present and the level of cross-reaction is 
not known.
EFFICIENCY — is the percentage of all test samples 
that were correctly identified for a given population. 
Efficiencies of 82-97% are shown in Table 3.5.
POSITIVE PREDICTIVE VALUE AND NEGATIVE PREDICTIVE 
VALUE — indicates the probability of positive or negative 
results being correct. Positive predictive values ranged 
from 69% for the CITE to 92% for IDS and EZ tests.
Negative predictive values were 98-100% for all tests 
indicating a high level of confidence can be placed in 
negative results for these tests. Predictive value 
results and comparisons of performance using single or 
duplicate wells and OD or % blank values are presented in 
Tables 3.7 and 3.8.
The purpose of the present study was to evaluate the 
performance of commercially available immunoassays for the 
detection of violative levels of SDM residues in channel 
catfish muscle using MSPD derived extracts. To fully 
utilize the speed and simplicity of newer determinative 
methods such as immunoassays in a drug monitoring program, 
rapid and simple drug isolation methods are needed.
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TABLE 3.7 OVERALL PERFORMANCE COMPARISONS OF
SINGLE/DUPLICATE NELLS AND OF OPTICAL DENSITY/% 
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60 samples/test; result determined using 95 % t distribution 
decision points
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TABLE 3.8 COMPARISONS OF INDIVIDUAL CONCENTRATION RESULTS 
AND PERFORMANCES FROM THE ANALYSIS OF MSPD 
EXTRACTED CATFISH MUSCLE* USING 
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Classical methods for the isolation of sulfonamide 
residues from animal tissues are complex and lengthy 
procedures that require multiple steps involving 
homogenization of the sample in aqueous or organic 
solvents, protein precipitation, centrifugation, pH 
adjustments, transfer of the supernatant, counter-current 
extraction, back-extraction, and/or solid phase isolation. 
The primary disadvantages of these traditional methods are 
that they are costly in terms of labor and solvent use, 
and they limit the number of samples analyzed due to their 
complexity and the time needed to complete the extraction. 
MSPD eliminates many of the steps and overcomes many of 
the difficulties associated with classical extraction 
techniques. The MSPD theory and process have been the 
subject of recent reviews [3.13,3.14]. In general, its 
main advantages are that it is a relatively rapid method 
that allows for the analysis of a larger numbe r  of 
samples, it considerably decreases solvent use because of 
the small sample size (0.5g) required, and is amenable to 
automation.
The performance results obtained using fortified 
samples indicate MSPD extracts of catfish muscle could be 
used in the SIGNAL, IDS, CITE, or EZ-SCREEN tests for 
screening catfish muscle samples for violative SDM 
residues. The SIGNAL and IDS tests are well suited for 
screening large numbers of samples in a properly equipped
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laboratory. The IDS tests' large difference in color 
between positive and blank samples might also permit its 
use as a visually determined qualitative test but requires 
further evaluation. Either the CITE or EZ-SCREEN tests 
could be used in a laboratory for regulatory purposes or 
used on-site to determine the advisability of harvesting 
treated fish that possibly contain violative levels of 
SDM. The CITE test, as used in this study, was less 
desirable because of the higher number of false positive 
results. This may be a matrix-specific effect and could 
possibly be rectified by sample dilution and a change in 
result evaluation criteria. It should be emphasized that 
the performances of these tests using muscle extracts 
should not be extended to milk or other matrices.
Further studies of the applicability of these 
procedures to catfish muscle containing incurred SDM 
residues are planned but were outside the scope of present 
methods development research.
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CHAPTER 4
EXTRACTION AND LIQUID CHROMATOGRAPHIC 
ANALYSIS OF SULFADIMETHOXINE AND 
4-N-ACETYLSULFADIMETHOXINE RESIDUES IN 
CHANNEL CATFISH {Ictalurus punctatus)
MUSCLE AND PLASMA
INTRODUCTION
The demand for fisheries products has greatly 
increased in the last 10 years and continued growth is 
expected [4.1,4.2]. As a result aquaculture is a large 
and rapidly growing industry and will play an increasingly 
important role in meeting the global demand for edible 
aquatic resources as wild fishery landings approach their 
biological limits [4.2]. The use of antibacterial drugs 
in intensive fish culture systems is commonly practiced 
and is necessary for control of infectious bacterial 
disease outbreaks [4.3]. However, the use of 
antibacterials creates the potential for drug residue 
problems in cultured fish. In the U.S., fish products are 
not required to pass continuous federal inspection. 
Regulatory authority for seafood safety is divided among a 
number of local, state, and federal agencies [4.4].
Public perceptions that uninspected seafood may contain 
harmful chemicals [4.1], the increase in seafood 
consumption, and the growth of aquaculture have led to 
calls for the establishment of a federal seafood
160
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inspection program similar to the ones that now exist for 
red meat and poultry [4.4,4.5].
Pending U.S. federal legislation concerning 
establishment of such an inspection program for seafood 
will require analytical methods for extraction, screening, 
quantitation, and confirmation of chemical residues in 
food fish [4.6]. At present there are few analytical 
methods that have been validated for use in seafood for 
detection of violative residues of the many therapeutic 
compounds used in aquaculture domestically or worldwide 
[4.5]. Therefore, methods are needed that are practical, 
sensitive, and specific for enforcement of the nation's 
present and anticipated future regulatory limits for 
chemical residues in aquatic food resources.
Drug residue violations in the United States red meat 
and poultry industries most frequently result from a 
failure by the producer to observe the stated withdrawal 
time for an approved drug [4.7,4.8]. If a similar trend 
holds for aquaculture, the greatest number of residue 
violations would be expected for approved drugs that have 
been used by the producer in a manner not in accordance 
with label directions. Therefore, methods development 
efforts for extraction and detection of drug residues in 
domestically produced aquaculture products should focus
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initially on the limited number of approved compounds used 
in cultured fish in the US.
There are presently only three systemic antibacterial 
agents that are approved for use in aquaculture in the 
United States; and only two of these are currently 
marketed. One of these, Romet-30®, is a potentiated 
sulfonamide containing sulfadimethoxine (SDM) and 
ormetoprim (OMP) in a 5:1 ratio. The channel catfish is 
the major aquaculture species in the US accounting for 56% 
of the total US aquacultural production in 1988 [4.2] and 
360 million pounds produced in 1990 [4.9] and Romet-30® is 
frequently used in this species for the control of enteric 
septicemia of catfish. Therefore, practical methods for 
detection, quantitation, and confirmation of SDM and OMP 
residues in channel catfish are urgently needed.
A number of analytical methods have been reported for 
SDM and OMP residues in edible aquatic tissues [4.10- 
4.21], However, no methods are available for the 
simultaneous quantitation of SDM and its primary 
metabolite, 4-N-acetylsulfadimethoxine (N-acetyl SDM), in 
channel catfish muscle. Further, several of the methods 
lack the sensitivity needed for detection of SDM residues 
at tolerance. Methods employing classical extraction 
techniques involving homogenization, liquid-liquid 
partitioning, and/or other sample preparation steps are
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lengthy and use relatively large volumes of organic 
solvent. One purpose of this study was to develop a 
practical, accurate, and precise method for rapidly 
extracting and quantifying SDM and N-acetyl SDM residues 
in channel catfish muscle and plasma at tissue 
concentrations about the FDA tolerance of 100 ng/g. 
Additionally, a method using small volumes of solvent was 
desired. This paper presents a simplified matrix solid 
phase dispersion (MSPD) extraction procedure for use with 
biological fluids and the first application of MSPD and 
microbore analytical column technology for the 
simultaneous extraction and high performance liquid 
chromatographic (LC) analysis of SDM and its primary 
metabolite as residues in channel catfish muscle and 
plasma.
EXPERIMENTAL
REAGENTS AND EXPENDABLE MATERIALS
(a) SOLVENTS — Liquid chromatography grade from 
commercial sources was used without further purification. 
Phosphate buffer (0.017M) for LC mobile phase was prepared 
by placing 1.143 ml of orthophosphoric acid (44.6N) in
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 6 4
triple-distilled water sufficient to make 1 L total 
volume.
(b) WATER — For LC analyses triple-distilled and 
passed through a Modulab™ Polisher I water purification 
system (Continental Water Systems Corp., San Antonio, TX)
(c) CHEMICALS — Note: Wear rubber gloves and 
protective clothing when handling. Sulfadimethoxine (SDM) 
and Sulfamethoxazole (SMX) were obtained from Sigma 
Chemical Co., (St. Louis, MO).
(d) 4-N-ACETYLSULFAJDIMETHOXINE. — synthesized 
according to the procedure of Nielsen [4.22]. Identity 
confirmed with high performance liquid chromatography and 
direct probe, chemical ionization, positive ion mass 
spectrometry.
(e) STANDARD SOLUTIONS — Separate stock solutions of 
SDM, N-acetyl SDM, and SMX were prepared by dissolving 40 
mg of compound in 50 ml methanol. Fortification solutions 
at concentrations of 5, 10, 20, 40, & 100 ngj ml were 
prepared for each compound by diluting stock solutions in 
methanol and were stored in the dark at 4°C
(f) MSPD COLUMN MATERIAL — preparative grade C18/ 40 
frn, 18% carbon load, end capped (Analytichem Bondesil™, 
Part No. 1221-3013)? obtained from Varian Associates 
(Harbor City, CA). The C18 was cleaned prior to use by 
washing with 2 volumes of dichloromethane; then vacuum
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aspirated to remove excess solvent. Stored at room 
temperature in a closed container until use.
(g) MSPD EXTRACTION COLUMNS
MUSCLE EXTRACTIONS — 10 ml disposable plastic syringe 
barrels (Becton Dickinson Co., Franklin Lakes, NJ) were 
washed with hot soapy water, triple rinsed with each of 
tap water, double distilled water, and methanol; air dried 
prior to use. Whatman no. 1, 1.5 cm paper filters were 
placed proximally and distally to the tissue-C18 blend to 
secure this material in place within the column. A 
syringe plunger, modified by removal of the rubber tip, 
was used to compact material in the column.
PLASMA EXTRACTIONS --0.8 X 4 cm disposable 
polypropylene chromatography columns containing a 35 p  
polyethylene frit were used as supplied without further 
cleanup (Poly-Prep column, cat. no. 731-1550, Bio-Rad 
Laboratories, Richmond, CA).
A plastic pipet tip (100 /xl), modified by removing -1 
cm from the proximal and distal ends, was placed on the 
syringe or column tip to direct and control flow rate 
through the column.
(h ) SAMPLES
MUSCLE — Drug-free channel catfish were obtained from 
an indoor recirculating water culture system. Skinless 
fillets were stored frozen (-20°C).
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PLASMA — Market sized channel catfish, with no 
history of drug administration, were captured by seining 
from a local commercial catfish farm. Blood samples were 
taken by venipuncture of the caudal vein. Heparinized 
blood samples were centrifuged and plasma stored at -20°C 
in glass tubes.
Muscle and plasma samples were found to be free of 
SDM concentrations greater than 25 ng/g as determined by 
LC analysis of MSPD extracts [4.19]. Three fish were used 
for muscle and plasma fortification studies; two samples 
from each fish were analyzed at each of the five SDM and 
N-acetyl SDM concentrations tested. All samples were used 
within 1 month.
EXTRACTION PROCEDURE
(a) MUSCLE — 0.5 g of catfish fillet was placed in a 
clean polystyrene weigh boat, allowed to reach ambient 
temperature, and injected with 5 pil each of separate SDM 
and N-acetyl SDM fortification solutions (concentrations 
of 0, 5, 10, 20, 100 pig SDM or N-acetyl SDM/ml methanol) 
appropriate to achieve tissue concentrations of 0, 50,
100, 200, and 1000 ng/g of each compound. SMX was added 
as an internal standard by the injection of 5 pi of a 100 
pig SMX/ml methanol fortification solution to give a tissue
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concentration of 1000 ng/g. The samples were allowed to 
stand 2 minutes, placed in a glass mortar containing 2 g 
of Cjg, and blended using a glass pestle until a homogenous 
mixture was obtained (-1 min.). The resulting blend was 
then placed in a column fitted with a 1.5 cm disc paper 
filter frit, another paper filter placed on top of the 
packing, and the packing compressed to a volume of ~4.5 ml 
using a modified syringe plunger.
The tissue-CIg blend was washed with 8 ml of hexane 
and the wash discarded. The column was placed over a 
clean 12 ml glass vial and the three sulfonamides eluted 
using 8 ml of dichloromethane (DCM). The DCM extract was 
placed in a 35°C water bath and evaporated to dryness 
under nitrogen. The eluent was reconstituted by the 
addition of 500 fil of mobile phase, vortexed, and 
sonicated (Bransonic® 1200, Branson Ultrasonic Corp., 
Danbury, CT) for 7 minutes. The sample extract was 
transferred to a 1.5 ml polypropylene test tube (Micro 
Tube, cat. no. 72.690.475, Sarstedt, Inc., Newton, NC), 
centrifuged for 5 minutes at 15,600 X g (Centra-M, 
International Equipment Co., Needham Hts., MA), and the 
supernatant was filtered using a 0.45 jLim syringe filter 
(Nalgene®, cat. no. 176-0045, Rochester, NY) into an LC 
autosampler vial.
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(b) PLASMA — 0.5 ml aliquots of catfish plasma were 
placed in 1.5 ml polypropylene test tubes and 5 pi each of 
SDM and N-acetyl SDM fortification solutions 
(concentrations of 0, 5, 10, 20, 40, 100 fig/ml methanol) 
were added to achieve plasma concentrations of 0, 50, 100, 
200, 400, and 1000 ng/g of each compound. 5 /il of a 100 
pg SMX/ml methanol fortification solution was added to 
each tube as an internal standard and vortex mixed.
Plasma samples were extracted using a modification of 
the MSPD procedure. The C18 was weighed (400 mg), placed 
in a Poly-Prep column, and 100 pi of plasma added. The 
plasma and C18 were vortex mixed for 30 sec; then packed to 
a volume of -0.8 ml using a glass rod. The snap-off tip 
was removed from the column, a modified pipette tip placed 
on the tip, and the column placed over a 6 ml glass tube. 
The plasma-C18 blend was washed with 2 ml of hexane and the 
wash discarded. The column was then placed over a clean 6 
ml glass tube and the three sulfonamides eluted using 2 ml 
of DCM. The DCM extract was placed in a 35°C water bath 
and evaporated to dryness under nitrogen. The eluent was 
reconstituted by the addition of 250 pi of mobile phase, 
then processed as with the muscle extracts.
(c) SOLID PHASE EXTRACTION — 100 pi of catfish plasma 
fortified with SMX at 1000 ng/ml, and SDM and N-acetyl SDM 
at 200 ng/ml each was diluted to 2 ml with 0.017 M aqueous
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phosphoric acid and applied to the top of a Poly-Prep 
column containing 400 mg of Clg. Positive pressure was 
applied to the head of the column using a bulb syringe to 
achieve a flow of -1 ml/min through the packing bed. Wash 
and elution solvents and sample processing were performed 
as with the plasma MSPD procedure.
LIQUID CHROMATOGRAPHIC ANALYSIS
(a) APPARATUS — All analyses were performed using a 
Hewlett Packard 1090 liquid chromatograph equipped with a 
variable volume auto-injector and a photodiode array 
detector set at 265 nm (20 nm bandwidth), reference 
spectrum of 450 nm (100 nm bandwidth), and spectrum range 
of 210-320 nm. LC control, data acquisition, and peak 
integration were performed using Hewlett-Packard HPLC30 
ChemStation Software (DOS Series)(Part No. G1300-900006).
A reversed phase narrow-bore column packed with 
octadecylsilyl (ODS) derivatized silica (200 X 2.1 mm, ODS 
Hypersil, 5 (m, Part No. 799160D-572, Hewlett-Packard, 
Wilmington, DE) maintained at ambient temperature was used 
for all analyses.
(b) SOLVENT — The mobile phase was a mixture of 0.017 
M aqueous H3P04 (pH 2.4)(PB) and acetonitrile (ACN) 
delivered at an isocratic flow rate of 0.4 ml/min.
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Solvent ratios of 71:29 (PB:ACN) for muscle analysis and 
73:27 for plasma analysis were used. The mobile phase was 
filtered over a 0.45 pm membrane filter (FP Vericel™,
Prod. No. 66480, Gelman Sciences, Inc., Ann Arbor, MI) and 
degassed with helium before use. A 10 /il aliquot of 
muscle extract or a 25 pi aliquot of plasma extract was 
injected for LC analysis.
DATA ANALYSIS
(a) LINEARITY OF RESPONSE — Five-point calibration 
curves for SDM and N-acetyl SDM for standards and 
extracted samples were constructed by plotting the peak 
height ratio of analyte to internal standard (SMX) using 
data derived from duplicate sample injections.
(b) LIMITS OF DETECTION AND QUANTITATION— The method 
detection limit (MDL) is defined as the minimum 
concentration that can be reliably identified with 99% 
confidence that the analyte concentration is greater than 
zero. The MDL was estimated by determining the 
concentration that corresponds to Student's value 
multiple of the standard deviation of instrument values 
for replicate samples containing 1-5 times the estimated 
MDL. The MDL was computed using the following equation:
MDL = t' (S)
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where t* is the Student's t value for n-1 degrees of 
freedom (n = 12) and a = 0.01; S = pooled standard 
deviation of peak height ratios for MSPD extracts of 
samples containing 50 and 100 PPB analyte [4.23]. The MDL 
peak height ratio value was converted to tissue 
concentration in PPB by linear regression using three 
point calibration curves developed with MSPD extracts of 
muscle or plasma samples. The practical limit of 
quantitation was estimated as the concentration equal to 
two times the MDL.
(c) INTRA-ASSAY VARIABILITY — The within-run 
precision or the precision of replicate injections of the 
same sample run under identical chromatographic 
conditions. Intra-assay variation was calculated for both 
MSPD extracted samples and standards for each of five 
concentrations examined and overall. The intra-assay 
variation at each concentration is defined as the 
coefficient of variation (CV) of triplicate injections of 
the same sample (n=6 samples/concentration), and was 
calculated using the mean and standard deviation (SD) of 
peak height ratios for these injections. The CVs of the 
six samples were averaged to obtain a CV for each 
concentration. Overall intra-assay variability of the 
method, at the concentrations examined in this study, was
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determined by averaging the CVs for the five 
concentrations examined.
(d) INTER-ASSAY VARIABILITY — The variation among 
samples containing the same concentration of analyte and 
internal standard; extracted and analyzed under identical 
conditions on different days. Inter-assay variation for 
each of five concentrations was determined for both MSPD 
extracted samples and standards using mean peak height 
ratio values of duplicate injections. Inter-assay 
variation at each concentration is defined as the CV of 
six samples extracted and assayed on six different days. 
Overall inter-assay variation (± SD) of the method was 
obtained by averaging the individual concentrations' CVs.
(e) RECOVERY — Recovery was evaluated by two methods. 
Absolute recovery was determined for SDM with tritium 
labelled SDM (Charm Sciences, Inc., Madden, MA) using 
liquid scintillation counting data (Packard TRI-CARB®
4640, Packard Instrument Co., Inc., Downers Grove, IL). 
Relative recovery of SDM and N-acetyl SDM was determined 
by a comparison of analyte:internal standard peak height 
ratios of MSPD extracted fortified samples to peak height 
ratios of standard solutions.




The mobile phase (MP) composition reported by Long et 
al. [4.19] of phosphate buffer and acetonitrile at a ratio 
of 65:35 did not provide adequate resolution of the three 
sulfonamides when used with a narrow-bore column 
containing hypersil ODS. Additionally, endogenous 
compounds in muscle and plasma extracts eluted very 
closely to the sulfonamides and interfered with peak 
resolution. Modification in the MP solvent ratio from 
29:71 to 27:73 (ACN:PB) resulted in adequate separation of 
the sulfonamide and interfering peaks such that they did 
not affect quantitation for muscle or plasma extracts.
SMX was chosen as the internal standard because of its 
favorable elution time and a UV absorbance maximum similar 
to those of the analytes. SDM was the latest eluting of 
the sulfonamides at ~5.8 minutes for plasma samples and 
~5.2 min for muscle extracts. A late eluting endogenous 
compound required run times of 12 minutes for plasma and 
muscle extracts. Representative liquid chromatograms of 
MSPD derived extracts of blank and sulfonamide fortified 
channel catfish muscle and plasma, and MSPD extracts of 
muscle and plasma from channel catfish fed Romet®-30
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medicated feed are shown in Figures 4.1-4.6. Figures 4.7- 
4.9 show the UV absorbance spectra of SDM and N-acetyl SDM 
in non-extracted standards and in MSPD extracts of 
incurred muscle and plasma. The absorbance maxima of SDM 
and N-acetyl SDM were 265 and 270 nm, respectively. A 
comparison of the UV spectra of standards to those 
obtained with MSPD extracts indicates excellent peak 
purity.
LINEARITY OF RESPONSE
A linear response was observed for daily five point 
calibration curves for standards and MSPD extracts of 
muscle and plasma using mean peak height ratio values of 
duplicate injections (concentrations of 50-1000 PPB). 
Correlation coefficients > 0.999 were obtained for all 
calibration curves using standard solutions. Daily 
standard curves for MSPD extracted muscle and plasma 
samples had correlation coefficients ranging from 0.993 - 
1.0 with average daily values of 1.0 for SDM in both 
matrices and 0.997 and 0.998 for N-acetyl SDM in muscle 
and plasma.











































3 LIQUID CHROMATOGRAM OF MSPD EXTRACT OF CHANNEL CATFI8H MU8CLE FROM ROMET® FED CATFISH; CALCULATED CONCENTRATIONS OF 507 ng SDM/g AND

































FIGURE 4.5 LIQUID CHROMATOGRAM OF M8PD EXTRACT FROM CHANNEL CATFISH PLASMA FORTIFIED 























6 LIQUID CHROMATOGRAM OF MSPD EXTRACT OF CHANNEL CATFISH PLASMA FROM ROMET® 
FED CATFISH; CALCULATED CONCENTRATIONS OF 1158 ng 8DM/ml AND 379 
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FIGURE 4.8 UV ABSORBANCE SPECTRA 07 SDM (--- ) AND N-ACETYL 8DM (---) IN MSPD EXTRACT
07 MUSCLE 7ROM ROMET® 7ED CHANNEL CAT7ISH. LIQUID CHROMATOGRAPHIC ANALYSIS 
























FIGURE 4.9 UV ABSORBANCE SPECTRA OF SDM (--- ) AND N-ACETYL SDM <--- ) IN MSPD EXTRACT
OF PLASMA FROM ROMET® FED CHANNEL CATFISH. LIQUID CHROMATOGRAPHIC ANALYSIS 
WITH DIODE ARRAY DETECTION. 183
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The MDL estimates were 26 ng/g for SDM in channel 
catfish muscle and 33 ng/ml in plasma. The MDLs for N- 
acetyl SDM were 26 ng/g and 11 ng/ml respectively for 
muscle and plasma. Practical limits of quantitation were 
52 ng/g for SDM and N-acetyl SDM in muscle, 66 ng SDM/ml 
plasma, and 22 ng N-acetyl SDM/ml plasma.
INTRA-ASSAY VARIABILITY
Current recommendations for the precision of animal 
drug residue assays are for the repeatability of a method 
not to exceed 10% at concentrations greater than or equal 
to tolerance (100 PPB) or 20% at concentrations less than 
tolerance [4.24]. The repeatability of the method as 
determined by the CV of triplicate injections was <10% for 
SDM and N-acetyl SDM at concentrations of 50-1000 PPB for 
all muscle and plasma extracts and standards (Table 4.1).
INTER-ASSAY VARIABILITY
The reproducibility of the method varied from -25% 
for SDM and N-acetyl SDM at concentrations of 50 ng/g 
muscle to 5% for muscle containing 400 ng N-acetyl SDM/g
























SDM N-acetyl SDM SDM N-acetyl SDM SDM N-acetyl SDM
50 5.3 5.8 8.4 5.6 9.1 6.5
100 4.2 3.7 4.9 2.8 5.1 6.6
200 1.4 0.9 3.9 1.1 4.9 3.5
400 0.8 0.7 1.7 1.4 1.4 1.7
1000 0.6 0.5 0.9 0.4 0.7 0.6
Overall CV 2.5 2.3 4.0 2.2 4.3 3.8
(mean ± SD) ± 2.2 ±2.2 ± 3.0 ± 2.1 ± 3.4 ± 2.7
* N = 6 (triplicate injections)
f N = 6 extractions/cone. (triplicate injections)
00Ul
1 8 6
using the mean peak height ratio values for duplicate 
injections. The overall daily variation among samples 
containing 50-1000 PPB SDM was 13% for muscle and 14% for 
plasma extracts, and 11% and 10% for N-acetyl SDM in 
muscle and plasma samples (Table 4.2).
RECOVERY OF METHOD
Absolute recovery of tritiated SDM at a tissue 
concentration of 150 PPB was 79% ± 4% for muscle and 67% ± 
5% for plasma. The mean relative recoveries of SDM and N- 
acetyl SDM based on a comparison of the peak height ratios 
of standard solutions and extracted spiked tissues were 
97% ± 4% and 91% ± 3% for SDM in muscle and plasma and 
126% ± 5% and 112% ± 6% for N-acetyl SDM in muscle and 
plasma. The high relative recovery of N-acetyl SDM was 
consistent across all concentrations examined and may 
result from an increased extraction efficiency of the 
acetylated compound compared to the two non-acetylated 
compounds. The 4-N-acetylated sulfonamides (except 
sulfapyrimidines) have decreased aqueous solubility 
compared to the parent compounds [4.25] and would be 
expected to have different solubility in extracting 
solvents than the parent compounds. The use of standard 
curves developed with peak height ratio values for
























SDM N-acetyl SDM SDM N-acetyl SDM SDM N-acetyl SDM
50 9.0 11.8 24.5 25.5 21.0 16.0
100 5.8 3.8 12.8 5.9 16.6 7.9
200 4.4 4.4 13.2 11.9 13.9 10.5
400 3.9 3.3 6.9 5.0 11.0 8.3
1000 2.5 1.7 6.6 8.8 9.1 7.6
Overall CV 5.1 5.0 12.8 11.4 14.3 10.1
(mean ± SD) ± 2.5 ± 4.0 ± 7.3 ± 8.3 ± 4.7 ± 3.5
* N = 6 (using mean of duplicate injections)
t N = 6 extractions/conc. (using mean of duplicate injections)
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fortified tissues eliminated the extraction inequity 
problem and resulted in near 100% agreement between known 
tissue concentration and calculated tissue concentration 
for SDM and N-acetyl SDM. Therefore, quantitation of N- 
acetyl SDM should be performed using standard curves 
developed with fortified samples.
The modified MSPD method for plasma extraction had a 
lower absolute recovery than the MSPD method for muscle. 
However, the plasma method offers several advantages. The 
technique of vortex-mixing a biological fluid, such as 
plasma, with in the extraction column eliminates the 
need for manual blending of the sample and C18 and transfer 
of the blended material from mortar to column that is 
required with the MSPD method for solid tissues. For 
tissues not requiring mechanical disruption of tissue 
architecture, this adaptation greatly speeds the 
extraction process and makes it more amenable to 
automation. The need for mortar and pestle cleanup and 
concerns about possible carryover are also eliminated with 
this modification. Additionally, the small sample size 
required (100 /xl) is advantageous in experimental studies 
involving small animals such as fish and rodents. The 
modified MSPD method has also been used with milk for the 
extraction of several /3-lactam antibiotics (unpublished
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data) and the method potentially can be applied to other 
biological fluids and compounds.
For comparison of the plasma MSPD method with solid 
phase extraction (SPE), fortified catfish plasma was 
extracted using a packing of 400 mg of CI8 in a Poly-Prep 
column (n=3). SPE yielded recovery and chromatography 
similar to that obtained with the plasma MSPD method. 
However, SPE required an additional sample dilution step 
and more importantly, flow of the diluted sample and 
solvents through the SPE column required either positive 
column head pressure or aspiration. While chromatography 
and recovery were similar with both methods, the ability 
to utilize gravity flow of solvents is a distinct 
advantage in some laboratories and essential for field 
applications.
A tiered approach to residue monitoring utilizes 
rapid screening assays for examining large numbers of 
samples and subsequent quantitation and/or confirmation of 
identified suspect samples. We previously presented an 
evaluation of commercially available enzyme immunoassays 
for screening channel catfish muscle for SDM residues 
using MSPD derived extracts [4.10]. A number of other 
techniques have been used for detection and quantitation 
of sulfonamides in animal tissues. A 1981 review of 
analytical methods for sulfonamides in animal tissues is
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available [4.11,4.12]. More recently, several methods for 
single or multiresidue analysis of sulfonamide residues in 
fish tissues have been published [4.13-4.21].
Several classical multi-residue methods for the 
isolation of SDM from fish tissues have been reported. An 
extraction method reported by Horie et al. yielded 
recoveries of 73-80% for SDM fortified at 1 /xg/g muscle in 
several fish species. The limit of detection for SDM was 
0.05 /xg/g [4.13]. Nose et al. reported a multi-residue 
method for three fish species that provided SDM recoveries 
of 88-92% from muscle tissue fortified at 0.5 /xg/g. The 
method of recovery determination was not provided. The 
lower limit of detection for SDM was 0.06 /xg/g [4.14]. 
Horie et al. published a multi-residue method for the 
determination of eight antibacterials in the muscle of 
five species of cultured fish. Recovery of SDM varied 
among species from 82-87% at a tissue concentration of 1 
/xg/g. The detection limit of the method was 0.05 /xg/g 
[4.15]. An extraction and LC method reported by Ueno et 
al. for sulfamonomethoxine, SDM, and their N-acetylated 
metabolites provided SDM recoveries of 88 and 81% from 
rainbow trout plasma and muscle fortified at 2 PPM, 
respectively. This study was the only method found in the 
literature for extraction and analysis of N-acetyl SDM in 
fish tissues. N-acetyl SDM recoveries were 83 and 89%
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from muscle and plasma. The method of recovery 
determination was not provided. The detection limits were 
0.05 /xg/g and limits of quantitation were 0.5 /xg/g for 
both compounds [4.16].
Two methods are reported for the simultaneous 
extraction and LC analysis of SDM and OMP in fish tissue. 
Weiss et al. reported a mean recovery of 97 % for SDM in 
catfish muscle. The limit of quantitation was 0.05 /xg/g 
[4.17], Walisser et al. reported a mean relative 
recovery, using peak height ratio comparisons, of 55% for 
SDM from chinook salmon muscle fortified at 0.5-6 /xg/g.
The minimum detectable concentration was 0.2 /xg/g [4.18],
Several MSPD methods have been reported for the 
isolation of SDM from fish tissues. Long et al. reported 
a relative recovery of 101% based on peak height ratios 
for SDM in catfish muscle using a single residue MSPD 
extraction procedure. The minimum detectable limit was 
0.05 /xg/g [4.19]. In two studies, Reimer & Suarez used 
MSPD for the simultaneous extraction of five sulfonamides 
from salmon muscle with quantitation by thin layer 
chromatography (TLC) or LC. For TLC, the method detection 
limit (MDL) of SDM was 0.13 /xg/g and recovery was 63% at 
concentrations of 0.5 and 2 /xg/g. In a second study, they 
reported 75% recovery for SDM fortified at 0.4-5 fig/g and 
a MDL of 0.15 /xg/g using LC analysis [4.20,4.21].
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Tolerances for animal drugs as set by the United 
States Food and Drug Administration (FDA) are often based 
on total residue present, including parent drug and all 
metabolites, in edible tissues (4.24]. The FDA tolerance 
for total SDM residues in channel catfish muscle is 100 
nU/5 [4.26]. The primary metabolite of SDM in channel 
catfish is 4-N-acetylsulfadimethoxine [4.27]. The 
relative contribution of this metabolite to total SDM 
residue varies among tissues and species. In channel 
catfish, N-acetyl SDM accounts for over 90% of total SDM 
residue in bile but in muscle and plasma SDM is present 
mainly (>95%) as parent compound [4.27]. However, in 
rainbow trout muscle the N-acetyl metabolite accounts for 
over half of total SDM residue [4.28]. Additionally, the 
ratio of parent SDM:N-acetyl SDM at tissue concentrations 
approaching tolerance is not known. Under the FDAs 
general food safety requirements, individual metabolite 
identification, concentration, and persistence should be 
obtained for metabolites comprising 100 ppb or >10% of the 
total residue (whichever is lower) at zero withdrawal 
[4.29], Extraction, detection, quantitation, and 
confirmatory methods should, therefore, be capable of 
simultaneous extraction or analysis of the parent drug and 
it's important metabolites at tolerance for such use and 
in situations where marker residues are not determined.
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The USDA has indicated that a method of residue 
analysis should take no more than 48 hours to perform 
[4.24]. The MSPD procedure and LC method as used in this 
study can easily be run in less than a half-workday. The 
sensitivity and recovery of SDM with this method is 
comparable to recoveries reported with published methods 
for SDM in fish tissues [4.13-4.21]. However, most of 
these studies used classical methods of analyte isolation 
involving homogenization, liquid-liquid partitioning, and 
multiple sample cleanup steps. With improvements in 
determinative methods a major limiting factor in a residue 
monitoring program becomes the isolation of the analyte(s) 
from tissues. Classical methods of extraction are the 
backbone of present residue monitoring programs and have 
withstood the test of time but are time, labor, and 
solvent use intensive and limit the number of samples that 
can be practically analyzed in a day. Additionally, 
several of the methods lack the sensitivity required for 
detection of SDM residues at present tolerance. Newer 
methods of analyte isolation that eliminate many of the 
disadvantages of traditional extraction methods are needed 
if we are to fully benefit from recent advances in 
determinative aspects of residue analysis.
One such isolation method is the MSPD procedure. The 
MSPD theory and process have been the subject of recent
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reviews [4.30,4.31]. In general, its main advantages are 
that it provides a more rapid and solvent sparing 
isolation method than do classical methods, provides 
adequate recovery at tolerance, and is amenable to 
automation. Therefore, the use of MSPD allows one to 
examine a larger number of samples per day and reduces 
labor and solvent costs. Solvent purchase and disposal 
costs and potential environmental contamination problems 
increasingly dictate that solvent use in routine 
analytical methods be reduced. The combined use of MSPD 
and a microbore analytical column often yields a greater 
than 50% reduction in solvent use compared to classical 
extraction and analysis techniques.
The extraction and LC methods presented in this study 
provide procedures to simultaneously analyze SDM and its 
major metabolite in channel catfish muscle and plasma. 
These methods provide rapid and simple extraction with 
adequate recovery of analytes, quantitation at tolerance 
with acceptable accuracy and precision, and minimal 
solvent use. The applicability of these procedures to 
channel catfish muscle and plasma samples containing 
incurred SDM residues are presented in Chapter 5.
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CHAPTERS
PLASMA/MUSCLE RATIOS OF SULFADIMETHOXINE 
RESIDUES IN CHANNEL CATFISH (Ictalurus punctatus)
INTRODUCTION
Pending federal legislation concerning mandatory 
seafood inspection will require a variety of analytical 
methods for the detection, quantitation, and confirmation 
of chemical residues in food fish [5.1]. A tiered 
approach to residue monitoring [5.2] uses rapid screening 
assays for an initial examination of large numbers of 
samples and more definitive methods of analysis for 
quantitation and identification of chemical residues in 
samples identified with screening assays. Thus, 
regulatory agencies will need practical methods that are 
rapid, accurate, precise, and specific for these purposes.
Traditional screening methods, such as microbial 
inhibition tests and chromatographic methods, as are 
presently used in poultry and red meat inspection, lack 
one or more of these characteristics. Additionally, there 
is a lack of screening methods available for use by the 
producer in a field setting for the pre-harvest detection 
of illegal drug residues. Screening methods compatible 
with field use could impact in a positive manner the 
function of an aquatic animal drug residue monitoring 
program by reducing the marketing of fish containing
199
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violative drug residues, would help prevent economic loss 
to producers resulting from the condemnation of large lots 
of harvested fish, and as part of a quality assurance 
program, help allay consumer concerns regarding 
aquaculture product safety.
One technique with potential field use application as 
a residue screening method is the enzyme-linked 
immunosorbent assay (ELISA). Enzyme-linked immunosorbent 
assays for detection of chemical residues are relatively 
inexpensive, easy to use, require no special equipment, 
and are presently commercially available for a range of 
compounds [5.3,5.4]. They also provide the sensitivity 
and specificity required for residue monitoring at 
tolerance [5.5]. Nonetheless, a major limiting factor in 
the practical use of these tests for residue detection in 
tissues is the need for analyte extraction from tissue 
samples prior to testing.
To facilitate the implementation of ELISAs for 
chemical residue monitoring several strategies for analyte 
extraction from target tissues have been used. These vary 
from simple tissue maceration [5.6] to matrix solid phase 
dispersion [5.5,5.7]. However, the simplest residue 
screening method is one that requires no tissue 
extraction, but rather uses the presence of the drug 
and/or its metabolite(s) in a readily accessible reference 
biological fluid to indicate the presence of violative
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residues in a target tissue(s). However, before such a 
technique can be implemented, a relatively constant 
relationship between the drug concentration in the target 
tissue and the reference biological fluid must be 
demonstrated. This is necessary because a relatively 
constant relationship between marker residue and target 
tissue residue concentration among animals is needed to 
provide the sensitivity and specificity required of a 
residue screening assay.
Biological fluids have been proposed as specimens for 
pre- or postmortem residue monitoring in several food 
animal species and the tissue concentration relationships 
for several sulfonamides in domestic food animal species 
have been evaluated [5.8-5.13]. However, little 
information regarding such drug concentration 
relationships in fish species is available in the 
literature. Several studies have examined the 
pharmacokinetic and tissue depletion behavior of 
sulfonamides in a limited number of fish species [5.14- 
5.18], but none have examined the concentration ratio of 
total sulfadimethoxine residues in biological fluids and 
target tissues over the range of tissue concentrations 
expected in channel catfish.
The determination of such a drug concentration ratio 
would permit the use of a readily obtainable biological 
fluid such as plasma to predict the presence of violative
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drug residues in edible tissues. This could enhance the 
application of an on-site test and increase throughput in 
a regulatory laboratory. The determination of such ratios 
must include data on total residue including the relative 
contribution by the parent compound and its important 
metabolites. Such information is relevant in relating 
concentration of the chemical species detected by the 
screening assay (marker compounds) to drug residue 
concentration in the tissue of interest.
We previously evaluated the performance of several 
commercially available ELISAs for detection of 
sulfadimethoxine in channel catfish muscle about the US 
Food and Drug Administration tolerance of 100 ng/g 
[Chapter 3,5.5]. All of the ELISAs examined cross-reacted 
equally well with the parent sulfonamide and its primary 
metabolite in channel catfish, 4-N-acetylsulfadimethoxine 
(N-acetyl SDM). Therefore, to use such ELISAs with plasma 
to identify fish containing violative SDM tissue levels 
one must first know the ratio of total SDM residue in 
plasma, including parent and cross-reacting metabolites, 
to total SDM residue in muscle.
Romet-30®, a potentiated sulfonamide containing 
sulfadimethoxine (SDM) and ormetoprim (OMP) in a 5:1 
ratio, is one of only two systemic antibacterial agents 
currently marketed for use in aquaculture in the United 
States. Romet-30® is frequently used in channel catfish
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
aquaculture for the control of enteric septicemia and 
other infectious bacterial diseases of catfish. The 
channel catfish is the major aquaculture species in the US 
and accounted for 56% of the total US aquacultural 
production in 1988 [5.19] with 360 million pounds produced 
in 1990 [5.20]. Drug residue violations in the United 
States' red meat and poultry industries most frequently 
result from a failure by the producer to observe the 
stated withdrawal time for an approved drug [5.21,5.22].
If a similar trend holds for aquaculture, the greatest 
number of residue violations would be expected for 
approved drugs that have been used by the producer in a 
manner not in accordance with label directions.
Therefore, practical methods for detection, quantitation, 
and confirmation of SDM and OMP residues in channel 
catfish are urgently needed.
The purpose of the present study was to determine the 
concentration ratio of total SDM residues, including the 
parent compound and its N-acetyl metabolite, between 
channel catfish plasma and muscle to enable the use of 
plasma drug concentration as an indicator of muscle drug 
concentration. This paper presents the first report of 
such tissue concentration ratios over the range of SDM 
tissue concentrations expected when Romet®-30 is used 
according to label instructions. Additionally, 
information regarding sulfadimethoxine depletion in
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channel catfish administered Romet®-30 at a water 
temperature of 27°C is provided.
EXPERIMENTAL
REAGENTS AND EXPENDABLE MATERIALS
(a) SOLVENTS — Commercially obtainable liquid 
chromatography grade solvents were used without further 
purification.
(b) WATER — Triple-distilled and passed through a 
Modulab™ Polisher I water purification system (Continental 
Water Systems Corp., San Antonio, TX) used for LC 
analyses.
(c) CHEMICALS — Note: Wear rubber gloves and
protective clothing when handling. Sulfadimethoxine (SDM) 
and Sulfamethoxazole (SMX) were obtained from Sigma 
Chemical Co., (St. Louis, MO).
(d) 4-N-ACETYLSULFADIMETHOXINE — The procedure of 
Nielsen [5.23] was used for synthesis. Identity confirmed 
with high performance liquid chromatography and direct 
probe, Cl, positive ion mass spectrometry.
(e) STANDARD SOLUTIONS — Stock solutions of SDM, N- 
acetyl SDM, and SMX were prepared and serially diluted in 
methanol to provide separate fortification solutions for
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each compound. Fortification solutions of 5, 10, 20, 40, 
100, 200, 500, 1000, & 2000 /ig/ml were prepared for SDM;
4, 10, 20, 50, 100, & 200 for N-acetyl SDM; and 100
Mg/ml for the internal standard SMX. All solutions were 
stored in the dark at 4°C.
(e) FORTIFIED MUSCLE MID PLASMA EXTRACTS — Extracts 
of fortified muscle and plasma for daily standard 
calibration curves were obtained as follows:
MUSCLE — 0.5 g of catfish muscle was injected with 5 nl 
each of separate SDM and N-acetyl SDM fortification 
solutions appropriate to give tissue concentrations 
(SDM:N-acetyl SDM) of 50:0, 100:0, 200:0, 400:40,
1000:100, 2000:200, 5000:500, and 10000:1000 ng/g. SMX 
was added as an internal standard by the injection of 5 fil 
of a 100 ng SMX/ml methanol fortification solution to give 
a tissue concentration of 1000 ng/g. The samples were 
processed and extracted by MSPD as described in chapter 4. 
PLASMA — 0.5 ml aliquots of catfish plasma were placed in
1.5 ml polypropylene test tubes and 5 nl each of separate 
SDM and N-acetyl SDM fortification solutions were added to 
achieve plasma drug concentrations of 50:0, 100:0, 200:0, 
400:40, 1000:100, 2000:200, 5000:500, 10000:1000, and 
20000:2000 ng/g (SDM:N-acetyl SDM). Five ^1 of a 100 ng 
SMX/ml methanol fortification solution was added to each 
tube as an internal standard, vortex mixed, and extracted
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using a modification of the MSPD procedure as given in 
chapter 4.
EXPERIMENTAL ANIMALS, DRUG ADMINISTRATION, AND SAMPLING
Eighty-four laboratory-reared male and female channel 
catfish (Ictalurus punctatus) with a mean body weight of 
59 ± 15 g were obtained from an indoor recirculating water 
culture system and assigned to seven circular fiberglass 
tanks, each containing 200 liters of water. The fish were 
maintained under flow-through conditions with a 13.5 hour 
light : 10.5 hour dark photoperiod. Water temperature was 
maintained at 27 ± 1°C, pH of 8.41 ± .04, and total 
hardness of 20 mg/1. The fish were allowed to acclimate 
for 4 weeks prior to drug administration.
Experimental fish were fed commercial non-medicated 
catfish pellets (Grow Big Floater, SF Services, Inc.,
North Little Rock, AR) at a rate of 2% of body weight once 
daily before and after the drug treatment period. Romet®- 
30 (Hoffman-La Roche, Inc., Nutley, NJ) medicated channel 
catfish feed (Grow Big Floater R-30 Medicated, SF 
Services, Inc., North Little Rock, AR) containing SDM and 
ormetoprim at concentrations of 0.42% and 0.084% 
respectively was fed free-choice at a rate of 1% of body 
weight once a day for five consecutive days to six tanks 
of fish. This feeding rate provided a daily dose of 50 mg
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Romet®-30/kg fish body weight. Control fish were fed the 
commercial non-medicated feed throughout the experiment.
Groups of 12 fish (1 tank) plus 2 control fish were 
sacrificed at sampling times of 6, 12, 24, 48, 72, and 96 
hours following the fifth day of medicated feed 
administration. Blood was collected from the caudal vein 
with a heparinized syringe and the plasma separated and 
placed in 1.5 ml polypropylene test tubes (Micro Tube, 
cat. no. 72.690.475, Sarstedt, Inc., Newton, NC).
Skinless muscle fillets were obtained and stored in Whirl- 
Pak® sample bags (Nasco). All samples were stored frozen 
at -20°C and analyzed within 2 months following 
collection.
EXTRACTION PROCEDURE
(a) MUSCLE — 0.5 g of catfish fillet was placed in a 
glass mortar containing 2 g of CI8. Sulfamethoxazole (SMX) 
was added as an internal standard by the injection of 5 /il 
of a 100 jug SMX/ml methanol fortification solution to give 
a SMX tissue concentration of 1000 ng/g. The muscle 
samples were allowed to stand 2 minutes and extracted 
using the matrix solid phase dispersion (MSPD) technique 
reported in Chapter 4.
(b) PLASMA — 0.5 ml aliquots of catfish plasma were 
placed in 1.5 ml polypropylene test tubes and 5 pi of a
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100 ng SMX/ml methanol fortification solution added to 
each tube as an internal standard and the sample was 
vortex mixed. Plasma samples were extracted using a 
modification of the MSPD procedure as given in Chapter 4.
LIQUID CHROMATOGRAPHIC ANALYSIS
(a) APPARATUS — All analyses were performed using a 
Hewlett Packard 1090 liquid chromatograph equipped with a 
variable volume auto-injector and a photodiode array 
detector set at 265 nm (20 nm bandwidth), reference 
spectrum of 450 nm (100 nm bandwidth), and spectrum range 
of 210-320 nm. LC control, data acquisition, and peak 
integration were performed using Hewlett-Packard HPLC30 
ChemStation Software (DOS Series)(Part No. G1300-900006).
A reversed phase narrow-bore column packed with 
octadecylsilyl (ODS) derivatized silica (200 X 2.1 mm, 0DS 
Hypersil, 5 /im, Part No. 799160D-572, Hewlett-Packard, 
Wilmington, DE) maintained at ambient temperature was used 
for all analyses.
(b) SOLVENT — The mobile phase was a mixture of 0.017 
M aqueous H3P04 (pH 2.4)(PB) and acetonitrile (ACN) 
delivered at an isocratic flow rate of 0.4 ml/min.
Solvent ratio's of 70:30 (PB:ACN) for muscle analysis and 
73:27 for plasma analysis were used. The mobile phase was
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filtered over a 0.45 pm. membrane filter (FP Vericel™,
Prod. No. 66480, Gelman Sciences, Inc., Ann Arbor, MI) and 
degassed with helium before use. A 10 pi aliquot of 
muscle extract or a 25 pi aliquot of plasma extract was 
injected for LC analysis.
DATA ANALYSIS
(a) DAILY CALIBRATION CURVES — Daily calibration 
curves for SDM and N-acetyl SDM for both standards and 
extracted fortified muscle and plasma samples were 
constructed by plotting the peak height ratio of analyte 
to internal standard (SMX) using data derived from single 
sample injections.
(b) DETERMINATION OF TISSUE CONCENTRATION — Tissue 
concentrations of experimental plasma and muscle samples 
were determined by the internal standard method using 
calibration curves obtained with extracts of fortified 
plasma or muscle. The concentrations of samples 
containing <1000 PPB analyte were determined using five 
point daily calibration curves derived from fortified 
tissue extracts containing 50-1000 PPB. The 
concentrations of samples containing >1000 PPB analyte 
were determined using daily calibration curves of 
concentrations of 50-20000 PPB.
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Experimental tissue samples containing drug 
concentrations less than the method detection limit (MDL) 
were reported as zero. Samples containing drug 
concentrations greater than the MDL but less than the 
practical limit of quantitation (LOQ) (i.e. trace 
quantities) were reported in Tables 5.1-5.6 as the 
estimated concentration value. However, samples in the 
above two categories were not used for calculation of 
plasma:muscle concentration ratios. For samples 
containing trace drug quantities, the estimated 
concentration was used for calculation of mean drug 
concentration values at each sampling period.
RESULTS AND DISCUSSION
Considerable variation in total SDM tissue 
concentration among individual fish within a sampling 
period was observed (Tables 5.1-5.6). Total SDM 
concentrations in individual experimental fish ranged from 
1.4-24.8 fig/ml and 0.6-12.6 ;xg/g for plasma and muscle, 
respectively, for the twelve fish sampled at the six hour 
post-dose sampling period. Mean total SDM residue 
concentrations for plasma and muscle samples for this same 
period were 9.1 fig/ml and 5.3 fig/g and relative standard 
deviations of 82.3% and 80.7% respectively. Similar large

















TABLE 5.1 SULFADIMETHOXINE RESIDUES* AND PLASMA:MUSCLE RATIOS - 6 HOURS POST-DOSE
_______N-acetyl SDM___________________SDM________________ Total SDM Residue
Fish # Plasma Muscle P:M Plasma Muscle P:M Plasma Muscle P:M
1
----------
1.43 0.53 2.7 10.29 8.54
4 • **
1.2 11.72 9.07 1.3
2 0.52 0.16 3.2 1.19 0.74 1.6 1.71 0.90 1.9
3 2.52 0.74 3.4 22.34 11.89 1.9 24.86 12.63 2.0
4 0.42 0.11 3.7 1.20 0.79 1.5 1.62 0.90 1.8
5 0.79 0.39 2.0 1.67 1.11 1.5 2.47 1.50 1.6
6 1.74 0.47 3.7 7.30 4.64 1.6 9.04 5.11 1.8
7 1.89 0.72 2.6 13.24 9.10 1.5 15.13 9.82 1.5
8 1.95 0.66 2.9 12.51 7.31 1.7 14.46 7.97 1.8
9 1.14 0.33 3.5 12.51 6.57 1.9 13.66 6.90 2.0
10 0.38 0.11 3.4 1.16 0.59 2.0 1.54 0.70 2.2
11 0.20 0.06 3.7 1.23 0.51 2.4 1.43 0.56 2.5
12 2.35 0.69 3.4 9.35 6.28 1.5 11.70 6.96 1.7
Mean 1.28 0.41 3.2 7.83 4.84 1.7 9.11 5.25 1.8
SD 0.81 0.26 0.5 6.78 4.01 0.3 7.50 4.24 0.3
RSD 64% 63% 16% 87% 83% 19% 82% 81% 17%



















TABLE 5.2 SULFADIMETHOXINE RESIDUES* AND PLASMAsMUSCLE RATIOS - 12 HOURS POST-DOSE
Fish #
N--acetyl SDM SDM Total SDM Residue
Plasma Muscle P:M Plasma Muscle P:M Plasma Muscle P:M
13 1.80 0.68 2.6 5.62 3.75 1.5 7.42 4.43 1.7
14 2.60 0.77 3.4 16.53 9.19 1.8 19.13 9.95 1.9
15 0.23 0.05 4.6 0.48 0.25 2.0 0.71 0.29 ***
16 1.40 0.43 3.2 6.09 3.06 2.0 7.48 3.49 2.1
17 1.34 0.88 1.5 6.46 6.08 1.1 7.80 6.95 1.1
18 0.14 --- *** 0.24 0.18 1.3 0.38 0.18 ***
19 0.12 (0.04) *** 0.21 0.24 0.9 0.33 0.27 ***
20 0.14 *** 0.42 0.18 2.4 0.57 0.18 ***
21 0.22 (0.04) *** 0.60 0.38 1.6 0.82 0.42 ***
22 1.94 1.13 1.7 19.98 10.64 1.9 21.92 11.78 1.9
23 2.29 0.55 4.1 17.28 8.36 2.1 19.58 8.92 2.2
24 0.20 --- *** 0.38 0.26 1.5 0.58 0.26 ***
Mean 1.04 0.38 3.0 6.19 3.55 1.7 7.23 3.93 1.8
SD 0.96 0.41 1.2 7.52 4.02 0.4 8.41 4.40 0.4
RSD 93% 108% 40% 122% 113% 26% 116% 112% 22%
SEM 0.28 0.12 0.5 2.17 1.16 0.1 2.43 1.27 0.2
  concentration < the method limit of detection
() trace level £ method limit of detection and < limit of 



















TABLE 5.3 SULFADIMETHOXINE RESIDUES4 AND PLASMA:MUSCLE RATIOS - 24 HOURS POST-DOSE
N--acetyl SDM SDM Total SDM Residue
Fish # Plasma Muscle P;M Plasma Muscle P:M Plasma Muscle P:M
25 0.43 0.17 2.5 1.67 1.17 1.4 2.09 1.34 1.6
26 0.62 0.32 1.9 5.54 3.50 1.6 6.15 3.82 1.6
27 1.95 0.77 2.5 13.44 9.04 1.5 15.39 9.81 1.6
28 (0.04) --- *** (0.03) --- *** 0.07 --- ***
29 0.46 0.22 2.1 2.17 1.34 1.6 2.63 1.56 1.7
30 (0.04)+ --- *** 3.22* 0.09+ 35.4+ 3.26+ 0.09+ ***
31 0.08 --- *** 0.17 0.10 1.7 0.25 0.10 ***
32 0.21 0.07 3.2 0.48 0.26 1.8 0.69 0.33 2.1
33 0.05 -- - *** 0.13 0.08 1.6 0.18 0.08 ***
34 0.47 0.14 3.4 1.92 1.04 1.8 2.39 1.18 2.0
35 1.66 0.61 2.7 7.75 3.57 2.2 9.40 4.18 2.2
36 --- --- *** --- --- *** --- --- ***
Mean 0.55 0.21 2.6 3.02 1.83 1.7 3.57 2.02 1.8
SD 0.66 0.26 0.5 4.27 2.73 0.2 4.91 2.99 0.3
RSD 120% 126% 20% 141% 149% 13% 138% 148% 16%
SEM 0.20 0.08 0.2 1.29 0.82 0.1 1.48 0.90 0.1
— - concentration < the method limit of detection
() trace level £ method limit of detection and < limit of
*** unable to accurately determine due to value(s) < limit




















TABLE 5.4 SULFADIMETHOXINE RESIDUES* AND PLASMA:MUSCLE RATIOS - 48 HOURS POST-DOSE
Fish #
N-acetvl SDM SDM Total SDM Residue
Plasma Muscle P?M Plasma Muscle P:M Plasma Muscle P:M
37 ------ ------ *** ------ a a a ***
38 ------ ------ *** ------ ------ *** ------ ------ ***
39 ------ ------ a a a ------ ------ a a a ------ ------ a a a
40 ------ ------ a a a ------ ------ *** ------ ------ ***
41 ------ ------ a a a ------ ------ *** — - ------ ***
42 0.06 ------ a a a (0.04) 0.05 a a a 0.10 0.05 ***
43 0.06 ------ *** 0.07 0.05 a a a 0.13 0.05 a a a
44 ------ ------ *** ------ ------ *** ------ ------ ***
45 0.05 ------ a a a (0.04) — - a a a 0.09 ------ ***
46 0.03 ------ a a a ------ ------ a a a 0.03 ------ a a a
47 0.08 *** 0.12 0.09 1.4 0.20 0.09 ***
48 ------ — — a a a ------ ------ AAA ------ ------ ***
Mean 0. 02 ------ *** 0.02 0.02 1.4 0.05 0. 02 AAA
SD 0.03 a a a 0.04 0.03 a a a 0.07 0.03 AAA
RSD 134% *** 173% 192% a a a 149% 192% AAA
SEM 0.01 a a a 0.01 0.01 a a a 0.02 0.01 AAA
  concentration < the method limit of detection() trace level t method limit of detection and < limit of 

















TABLE 5.5 SULFADIMETHOXINE RESIDUES* AND PLASMA;MUSCLE RATIOS - 72 HOURS POST-DOSE
N-acetyl SDM___________________SDM________  Total SDM Residue




49 -- — - *** -- -- *** -- 0 ***
50 -- -- *** -- -- *** -- 0 ***
51 -- -- *** -- -- *** -- 0 ***
52 -- -- *** -- -- *** -- 0 ***
53 -- -- *** -- -- *** -- 0 ***
54 -- -— *** -- -- *** -- 0 ***
55 -- -- *** -- -- *** -- 0 ***
56 -- -- *** -- -- *** -- 0 ***
57 -- -- *** -- -- *** -— 0 ***
58 «•* -- *** -- 0.05 *** -- 0.05 ***
59 -- -- *** -- -- *** -- 0 ***
60 -- -- *** -- — — *** -- 0 ***
Mean --- --- *** --- 0.00 *** --- 0.00 ***
SD *** 0.01 *** .01 ***
RSD *** 343% *** 343% ***
SEM *** 0.00 *** 0.00 **** concentration in parts per million
  concentration < the method limit of detection






















RATIOS -96 HOURS POST-DOSE
Total SDM Residue
Fish # Plasma Muscle P:M Plasma Muscle P:M Plasma Muscle P: MRatio Ratio Ratio
61 ------ ----- *** ------ — — *** ----- ----- ***
62 ------ ------ *** — _ ----- *** ------ ----- ***
63 ------ ----- *** — ~ ----- *** ----- ----- ***
64 -- ----- *** ------ ------ *** ------ ----- ***
65 ------ ------ *** ------ ----- *** ----- ----- ***
66 ----- *** ------ ----- *** ----- ----- ***
67 ----- ------ *** ------ ----- *** ------ ------ ***
68 ----- ----- *** ------ ----- *** ----- ------ ***
69 -- *** ------ ----- *** ------ ----- ***
70 ------ ------ *** ------ ----- *** ------ ***
71 ----- ------ *** — — ----- *** ------ ______ ***
Mean ------ ----- *** ------ ----- *** - — ----- ***
SD *** *** ***
RSD *** *** ***
SEM *** *** **** concentration in parts per million
  concentration < the method limit of detection
() trace level £ method limit of detection and < limit of quantitation 
*** unable to accurately determine due to value(s) < limit of quantitation
toH0>
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variations in tissue antibacterial concentrations have 
been reported in other studies with fish fed free-choice 
medicated feed containing a potentiated sulphonamide 
[5.14,5.24,5.25].
A number of factors can influence the consumption, 
metabolism, distribution, and elimination of xenobiotics 
in the body [5.26-5.30]. These include individual animal 
factors and systemic variation within an experimental unit 
attributable to age, weight, sex, and reproductive status. 
Variability due to the analytical technique employed may 
also contribute to scattering of data, but does not appear 
to be the case here.
Additionally, palatability may affect the consumption 
of medicated feed and hence actual dose administered per 
fish. Variable medicated feed intake may be partially 
responsible for the range of tissue drug concentrations 
seen among fish within a single group in this study. Fish 
feeds containing potentiated sulfonamides, such as Romet®- 
30 or Tribrissen® (sulfadiazine-trimethoprim), reportedly 
have decreased palatability compared to non-medicated 
feeds [5.25,5.30,5.31]. For Romet®-30 medicated feed the 
ormetoprim component has been identified as the factor 
responsible for decreased palatability [5.31].
In a related study, Walisser et aI. suggested the 
variation in drug tissue concentration among individual 
Chinook salmon within a group treated with Romet®-30 may
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have been the consequence of hierarchial feeding within a 
tank [5.24]. Hierarchial feeding, however, appears not to 
be the primary cause of variability of tissue drug 
concentration in this study. In the present study all 
experimental fish actively fed on non-medicated feed but 
were observed to have reduced feeding activity when given 
the Romet®-30 medicated feed. Further, feeding activity 
with the medicated feed was not uniform among all fish 
within a tank. Individual fish fed more actively than 
others on the medicated feed although sufficient 
quantities of feed were freely available to all fish.
The low palatability of Romet®-30 medicated feeds 
also has implications in regards to drug delivery and 
efficacy in diseased fish in addition to its effect on 
drug residue concentration. In general, sick fish consume 
less medicated feed than healthy fish. It is conceivable 
that the decrease in feed intake by sick fish would be 
exacerbated by administration of an unpalatable feed.
Sick fish may, therefore, exhibit greater variability in 
medicated feed intake and attain lower and more variable 
tissue drug concentrations than the fish in this 
experiment.
Nevertheless, despite the large variation in tissue 
drug concentrations a mean plasma:muscle drug 
concentration ratio of 1.8:1 ± 0.3:1 (SD) was obtained for 
fish over all concentration ranges and sampling periods.
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The 95% Cl for the mean plasma:muscle drug concentration 
ratio is (1.7:1, 1.8:1). The plasma:muscle total SDM 
concentration ratio in individual fish ranged from 1.3:1 
to 2.5:1 with a 95% confidence interval for individual 
fish of (1.2:1, 2.4:1). The general correlation between 
plasma and muscle concentrations attained in this study is 
illustrated in Figure 5.1. A correlation coefficient of
0.967 and visual examination of the plot indicate a strong 
correlation between plasma and muscle total SDM 
concentrations over a large concentration range. The 
points on the graph represent individual fish with plasma 
and muscle SDM concentrations above the practical limits 
of quantitation of the analytical method. The plotted 
line and its slope were determined by linear regression. 
Figure 5.2 illustrates similar results for samples 
containing muscle drug concentrations less than 2000 ng/g. 
Although samples containing concentrations below the LOQ 
were not included in this plot, an examination of total 
plasma and muscle concentrations of such samples in Tables 
5.1-5.3 indicates the relationship between total SDM 
residues in plasma and muscle is maintained at 
concentrations about tolerance. This relatively stable 
plasma:muscle ratio should permit the use of plasma drug 
concentration to predict violative muscle drug 
concentration.
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Such a drug concentration ratio should enable one to 
use channel catfish plasma as the test material in an 
ELISA to determine qualitatively the presence of violative 
muscle residues of SDM. The number of fish from a Romet®- 
30 treated pond required to ensure detection of a residue 
violation problem is dependent upon the percentage 
violative in the sampled population (pond) and the desired 
percent probability of detection [5.2]. Additional field 
studies to determine the expected percent violative fish 
in a catfish pond treated with Romet®-30 medicated feed 
are needed.
Sulfadimethoxine depletion from plasma and muscle 
approximates first-order kinetics (Figures 5.3, 5.4) based 
on the sampling intervals used in this study. This is in 
agreement with data from Squibb et al. [5.16]. The 
calculated half-lives for total SDM residues at a water 
temperature of 27°C were approximately 11 hours for muscle 
and 13 hours for plasma. The label withdrawal period for 
Romet®-30 following administration to channel catfish is 
three days [5.33]. The estimate, based on the total SDM 
residue depletion curve using mean tank values, of the 
time required for the mean concentration to reach the 
tolerance of 100 ng/g muscle is 49 hours. In this study 
however, no fish contained total SDM residues of >0.1 PPM 
in muscle by the 48 hour post-dose sampling period. This 
indicates the present three day drug withdrawal period for
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Romet®-30 is adequate for the SDM component for channel 
catfish at a water temperature of 27°C. This is in 
agreement with Brown's estimate of an -48 hour mean 
depletion time at 28°C [5.17]. All control fish (n=12) in 
the study were negative for SDM and the N-acetyl 
metabolite at the LODs for the analytical methods 
employed. An evaluation of the performance of commercial 
ELISAs when using plasma as a means to identify fish 
containing violative SDM residues is planned but was 
outside the scope of present research goals.
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CHAPTER 6 
SUMMARY AND CONCLUSIONS
The goal of the research presented in preceding 
chapters was to develop the analytical methods and basic 
pharmacokinetic relationships needed for establishing a 
drug residue monitoring and surveillance program for 
sulfadimethoxine residues in channel catfish. The process 
applied and the results obtained may serve as a model for 
monitoring programs for other veterinary drugs used in 
aquaculture. Screening and quantitative analytical 
methods were developed and the relationships between drug 
concentrations in tissue compartments were examined.
An effective residue monitoring program should have 
analytical methods available for use on two levels - in 
regulatory agency laboratories and at the producer level,
i.e. pond-side tests. One of the major weaknesses of 
present residue monitoring programs in general is the 
relative lack of qualitative assays available for use on­
site by the producer or veterinarian. Further, there is a 
lack of rapid and practical drug residue extraction and 
determinative methods available for the analysis of 
veterinary drug residues by regulatory agency 
laboratories.
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On-site qualitative residue detection tests will 
permit pre-marketing identification of individual food 
animals or treatment groups of animals containing 
violative drug residues. Early identification of such 
animals would have a positive impact on ensuring a safe 
food supply and help prevent producer losses resulting 
from carcass condemnation. The US Department of 
Agriculture Food Safety Inspection Service has indicated 
its commitment to developing rapid and practical tests for 
such purposes for use in several food animal species. 
However, initial methods development efforts have involved 
microbial inhibition tests (MIT). Although MITs may be 
suitable in some cases, they are generally not amenable to 
field use.
Because the effectiveness of a residue monitoring 
program begins at the producer level, education of 
aguaculturists in proper drug use, maintenance of 
treatment records, and observation of recommended drug 
withdrawal periods may help prevent the marketing of fish 
with violative drug residues. A problem unique to 
aquaculture, however, is the poikilothermic nature of fish 
and their temperature-dependent elimination rate for 
drugs. In general, for each 1°C decrease in temperature
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there is a corresponding 10% decrease in drug elimination 
rate in fish. Therefore, at low water temperatures, even 
when medications are administered according to label 
instructions and the recommended withdrawal time observed, 
violative drug residues in harvested fish may result. As 
a result, on-site qualitative tests for detection of such 
residues are more urgently needed in aquaculture than in 
some other forms of animal agriculture.
An ideal drug residue screening test for field use is 
one that is rapid, inexpensive, and simple to run; 
requires minimal training and no complex or costly 
equipment; and provides adequate sensitivity, specificity, 
and ruggedness. Such an ideal test would require minimal 
or no sample extraction. Although a variety of methods 
are available for field use, commercially available ELISA 
kits, using a biological fluid as a marker tissue, most 
nearly meet the above needs.
One of the research goals for this dissertation was 
the determination of an appropriate marker residue in a 
biological fluid to indicate drug residue concentration in 
channel catfish muscle. However, a relatively constant 
relationship between drug concentration in the target 
tissue and the reference biological fluid need first be 
demonstrated. Total sulfadimethoxine (SDH) residue in 
plasma was chosen as the marker residue because of the
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relative ease of obtaining plasma samples and the fact 
that all commercially available ELISAs for detection of 
SDM residues were demonstrated to detect parent SDM and 
its primary metabolite, 4-N-acetylsulfadimethoxine (N- 
acetyl SDM), equally well. To determine total SDM 
residues in plasma and muscle, high performance liquid 
chromatographic (LC) methods were developed for both 
matrices for the simultaneous analysis of parent SDM and 
N-acetyl SDM. These LC methods were used to determine 
plasmarmuscle total drug concentration ratios for 
individual fish. From these data, plasma:muscle 
correlations and a 95% confidence interval for 
plasma:muscle ratios of individual fish were calculated.
The excellent correlation obtained over a range of 
concentrations demonstrates that total plasma SDM 
concentration accurately reflects total muscle SDM residue 
in the channel catfish. Thus, the results indicate that, 
with an appropriate dilution factor, plasma may be used in 
an on-site ELISA or other screening assay to identify 
catfish with violative SDM residues. At present, all 
commercially available qualitative ELISAs for SDM have a 
detection cut-off of 10 ng/ml. Therefore, if one uses the 
lower end of the 95% confidence interval for plasma:muscle 
ratios of individual fish (1.2:1 or 120 ng/ml plasma:100 
ng/g muscle) and an assay detection cut-off level of 10
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ng/ml, then plasma diluted by a factor of 1:11 
(plasma:buffer) and analyzed by ELISA should correctly 
identify >95% of fish containing SDM muscle residues at 
tolerance (100 ng/g). Further, an even greater percent of 
fish containing SDM at concentrations well above tolerance 
should be accurately identified using this protocol. This 
could be determined pond-side or plasma analysis used in a 
regulatory laboratory to greatly increase throughput for 
initial screening of samples. The application of this 
protocol to samples containing incurred SDM residues for 
the identification of fish containing violative SDM 
residue by ELISA analysis of plasma is part of the 
continuing research.
LABORATORY ANALYSIS OF RESIDUES
The second part of an effective monitoring program 
involves regulatory laboratory function. The analytical 
needs of a regulatory agency are somewhat different than 
those of the producer. The tiered approach to residue
monitoring requires rapid screening tests for an initial
\
examination of large numbers of samples and more 
definitive analytical methods for quantitation and 
identification of residues in samples identified by 
screening assays. A regulatory laboratory is typically
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presented with animals of unknown treatment history and 
must therefore examine samples for a number of unknown 
compounds. To effectively examine such samples for a 
range of compounds requires the use of rapid screening 
tests.
Animals presented for slaughter and inspection may 
have been treated with approved or non-approved compounds. 
For detection of approved compounds, marker residues are 
often available. As previously discussed, marker residues 
permit the use of a biological fluid for drug residue 
screening. However, for detection of non-approved 
compounds, marker residues are often not well defined. 
Identification of animals containing such residues 
requires an analysis of the target tissue itself.
Screening methods for such tissues are limited, in part, 
by the drug extraction process. Thus, the need for rapid 
and efficient extraction of the drug from the target 
tissue.
The combined use of matrix solid phase dispersion for 
extraction and ELISA for detection allows one to rapidly 
and effectively screen large numbers of muscle samples for 
violative residues in a laboratory setting. Further, the 
use of an ELISA employing the microtiter well format and 
optical density determination allows one to examine a 
number of samples simultaneously rather than serially and
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may provide significant time savings over individual 
testing. Chapter 3 presents the results of efforts to 
develop a rapid muscle extraction method that provides an 
extract compatible with commercially available ELISAs for 
the detection of total SDM residues in channel catfish 
muscle. The results presented offer several rapid 
screening protocols with excellent sensitivity and 
specificity that will permit a regulatory laboratory to 
examine large numbers of catfish muscle samples.
For regulatory enforcement, samples identified by 
screening tests as suspect require more definitive 
quantitation and identification of any drug residue 
present. Quantitation and presumptive identification of 
veterinary drug residues is most commonly accomplished 
using LC with UV or diode array detection. An analytical 
protocol employing matrix solid phase dispersion 
extraction and LC with diode array detection was developed 
here for the simultaneous extraction and determination of 
SDM and N-acetyl SDM as residues in channel catfish 
muscle. The results of this method development effort are 
presented in Chapter 4. This rapid procedure provides 
adequate recovery of the two analytes and accuracy and 
precision acceptable for drug residue analysis about 
tolerance. Demonstration of the applicability of this 
procedure to samples containing incurred SDM residues is
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provided in Chapter 5. This protocol should, therefore, 
be suitable for use by regulatory agencies for 
quantitation and presumptive identification of total SDM 
residues in channel catfish muscle. Further, this LC 
method is potentially suitable for use in other fish 
species, where information on marker residues is lacking, 
for the determination of total SDM residues.
CONCLUSIONS
Protocols were developed and are presented in this 
dissertation for the rapid extraction, screening, and 
determination of sulfadimethoxine residues in channel 
catfish. Protocols are included for field application or 
regulatory laboratory use. From these data it is possible 
to construct a model for a comprehensive tissue residue 
monitoring program for aquaculture but with general 
applicability to any species of food animal. Such a model 
begins with prevention of violative drug residues by 
producer education concerning avoidance of drug residues 
in fish and provides the producer with simple analytical 
methods for detection of violative drug residues under 
field conditions. Included in this model are rapid and 
efficient methods of drug extraction and analysis for use 
by regulatory laboratories. These methods should decrease
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'turnaround tine and increase the number of samples 
analyzed by a regulatory agency laboratory as a result of 
greater efficiency of residue screening and determinative 
protocols. For these reasons, the use of such a model 
should improve the effectiveness of residue monitoring in 
channel catfish and in food animals in general.
With additional study to determine possible species- 
specific matrix effects, these protocols may be extended 
to other cultured fish species in which Romet-30®- 
medicated feeds may be used. Such protocols could 
facilitate compliance with the Extra-Label Drug Use policy 
of the FDA and improve and expand implementation of the 
IR-4 initiative for drug approval in minor species such as 
fish. A major concern with these two programs is the 
possibility of illegal residues resulting from limited 
data relating to drug depletion times and metabolite 
profiles in non-approved species and with non-approved 
uses. As a result, the IR-4 initiative generally requires 
a procedure for assuring that animals marketed following 
experimental drug use contain no residues. A testing 
protocol such as the one provided here offers a reasonable 
assurance that such fish are free of unwanted residues and 
may facilitate attainment of the IR-4 goal of increasing 
the availability of medications for use in minor species. 
Further, the process and results offered may serve as a
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new approach for the development of a national aquaculture 
products drug residue monitoring program.
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APPENDIX A
OPTICAL DENSITY VALUES OBTAINED WITH 
THE IDS SULFADIMETHOXINE ONE-STEP ELISA*
Sample # OD Well A OD Well B Mean OD Mean
______________________________________________ Blank/Sample
0 nq SDM/q
1 0.817 0.822 0.820 1.000
6 1.211 1.162 1.187 1.000
11 1.401 1.352 1.377 1.000
16 0.962 0.952 0.957 1.000
21 1.304 1.150 1.227 1.000
26 0.928 0.913 0.921 1.000
31 1.197 1.164 1.181 1.000
36 0.887 0.993 0.940 1.000
41 1.084 0.956 1.020 1.000
46 1.025 1.210 1.118 1.000
51 1.096 1.019 1.058 1.000
56 0.966 0.964 0.965 1.000
Mean 1.064 1.000
Standard Deviation 0.158 0.000
CV f%)f=inter-assav variation) 14.9% 0.0%
25 na SDM/a
2 0.664 0.613 0.639 0.779
7 0.920 0.948 0.934 0.787
12 0.937 1.010 0.974 0.707
17 0.652 0.705 0.679 0.709
22 0.703 0.687 0.695 0.566
27 0.617 0.757 0.687 0.746
32 0.735 0.796 0.766 0.648
37 0.595 0.650 0.623 0.662
42 0.540 0.655 0.598 0.586
47 0.693 0.814 0.754 0.674
52 0.737 0.740 0.739 0.698
57 0.683 0.640 0.662 0.685
Mean 0.729 0.687
Standard Deviation 0.117 0.067
CV (%)f=inter-assav variation) 16.1% 9.8%* using matrix solid phase dispersion extracts of
fortified catfish muscle; 10 minute incubation
OD Optical Density
IDS International Diagnostics Systems, Inc.
SDM sulfadimethoxine 
appendix con'd. 239
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Sample # OD Hell A OD Hell B Mean OD Mean
Blank/Sample
50 nq SDM/q
3 0.516 0.452 0.484 0.591
8 0.528 0.588 0.558 0.470
13 0.688 0.762 0.725 0.527
18 0.571 0.584 0.578 0.603
23 0.588 0.546 0.567 0.462
28 0.525 0.517 0.521 0.566
33 0.555 0.586 0.571 0.483
38 0.549 0.538 0.544 0.578
43 0.394 0.450 0.422 0.414
48 0.510 0.610 0.560 0.501
53 0.594 0.612 0.603 0.570
58 0.516 0.455 0.486 0.503
Mean 0.551 0.522
Standard Deviation 0.074 0.060
CV f%)(=inter-assav variation) 13.5% 11.4%
100 ncr SDM/a
4 0.356 0.236 0.296 0.361
9 0.504 0.534 0.519 0.437
14 0.358 0.418 0.388 0.282
19 0.309 0.379 0.344 0.359
24 0.224 0.188 0.206 0.168
29 0.307 0.289 0.298 0.324
34 0.375 0.366 0.371 0.314
39 0.346 0.370 0.358 0.381
44 0.240 0.253 0.247 0.242
49 0.330 0.344 0.337 0.302
54 0.344 0.317 0.331 0.313
59 0.319 0.272 0.296 0.306
Mean 0.332 0.316
Standard Deviation 0.078 0.069
CV f%)(=inter-assav variation) 23.5% 21.8%* 10 minute incubation time
OD Optical Density
IDS International Diagnostics Systems, Inc.
SDM sulfadimethoxine
appendix con'd.
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Sample # OD Well A OD Well B Mean OD Mean
Blank/Sample
250 nq SDM/q
5 .142 .146 .144 .176
10 .288 .317 .303 .255
15 .252 .275 .264 .191
20 .164 .184 .174 .182
25 .318 .315 .317 .258
30 .159 .153 .156 .169
35 .190 .210 .200 .169
40 .201 .258 .230 .244
45 .133 .124 .129 .126
50 .176 .175 .176 .157
55 .160 .160 .160 .151
60 .143 .152 .148 .153
Mean 0.200 0.186
Standard Deviation 0.064 0.043
CV f%W=inter-assav variation) 31.9% 23.4%
* 10 minute incubation time
OD Optical Density
IDS International Diagnostics Systems, Inc. 
SDH sulfadimethoxine
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APPENDIX B
OPTICAL DENSITY VALUES OBTAINED WITH 
THE SIGNAL SULFAMETHAZINE ELISA*
Sample t OD Well A OD Well B Mean OD Mean
Blank/Sample
0 na SDM/a
1 1.635 1.538 1.587 1.000
6 1.329 1.296 1.313 1.000
11 1.210 1.217 1.214 1.000
16 1.340 1.442 1.391 1.000
21 1.921 1.629 1.775 1.000
26 1.876 1.771 1.824 1.000
31 1.777 1.904 1.841 1.000
36 1.744 1.821 1.783 1.000
41 1.956 1.872 1.914 1.000
46 1.584 1.718 1.651 1.000
51 1.612 1.532 1.572 1.000
56 1.709 1.692 1.701 1.000
Mean 1.630 1.000
Standard Deviation 0.223 0.000
CV (%)(=inter-assay variation) 13.7% 0.0%
25 na SDM /a
2 1.483 1.176 1.330 0.838
7 1.114 1.144 1.129 0.860
12 1.305 1.141 1.223 1.008
17 1.187 1.186 1.187 0.853
22 1.696 1.638 1.667 0.939
27 1.630 1.579 1.605 0.880
32 1.670 1.602 1.636 0.889
37 1.573 1.548 1.561 0.875
42 1.682 1.T27 1.705 0.891
47 1.446 1.499 1.473 0.892
52 1.286 1.293 1.290 0.820
57 1.373 1.380 1.377 0.809
Mean 1.432 0.880
Standard Deviation 0.202 0.054
CV (%)(=inter-assav variation) 14.1% 6.1%
* using matrix solid phase dispersion extracts
fortified catfish muscle; 30 minute incubation 
OD Optical Density 
SDH sulfadimethoxine
appendix con'd. 242
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Sample # OD Well A OD Well B Mean OD Mean
Blank/Sample
50 nq SDM/q
3 1.218 1.119 1.169 0.737
8 1.003 1.067 1.035 0.789
13 1.100 1.043 1.072 0.883
18 1.293 1.190 1.242 0.893
23 1.553 1.515 1.534 0.864
28 1.592 1.517 1.555 0.852
33 1.473 1.477 1.475 0.801
38 1.475 1.442 1.459 0.818
43 1.534 1.506 1.520 0.794
48 1.359 1.350 1.355 0.820
53 1.211 1.282 1.247 0.793
58 1.275 1.397 1.336 0.786
Mean 1.333 0.819
Standard Deviation 0.181 0.046
CV (%)(=inter-assav variation) 13.6% 5.6%
100 nq SPM/q
4 1.296 0.896 1.096 0.691
9 0.885 0.926 0.906 0.690
14 0.953 0.885 0.919 0.757
19 0.971 0.900 0.936 0.673
24 1.247 1.193 1.220 0.687
29 1.206 1.209 1.208 0.662
34 1.035 1.013 1.024 0.556
39 1.268 0.997 1.133 0.635
44 1.263 1.288 1.276 0.666
49 1.183 1.138 1.161 0.703
54 0.825 0.887 0.856 0.545
59 1.001 1.068 1.035 0.608
Mean 1.064 0.656
Standard Deviation 0.139 0.061
CV (%)f=inter-assav variation) 13.1% 9.3%
* 30 minute incubation time
OD Optical Density 
SDM sulfadimethoxine
appendix con'd.
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Sample # OD Well A OD Well B Mean OD Mean
Blank/Sample
250 ppb
5 0.742 0.665 0.704 0.443
10 0.748 0.761 0.755 0.575
15 0.794 0.749 0.772 0.636
20 0.682 0.698 0.690 0.496
25 0.968 1.016 0.992 0.559
30 1.010 1.052 1.031 0.565
35 1.200 1.248 1.224 0.665
40 1.007 0.960 0.984 0.552
45 1.011 1.038 1.025 0.535
50 0.888 0.921 0.905 0.548
55 0.839 0.820 0.830 0.528
60 0.844 0.943 0.894 0.525
Mean 0.900 0.552
Standard Deviation 0.159 0.058
CV f%>f=inter-assav variation) 17.7% 10.5%
* 30 minute incubation time
OD Optical Density 
SDM sulfadimethoxine
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